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ABSTRACT 
 
 
The Internet is a powerful and very popular vehicle for distributing judgment-free 
health information to patients. Multiple studies have examined the role of online health 
information as well as physician-rating websites in health care. Studies have examined 
the value of online drug information for patients and the value of the online drug 
information for patients. However, no study has examined the usefulness or value of 
online medication rating websites in facilitating physician-patient communication or 
participant-reported outcomes. In this study, the value of online medication rating 
websites to older adults in facilitating communication with their physicians using a newly 
developed tool was assessed. Additionally, the participant-reported outcomes of quality 
of life, satisfaction with physician communication, beliefs about medications, and 
medication adherence plus the relationship between the older adults’ actual ratings of 
their antihypertensive medications and their self-reported outcomes were examined. 
 
Older adults with poor quality of life were more likely to view the online medication 
rating websites more favorably than participants who enjoy good quality of life. 
Participants who liked to share health decisions with their physicians were also more 
likely to have favorable views of the online websites. In addition, older adults with 
hypertension, who highly rated their antihypertensive medication regimens, were more 
likely to have good physical quality of life, high satisfaction with physician 
communication, positive beliefs about medications, and high medication adherence. 
Older adults with poor quality of life were more likely to be unsatisfied with their 
antihypertensive medications, have multiple comorbidities, limited health literacy, low 
satisfaction with their communication with their physicians, take multiple medications, 
and were more likely to view online medication rating websites favorably compared to 
their counterparts with good quality of life. Online medication rating websites may play 
an important role in enhancing physician-patient communication particularly among this 
segment of the patient population.  
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CHAPTER 1.    INTRODUCTION 
 
 
1.1 Background 
 
As people age they become more prone to diseases in general and to the chronic 
health conditions (i.e., diabetes, hypertension, and osteoporosis) in particular. Thus, 
chronic diseases are more prevalent among this segment of the population. Further, an 
ever-greater proportion of this population survives with multiple health conditions. 
Hence, older adults take a greater number of prescription medications than any other 
segments of the population. This makes them more susceptible to adverse drug events 
given their diminished physiological reserve (Wasson, 2008). In addition, many studies 
have shown a correlation between increasing age and higher adverse drug events (ADEs) 
rate. Besides the frailty of the elderly, which makes them more predisposed to the side 
effects of the medications, they are usually on multiple prescription medications. Taking 
multiple medications increases the likelihood of developing adverse drug reactions or 
interactions since the toxicity of any medication can be potentiated by another medication 
in the patient’s medication list (i.e., by inhibiting or inducing its metabolism). Therefore, 
effective communication between the physicians and their patients can address some of 
these issues by changing or removing certain medications from their medication lists, and  
by adopting a holistic approach in managing the elderly patients’ health conditions rather 
than treating each condition separate from the other (Routledge, O'Mahony, & 
Woodhouse, 2004).  
 
Generally speaking, patients want their physicians to inform them about their health 
conditions, the treatment options, as well as the safety profile and cost of each medication 
if pharmacological options were chosen (Nair et al., 2002). The patients’ desire to learn 
about their health conditions, and the available treatment options, suggests they want to 
participate in the prescribing decision with their physicians. Involving the patients in the 
prescribing decision-making process after providing them with needed information about 
treatment options could result in improved patient treatment experience and satisfaction. 
It also may result in improved treatment outcomes (Bond, Blenkinsopp, & Raynor, 2012). 
This partnership between patients and their physicians regarding the prescribing decision 
is even more important among the elderly. Since the elderly are mostly excluded from the 
randomized clinical trials that investigate the benefits of preventive medications. These 
medications are usually prescribed to treat different chronic diseases, such as 
hypercholesterolemia and hypertension, that are prevalent among the elderly population 
(Garattini & Chalmers, 2009; Wasson, 2008). Thus, they fail to address important aspects 
of drug use from the patients’ perspective (i.e., side effects, drug-food interactions, 
medication costs, drug-drug interactions).  
 
Many patients seek information about different drugs that they are taking or will 
probably be taking in the future from multiple sources including the Internet. Further, 
studies that assessed the quality of medication prescribing among the ambulatory elderly 
patients, have indicated many of the prescribed medications were considered 
inappropriate (Goulding, 2004; Schmader, Hanlon, Weinberger, & Landsman, 1994). 
 2 
Although medication prescribing appropriateness was assessed among the elderly in 
several studies, the patients’ perspective regarding their medications was not taken into 
account (Goulding, 2004; Spinewine et al., 2007). Exploring elderly patients’ opinions 
about their prescription medications can be useful to explain the variation in the 
medication utilization and adherence among this important segment of the population. 
This can be attained by asking the patients’ about their level of satisfaction with regard to 
important aspects of medication use (i.e., effectiveness, side effects, ease of use, cost, and 
drug interactions), and substantiates the need to engage the elderly patients in prescribing 
decisions. 
 
Today, many federal and private health institutions provide online educational 
information about different medical conditions and their treatments (i.e., Centers for 
Disease Control and Prevention, MedlinePlus, Mayoclinic®). However, the information 
presented on these websites about the different treatments whether invasive (i.e., surgery) 
or non-invasive (i.e., pharmacological) are merely the same information provided in the 
medications’ leaflets in layman’s terms. In an era of empowered consumers, many 
websites provide the feedback of consumers about different products and services. 
Hence, patients in multiple online websites evaluate medications and services provided 
by medical professionals. This gives the patients who are looking for physicians in 
special practice areas, or are likely to be on a certain medication, the opportunity to view 
the evaluations and the overall ratings by other patients who had already seen those 
physicians or are/were on that medication. The factors that influence the patients’ 
opinions of the content and value of these websites have not been investigated. Although 
patients with higher socioeconomic status might have a favorable opinion of these 
websites, other factors might also influence patient perception. For instance, patients’ 
quality of life (QOL), a subjective and overarching concept involving multiple 
dimensions of the patient’s life could potentially influence the opinion and value of such 
websites. Further, in an era of patient-centered care that entails effective communication 
between the physicians and their clients (patients), it is worthwhile to examine the 
significance of the relationship between patients’ satisfaction with their physicians’ 
communication style and their opinion of such website. Websites browsing may 
encourage and facilitate the patients’ engagement in effective dialogs with their 
physicians. Patients’ beliefs about medications could also affect the value of such 
websites to patients, since it was found to influence patients’ adherence to their 
medications (Horne & Weinman, 1999). 
 
This study examined the relationship between the older adults’ views of online 
medication rating websites (i.e., Askapatient.com®, Drugs.com®) and: 
 
1. Important aspects of patient-centered care (i.e. attentive listening, quality 
of conversation, respect, and friendliness). 
2. Older adults’ quality of life from both the physical and mental 
perspectives. 
3. Older adults’ beliefs about medications in general.  
4. Older adults’ adherence to antihypertensive medications.  
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1.1.1 Online Health Rating Websites 
 
The implementation of public reporting systems in the United States (U.S.) in the 
1980s was mainly driven by the need to improve the quality of care provided by 
healthcare organizations. These systems generate reports that compare the quality of care 
provided by different healthcare practitioners. The New York State Cardiac Surgery 
Reporting System (CSRS), Nursing Home Compare, and the German Kinikfuhrer Rhein-
Ruhr are examples of such systems (Emmert, Meier, Pisch, & Sander, 2013; Mukamel & 
Mushlin, 1998; Mukamel, Weimer, Zwanziger, Gorthy, & Mushlin, 2004; Stevenson, 
2006). These systems play a very important role in informing the patients, physicians, 
and health policy makers about the quality of care of multiple health institutions and 
healthcare providers. Further, these reports intend to encourage patients to participate in 
their own care by making informed choices about their healthcare providers, health plans 
and services (Faber, Bosch, Wollersheim, Leatherman, & Grol, 2009).  
 
Based on the Public Reporting theory, it is generally assumed that patients make an 
effort to learn about a product, such as a medication, before buying it. This applies to 
patients who usually search for healthcare services with good quality such as health 
insurance plans, physicians, and medications (Emmert, Sander, & Pisch, 2013). The 
advent of the Internet provides a great opportunity for health activists and non-profit 
consumer protection organizations to design and create information rich websites. These 
websites contain a wealth of information about a variety of products including healthcare 
services that customers can utilize to make informed choices (Chen & Xie, 2008; Longo 
et al., 1997). Nonetheless, these websites along with the public reports provide quality of 
care evaluation and comparisons across different health institutions and physicians based 
on clinical and scientific criteria and not from patients’ perspective (Emmert, Sander, et 
al., 2013). 
 
Websites that evaluate physicians and services from patients’ perspective are 
ubiquitous in the Internet. Physicians’ rating websites (i.e., RateMDs®, Healthgrades®) 
are examples that have gained popularity among patients who look for physicians with 
positive feedbacks from patients. These websites convey important information to both 
physicians and patients alike. Patients can easily search for specific physicians near their 
residence with the highest rating. Further, physicians can read patients’ reviews and 
comments about their practices, and try to improve the quality of provided care (Tara 
Lagu , Hannon, Rothberg, & Lindenauer, 2010). However, critics of such websites list 
several limitations. First, they do not include all practicing physicians in their databases; 
merely including 30% of them at best (Emmert, Maryschok, Eisenreich, & Schöffski, 
2009). Secondly, most physician rating websites rely only on few patient reviews with 
few physicians rated by more than five patients (Mostaghimi, Crotty, & Landon, 2010). 
Thirdly, only a few use validated criteria to evaluate physicians (Reimann & Strech, 
2010). Fourth, male physicians, those with board certifications and certain subspecialties 
(i.e., primary care, obstetrics and gynecology) are more likely to be rated than other 
specialties such as general surgery (Black, Thompson, Saliba, Dawson, & Paradise Black, 
2009) and physicians with malpractice claims are likely to be evaluated and rated 
negatively (Segal, 2009). Fifth, most contain positive reviews of the listed physicians and 
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rarely contain negative feedbacks of the rated physicians (Kadry, Chu, Kadry, Gammas, 
& Macario, 2011). This raises the question of the validity of such reviews since they are 
provided by anonymous people and the possibility of fraud cannot be excluded (i.e., some 
physicians can write positive reviews of themselves). Sixth, many physicians question the 
ability of patients to make sound judgment of their physicians’ quality of care. Most 
patients according to some physicians are not knowledgeable about the clinical skills 
needed to evaluate the quality of the provided care (Emmert, Sander, Esslinger, 
Maryschok, & Schöffski, 2012). Taken together, this limits the usefulness of such 
websites (Emmert, Sander, et al., 2013). However, proponents see in such websites that 
evaluate not only physicians, but also other healthcare services and products (i.e., 
psychologists, prescription medications, over-the-counter medications and herbal 
products) an opportunity to understand patients’ views and preferences. Further, their 
availability may offer a channel for patients to express their opinions in an anonymous 
and confidential way about the quality of the received care (Trigg, 2011).  
 
Although these websites have several shortcomings and limitations, they can be 
addressed by taking measures to improve their content and value. For example, a 
minimum number of ratings/reviews for any physician or product should be determined. 
Further, the reviews should cover several aspects of care (i.e., satisfaction with the 
overall care, description of the physicians’ communication style). In addition, websites 
should run security checks to protect reviewers’ privacy. Finally, validated quality 
standards should be followed and word filters should be applied to prevent vulgar words 
or defamation from being posted (Emmert, Sander, et al., 2013; Segal, 2009). 
 
 
1.1.2 Medication Rating Websites 
 
Medication rating websites are newly emerged online websites, which have not been 
researched or reported in the literature before. The information presented on these 
websites are variable and contingent upon the sponsors as well as the affiliations. For 
example, the National Library of Medicine provides a useful website 
(www.ncbi.nlm.nih.gov/pubmedhealth/) about different medications in terms of their 
routes of administration, dosage forms, indications, brand names, side effects, as well as 
warnings about drug-drug and drug-food interactions. Further, the major chain 
pharmacies in the United States (U.S.) like Walgreens® (www.walgreens.com) and 
CVS® (es.cvs.com/drug/overview) provide useful and valid online information about 
multiple prescription and over-the-counter (OTC) medications to patients with respect to 
several aspects of medication use (i.e., indications, dosages, dosage forms, side effects, 
and food and drug interactions). Some health insurance plan websites, such as Cigna® 
(www.cigna.com), also offer valid information about different prescription medications 
to their enrollees. Although, providing valid and detailed information in layman’s terms 
to patients about different medications, they lack, with few exceptions, patient reviews of 
the medications. Therefore, several independent websites have recently emerged on the 
Internet offering patients the opportunity to rate their medications as well as to view the 
opinions of other patients about different medications.  
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Most of these rely heavily on commercial advertisements, and vary in their content 
and layout. This can be ascribable to the website administrators or authors, as some are 
operated by healthcare practitioners or by professional editorial staff, while consumer-
reporting agencies manage others. The WebMD® (www.webmd.com) and Drugs.com® 
(www.drugs.com) are well-known examples of the professionally operated websites that 
include updated scientific information in both layman’s and medical terms about the 
medications and the health conditions they are prescribed for. Also included are reviews 
and comparisons of different medications prescribed for similar health conditions by 
patients in terms of their effectiveness, side effects and patients’ satisfaction. Patients can 
rate their medications on a scale from one to five where one means dissatisfied and five 
means highly satisfied. Further, they include the prices as well as coupons and patient 
assistance programs for prescription medications that patients can refer to in case they are 
needed. In addition, some websites include support groups, where patients can ask 
questions related to a particular medication that will be answered by a medical expert. On 
the other hand, websites like DrugRatingZ® (www.drugratingz.com) and AskaPatient® 
(www.askapatient.com) are operated by consumer reporting agencies that merely include 
patients’ reviews and ratings of different prescription medications with regard to their 
effectiveness, convenience, side effects, and overall value. The main mission of these 
websites is to convey to physicians, pharmaceutical industry, and other patients the 
opinions of the websites users. However, these websites have limitations similar to the 
physicians rating websites. As with the physicians rating websites, these do not include 
important information about the reviewers such as sociodemographics, health conditions, 
number of medications, and prescriber specialties. These issues need to be addressed to 
improve their value to patients. Overall, medication-rating websites may empower 
patients to become more engaged in their health care. 
 
 
1.1.3 Why Geriatric Population? 
 
The growth of the older adult population in the U.S. over the next 50 years is 
expected to have a tremendous impact on the health care system. The number of older 
adults is projected to reach 55 million by 2020 as baby boomers age (McGinnis, March 
2006). According to the Administration on Aging (AoA), the older population (≥65 
years) represented 12.9% in 2009, and is expected to reach 19% in 2030 (Administration 
on Aging). In addition, more than 90% of older adults have at least one chronic medical 
condition, and 77% have multiple chronic conditions. Chronic diseases such hypertension 
and diabetes account for 75% of the total U.S. health care expenditure (Schwartz, 2011). 
The average number of office visits for older adults in 2012 according to the AoA is 7.1; 
which is twice that for adults between 45 and 65 years of age (U.S. Administration on 
Aging (AOA), 2012). Further, although seniors (≥65 years) do not represent more than 
13% of the US population; they consume approximately 34% of the total number of 
prescriptions per year (Control, 2004). This makes their utilization of the healthcare 
services higher than any other segments of the population. However, older adults are 
underrepresented in clinical trials and observational studies as well as in the clinical 
practice guidelines since they are mostly presented with multiple comorbidities that entail 
different treatment guidelines (Boult C, 2010; Boyd et al., 2005; Konrat et al., 2012; 
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Lugtenberg, Burgers, Clancy, Westert, & Schneider, 2011). The current elderly 
population is more diverse than a decade ago and is likely to be even more diverse in the 
next decades. It is projected that older adults of the minority population will increase by 
217% by 2030 compared with 81% for Caucasian population (Administration on Aging, 
2013). 
 
The fact that many older adults are heterogeneous with regard to socio-demographics, 
medical conditions, severity of illness, personal experiences and preferences, and their 
quality of life demands flexible approaches in caring for this segment of the population. 
In addition, since many of the older adults with multiple comorbidities are on multiple 
medications to keep their chronic illnesses under control, they face “preference sensitive” 
decisions when their physicians decide to put them on a different medication or add 
another one. This comes as a result of their increased awareness of the adverse events as 
well as the possible drug interactions when a new medication is introduced in their 
medication lists (American Geriatrics Society Expert Panel on the Care of Older Adults 
with Multimorbidity, 2012). Further, the challenging task that faces almost every patient 
in general and particularly the elderly, is the adherence to their prescription medications. 
Medication adherence is more challenging for older adults compared to the younger 
populations due to their tendency to forget as well as their long medications lists (E. J. 
MacLaughlin et al., 2005). Thus, empowering elderly patients should be one of the 
utmost priorities of any physicians in general, and the primary care providers in particular 
since they are the gatekeepers in any successful health care system (American Geriatrics 
Society: American Geriatrics Society Expert Panel on the Care of Older Adults with 
Multimorbidity, 2012). The patients’ empowerment would hopefully make the elderly 
patients feel that they are involved in their own care since their participation is pivotal in 
the success of any disease management plan (Schwartz, 2011). 
 
 
1.1.4 Physicians’ Communication and Interpersonal Skills  
 
As the practice of medicine evolved over time, physicians felt that the success of any 
disease management plan depends on the patients themselves. Thus, a new principle in 
health care known as patient autonomy and patient-centered clinical practice was ushered 
in (Chin, 2002; Rodriguez-Osorio & Dominguez-Cherit, 2008). This necessitates that the 
current and future physicians be equipped with new skills that enable them to address the 
needs of the patients in general and the elderly in particular since elderly patients are 
usually presenting with multiple health conditions. Hence, many physicians have started 
adopting a patient centered practice model instead of the traditional paternalistic practice 
model that prevailed for decades (R. Baker, 1999; American Geriatrics Society Expert 
Panel on the Care of Older Adults with Multimorbidity, 2012). This model takes into 
consideration the patients’ experiences and insights that are believed to be relevant in the 
medical decision-making process (Charles, Gafni, & Whelan, 1997). Understanding the 
patients’ needs and concerns will likely have a positive impact on both the clinical 
outcomes as well as on the participant-reported outcomes (PROs) (Falkum & Førde, 
2001; Roumie et al., 2011).  
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Elderly patients are not different from any other segment of the patient population in 
their desire to be involved in their own care. However, elderly patients are heterogeneous 
in their medical and personal characteristics. Further, their definition of involvement is 
different from the younger patient population who tend to participate more in the decision 
making process (Coulter, Parsons, & Askham, 2008). The elderly patients’ definition is 
more centered on “receiving information”, “patient-centered approach”, and “caring 
relationship” (Bastiaens, Van Royen, Pavlic, Raposo, & Baker, 2007). Therefore, 
physicians need to have effective communication techniques in order to initiate 
constructive dialogs with their patients that enable them to elicit the patients’ concerns 
and needs. Skills like attentive listening, speaking slowly, providing simplified medical 
information, being empathic, and making informed decision based on patients’ needs and 
preferences are all important attributes of effective communication that physicians should 
possess (Duffy, Gordon, Whelan, Cole-Kelly, & Frankel, 2004; Travaline, Ruchinskas, & 
D'Alonzo, 2005). Effective communication and interpersonal treatment are integral in 
any therapeutic treatment plan, since it does not only address the physical aspect of the 
disease, but also addresses the psychological aspect of it (Travaline et al., 2005). Further, 
evidence suggests that effective patient-physician communication is correlated with 
improved patient health outcomes, lower health-related costs, reduction in the number of 
emergency department visits, improvement in the quality of life, medication adherence, 
and higher patient satisfaction (Stewart, 1995; Travaline et al., 2005).  
 
However, in the real world many physicians are ineffective communicators, putting 
more pressure on patients to initiate constructive dialogs with their physicians that will 
ultimately serve both providers and patients. Thus, patients’ empowerment tools such as 
educational television (TV) programs, public awareness programs, online patients’ 
educational websites (i.e., Medline®), and even TV and online drugs ads may encourage 
patients to discuss with their physicians the signs and symptoms of certain medical 
conditions they may have as well as exploring possible treatment options (Jacob, 2002; 
Van Woerkum, 2003). The advent of the Internet has revolutionized the provision of 
health information to the public. Today, patients can surf it and find hundreds if not 
thousands of health education websites that provide a wealth of information about almost 
any known disease. However, little is known about the value of such websites to patients 
in general and to elderly patients in particular in improving the patient-physician 
communication. Such websites may empower elderly patients who usually play a passive 
role when communicating with their physicians.  
 
 
1.1.5 Patients’ Quality of Life 
 
Patients’ health-related quality of life (HRQoL) is one of the patient-reported 
outcome measures (PROMs). Unlike the clinician-reported outcomes (ClinROs) that 
measure the effectiveness of the treatment (i.e. Hb1Ac, BP), the PROMs are mostly self-
completed questionnaires, which can be completed by the patients themselves or by 
others on their behalf in structured  interviews (Meadows, 2011). Quality of life (Qol) is a 
subjective multidimensional concept that involves several domains of life and assesses 
the impact of a treatment intervention, health conditions or employment status on the 
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individual’s life from their perspective. The physical, material, social, productive, 
emotional and civic well-being are the main domains of life that fall under the quality of 
life umbrella (Felce, 1997). This concept can also be concisely defined as “the 
satisfaction of an individual’s values, goals and needs through the actualization of their 
abilities or lifestyle” (Emerson, 1985, p. 282). Hence, personal satisfaction, life 
conditions, and quality of life are inseparably intertwined concepts (Felce & Perry, 1995). 
 
The quality of life is variably defined across and within different groups of the 
population. For instance, the elderly people describe their quality of life differently 
compared to younger individuals. Multiple factors lead to this variation in the elderly’s 
definition of this subjective concept. As people age, they face several physical and 
emotional limitations making their life experience very different. Further, due to the 
subjectivity of the quality of life concept, elderly people differ in their opinions of their 
quality of life even if their health and socioeconomic status are similar. Thus, some 
elderly people describe their lives as full of joy and happiness, whereas others feel their 
lives are depressing and miserable. The variability in describing quality of life among the 
elderly can be ascribable to the way elderly people interpret their losses, personality type, 
sets of belief, stress coping strategies, strength of family and social networks, economic 
status, health conditions, and functional ability (Wilhelmson, Andersson, Waern, & 
Allebeck, 2005; Xavier, Ferraz, Marc, Escosteguy, & Moriguchi, 2003). 
 
Besides the subjective and objective factors considered as determinants of the 
individual’s quality of life, other factors might also shape a person’s perception of their 
quality of life. In an era of high technology, the Internet transformed many parts of our 
lives including the way we communicate with each other (i.e. Email, Facebook®, and 
Twitter®). The U.S. is one of the top countries in the world in terms of the number of the 
subscribers to Internet services, with a percentage over 70% (Stats, 2012). This was 
found to have a significant impact on quality of life (Albarran & Goff, 2000; Cairncross, 
2001; DiMaggio, Hargittai, Neuman, & Robinson, 2001). People with weak social ties 
and poor communication skills as well as the elderly can expand their acquaintances and 
gain a wealth of knowledge through online connection. Further, the use of online forums, 
counseling, and news can enhance self-sufficiency, psychological empowerment, and 
rehabilitation (Leung, 2010). Also, Internet use among older adults is associated with 
lower perceived life stress, improved psychological well-being, self-confidence, and 
higher personal satisfaction with social relations including family members and friends 
(Leung, 2010; Liang, 2011). 
 
Today, many patients turn to the Internet to share their illness experiences with their 
illnesses with other patients through self-created personal blogs. Others use certain 
websites that facilitate communication with other patients who have the same health 
conditions. Such websites help reduce the feeling of depression and loneliness among 
patients in general and those with serious health conditions in particular (Klemm et al., 
2003). However, little is known about the recently developed websites that ask patients to 
evaluate and rate their physicians or their treatment regimens and whether they have any 
impact on their personal quality of life. 
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Finally, although several studies have investigated the effects of the Internet on the 
people’s quality of life, studies that examined the effect of the Internet services on the 
quality of life are rare (Liang, 2011). 
 
 
1.1.6 Patients’ Beliefs about Medications 
 
People vary in their beliefs about medications. Some have negative views of 
medications in general regardless of their origin. However, others have positive views of 
alternative medicine (i.e. medications from natural origins) and not of western medicine 
(i.e. prescription medications). Their views and beliefs about medications are influenced 
by multiple factors such as age, gender, race, cultural background, and experience with 
taking prescribed medications (Horne et al., 2004). For instance, Asians are more likely 
to believe in herbal medicine effectiveness in treating most of the common diseases 
compared to people from European descent. 
 
The importance of the patients’ beliefs about medications stems from the fact that the 
success of any disease management plan depends largely on the level of patients’ 
adherence to their treatment regimens. Medications’ adherence is significantly associated 
with medication beliefs. Thus, patients with negative views about medications were more 
likely to report low adherence levels to their medication regimens compared to those with 
positive views (Gatti, Jacobson, Gazmararian, Schmotzer, & Kripalani, 2009). Further, 
research has shown that medication beliefs are more powerful predictors of patient-
reported medication adherence than clinical and sociodemographic factors (Horne & 
Weinman, 1999). Medication beliefs affect patients’ adherence to medications prescribed 
for many acute and chronic illnesses. Asthmatic, the renally compromised, oncology, and 
cardiac patients are some of patient subpopulations in which medication beliefs were 
found to affect patient adherence to prescribed medication regimens (Conn, Halterman, 
Lynch, & Cabana, 2007; Horne & Weinman, 1999). Patients tend to be more adherent to 
their prescribed medication regimens when the perceived necessity of these medications 
exceeds their perceived harmfulness (Aikens, Nease, Nau, Klinkman, & Schwenk, 2005). 
Further, those with multiple comorbidities and functional limitations are more likely to 
believe that the benefits of taking medications to manage their health conditions outweigh 
their risks (Schüz et al., 2011). Older adults are more likely to have chronic health 
conditions as well as more physical limitations than their younger counterparts are. 
Therefore, older age was significantly associated with positive beliefs about medications 
(Aikens, Nease, & Klinkman, 2008). 
 
Another important factor that influences patients’ beliefs about medications is the 
physicians’ communication style. Patients who were satisfied about their physician’s 
communication style held positive views about their own medication regimens and were 
more likely to be seen by their physicians for a follow-up visit (Bultman & Svarstad, 
2000). Although age, culture, health conditions, and physicians’ communication style 
have shown to impact patients’ beliefs about medications, the impact of other important 
factors on medication beliefs have not been investigated yet. For example, in an era 
where patients can access an immense amount of health information with the click of a 
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mouse, no one knows if the information encountered online would change their beliefs 
about medications. Further, it is also unknown if the online-posted reviews and ratings of 
medications by patients would influence the physician-patient communication style of 
those who browsed such websites. 
 
 
1.1.7 Medication Adherence 
 
The prescribing of medications is the most common and effective healthcare 
intervention. However, even though most of the prescription medications are effective in 
managing many health conditions, 30-50% of these medications are not taken as 
recommended (Banning, 2009). Medication adherence is a complex and interesting 
psycho-behavioral issue which has been defined as “the extent to which the patients’ 
behavior matches agreed recommendations for the prescriber” (Horne, 2005, p.27). 
Multiple factors can influence patient adherence. Patients’ cultural background, social 
support, medical status, age, gender, and beliefs about illnesses and medications are some 
of these factors that might influence patient’s adherence to prescription medications 
(Banning, 2009; Horne & Weinman, 1999). Health and medication beliefs are considered 
one of the strongest predictors of medication adherence among patients in general and 
those on chronic or multiple medications in particular (Phatak & Thomas, 2006). 
Therefore, understanding patients’ beliefs about health and medications is of paramount 
significance to address medication non-adherence. Further, low patients’ satisfaction with 
their treatment has a negative impact on their adherence to prescription medications 
(Sa’ed, Al-Jabi, Sweileh, & Morisky, 2013). In addition, low patients’ health-related 
quality of life is another barrier to achieving high medication adherence (Holt, Muntner, 
Joyce, Webber, & Krousel-Wood, 2010).  
 
Although medication non-adherence is prevalent among multiple patient populations, 
it is an increasing problem among older adults. This can mainly be attributable to 
multiple comorbidities that elderly patients usually suffer from as well as the complexity 
of their medication regimens. Further, the declining cognitive abilities, dexterity 
problems, poor physician-patient communication, and high risk of adverse drug events 
are additional factors that can lead to non-adherence and are common among elderly 
patients (Macías-Núñez et al., 2008). Thus, the elderly patients are at higher risk of 
adverse drug events, medication mismanagement, and poor health outcomes. This is 
particularly true in older adults with chronic health conditions such as hypertension and 
diabetes that require long-term management (Banning, 2009). For example, it was 
estimated that 10% of the unplanned admissions among older adults were related to 
adverse drug events (Pearson, Skelly, Wileman, & Masud, 2002). Therefore, managing 
poor medication adherence among the elderly patients requires good communication 
between the patients and their physicians. Physicians need to form a therapeutic alliance 
with their patients whereby patients can share their concerns and beliefs about 
medications as well as their treatment preferences (Pound et al., 2005). Unfortunately, 
physicians tend to spend less time with the elderly patients despite the fact that they 
require additional time for giving and receiving information (Radecki, Kane, Solomon, 
Mendenhall, & Beck, 1988). Hence, older adults should be empowered to start 
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constructive conversations with their physicians where they can express their needs and 
concerns about the prescription medications as well as their preferences.  
 
Education is power and a key approach in tackling the issue of non-adherence among 
patients. Thus, providing patients with information about their health conditions and the 
pros and cons of different available treatment options may improve their medications 
adherence. It also facilitates partnerships with their physicians in managing their health 
conditions (Banning, 2009). Nonetheless, given the short visit length, long medication 
lists, and the need to educate and follow up with elderly patients; new and creative ways 
of communication between physicians and patients should be developed. In an era of high 
technology, the Internet has become one of the new avenues that physicians use to 
communicate with their patients. Physician’s communication with their patients through 
secure websites can help physicians understand patients’ beliefs and adherence barriers. 
Further, physicians can use these websites to assess the patients’ progress and update 
their treatment regimens accordingly. Such online interventions had a positive impact on 
patients’ medication adherence levels (Linn, Vervloet, van Dijk, Smit, & Van Weert, 
2011). However, the use of Internet is not limited to the communication between 
physicians and their patients. Many health websites are competing in providing health-
related information about multiple health services and medications in layman’s term 
(Jenkins & Dunn, 2004). These websites differ in their content, design, and affiliations. 
Some of these websites provide patients reviews of medical devices, physicians, and 
medications (Emmert, Sander, et al., 2013).  
 
Online health information seeking was seen to help patients initiate constructive 
dialogs with their physicians, and improve their satisfaction with provided care (Bylund 
et al., 2007; Jacob, 2002). However, it is unknown whether the websites that provide 
patients’ reviews of medications will enhance patient-physician communication, and 
eventually improve patients’ medication adherence levels. 
 
 
1.1.8 Why Hypertensive Patients? 
 
As people age, they become more susceptible to chronic diseases such as 
hypertension and diabetes (Abrass, 1990). Essential hypertension is an asymptomatic 
chronic medical condition that is highly prevalent among the older adults especially 
among women and minorities. According to the latest report published by the Centers for 
Disease Control and Prevention, the prevalence of hypertension among older adults who 
are between 65 to 74 years of age approximates 65%, and among those over 75 years 
approximates 75% (Hamilton, 2003; Health, United States, 2012: With Special Feature 
on Emergency Care). It has been estimated that hypertensive patients are two times more 
likely to develop coronary artery diseases, three times more likely to have 
cerebrovascular diseases, and 3.5 times more likely to have heart failure at some point in 
their life when compared to the non-hypertensive population; and the likelihood of 
developing such serious illnesses increases with age (Kannel, 2003). Further, it is 
estimated that more than 60% of the older adults with hypertension had an incident of 
myocardial infarction, stroke, and/or heart failure (Lloyd-Jones et al., 2009). According 
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to one study, the death rate attributable to hypertension among older adults (≥60 years) is 
735 cases per 100,000 people (Mensah, Mendis, Greenland, & MacKay, 2004). Further, 
hypertension often represents a management dilemma to cardiovascular specialists 
because of the multiple physiological and behavioral factors that eventually determine the 
success of any treatment plan (Lionakis, Mendrinos, Sanidas, Favatas, & Georgopoulou, 
2012).  
 
Although hypertension is considered a significant risk factor for cardiovascular 
diseases, the good news is that it is a modifiable risk factor. Patients who adhere to their 
antihypertensive medication regimens, which include both the pharmacological and the 
non-pharmacological measures, are likely to bring their blood pressure under control. 
Therefore, their risk of developing serious diseases such as myocardial infarction or 
stroke in the future will eventually be diminished (Sacco et al., 1997). To reach that goal, 
both patient and physician need to have a collaborative agreement where each one of 
them understands his/her roles and responsibilities. This agreement should also respect 
each party’s expectations and values. Unfortunately, some evidence indicates that 
healthcare professionals treat their elderly patients in a condescending and impatient 
manner (Harwood, 2007; Nussbaum & Coupland, 2004). Further, physicians seem to 
spend less time , provide less information, and often fail to stress the importance of the 
non-pharmacological preventive measures (Greene & Adelman, 2001; Harwood, 2007). 
Finally, physicians should adopt effective communication strategies to build a 
constructive collaborative agreement with their hypertensive patients in order to achieve 
the desirable treatment outcomes and prevent future complications. 
 
 
1.2  Study Objectives and Research Questions 
 
The value and usefulness given to online patients’ ratings of medication websites by 
older adults about the process of patient-physician communication (i.e., facilitating the 
communication, discussing the content of these websites with their physicians, asking 
their physicians to prescribe the top rated medications) can be associated with multiple 
factors. Thus, the following were studied: 
 
1. Are the online medication reviews viewed more favorably by those who 
are satisfied with their communication with physicians and will the older 
adults’ rating of their own treatment regimen influence their satisfaction 
with communication with physicians? 
2. Do older adults with high quality of life scores have favorable views of the 
online medication reviews in comparison to those with lower quality of 
life scores and will the rating of their treatment regimens influence their 
quality of life? 
3. Do older adults with positive beliefs about medications find the online 
medication reviews useful in comparison to those with negative beliefs 
and will the rating of their treatment regimens influence their medication 
beliefs? 
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4. Do older adults’ adherence to their antihypertensive treatment regimen 
influence their views of the online medication reviews and do older adults’ 
rating of their antihypertensive medication regimens influence their 
medication adherence and their views of the online reviews of 
medications?  
 
1.3  Theoretical Framework 
 
In order to understand how the online medication reviews can affect certain indicators 
of health outcomes, such as the quality of life and medication adherence, the Donabedian 
model was used to evaluate how these factors are interrelated. The Donabedian model is 
a conceptual model proposed by Avedis Donabedian, a physician and health care services 
researcher at the University of Michigan, in 1966. The purpose of this model was to 
provide a framework to assess the quality of health care services and relate that to the 
ultimate outcomes such survival, blood pressure reduction, and A1C improvement 
(Donabedian, 1966). According to the Donabedian model, the measurement of the health 
care quality should be based on three main components: Structure, Process, and 
Outcomes. Each of these components has a direct influence on the next one starting from 
the Structure, then the Process, and finally Outcomes (Donabedian, 2005). To apply this 
model to the study, physician education and training to communicate effectively and 
address the needs and concerns of the elderly patients represents a Structure component. 
Whereas, the appropriateness of the diagnosis and prescribing as well as the 
communication style and interpersonal aspect of the relationship between the physicians 
and their patients which can be influenced by their medical, cultural, and religious beliefs 
are Process components. Finally, patient’s satisfaction with care, quality of life, and 
medication adherence considered indicators of health status are Outcome components, as 
is, patient beliefs about medications since effective communication can influence patient 
beliefs about medications and eventually affect patient adherence.  However, to know the 
value of the online patients’ medications reviews in facilitating patient-physician 
communication as well as its relationship with health status indicators; it is believed that 
the online patients’ medication reviews can be considered as an intervention directed 
towards the Process component (i.e. facilitating the patient-physician 
communication)(Friedman et al., 2008) (Figure 1-1). Although, the online reviews of 
medications can influence patient-physician communication and indirectly affect 
outcomes (i.e. satisfaction with physicians, quality of life, beliefs about medications, and 
medication adherence), the same outcomes can also influence patients’ opinions of such 
online websites (Figure 1-2). 
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Figure 1-1. The potential effect of online reviews of medications on physician-
patient communication.  
 
Source: Donabedian A, Evaluating the Quality of Medical Care. Milbank Quarterly 2005 
December; 83(4): 691-729. 
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Figure 1-2.  Factors that may influence patient views of online medication reviews. 
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CHAPTER 2.    LITERATURE REVIEW 
 
 
2.1  Physician-Patient Communication 
 
There is a belief that effective communication is both essential and lacking among 
physicians (Stein, 2006). A review of physician-patient communication by Persaud 
showed only 5% of the clinical consultations provided by physicians to patients were 
considered to be friendly or social (Persaud, 2005). Some argue that the deterioration in 
the physician-patient relationship or encounter probably came after the infiltration of 
corporate interests in the U.S. healthcare system, which resulted in diminished trust 
between the physicians and patients (Laugesen & Rice, 2003). Furthermore, the main 
reason patients sue their physicians for malpractice is not because of their negligence, but 
for the lack of respect and ineffective communication from the physicians’ side 
(Levinson, Roter, Mullooly, Dull, & Frankel, 1997). The quality of physicians’ 
communication skills has been found to be a positive predictor of patient adherence with 
medical advice (Robins & Wolf, 1988). Hence, there seems to be a consensus among 
physicians and policy makers alike to adopt a patient-centered approach where patients 
are involved in their own care as partners with their physicians and not solely as receivers 
of care. Bensing (Bensing, 2000) and Mead, Bower, and Hann (Mead, Bower, & Hann, 
2002) summarized the basic elements of patient-centered practice as follows: 
 
? Attending to patients’ psychological and physical needs, 
? Encouraging patients to disclose their concerns, 
? Conveying a sense of partnership during the consultation sessions, and 
? Actively facilitating the involvement of patients in the decision making 
process. 
Thus, the provision of patient-centered care requires collaboration between all 
personal, professional, and organizational levels in healthcare. This can only be achieved 
through education and training of physicians that show friendliness and empathy in their 
conversations with patients and create a supportive environment and system that rewards 
those physicians who foster and provide patient-centered care for patients (Epstein & 
Street, 2007; Epstein, Fiscella, Lesser, & Stange, 2010; Epstein & Street, 2011). Hence, 
structural changes need to be implemented in the healthcare system to strengthen the 
relationship between physicians and patients, and promote the communication between 
them in order to make the physician-patient encounter an enjoyable and informative 
experience that eventually leads to a constructive partnership between patients and 
physicians (Epstein & Street, 2011). 
 
To build that partnership both patients and physicians need to agree on the goals and 
tasks of the treatment plan and act upon them. By doing so, they form what is currently 
known as a “Working Alliance.” This term has been studied extensively in the last few 
decades and it encompasses a wide array of cognitive and emotional factors that need to 
be included in this partnership (Boylan & Fontanella, 2009). A good therapeutic working 
alliance consists of the following (Bordin, 1979): 
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? Agreement on goals, 
? Assignment of tasks, and 
? Development of an effective bond between the physicians their patients. 
This working alliance between the physicians and patients cannot succeed without a 
genuine effort made by the physicians to involve the patients in this partnership. 
Engaging patients in their own care is not by any means an easy task and only those with 
a good communication style and interpersonal skills can succeed (Brennan, Rivera-Tovar, 
Martin, Hepworth, & Makoul, 2010). A sense of connection and mutual understanding 
has to exist between the physicians and patients in order to have an effective and 
meaningful communication. Otherwise, the physician-patient communication will merely 
be an exchange of medical information divorced from the context and complexities of the 
patient’s life.  
 
Empathy is regarded by most researchers in the domain of patient-centered care 
research as one of the most important interpersonal skills that healthcare professionals 
need to learn to effectively communicate with their patients (Boylan & Fontanella, 2009). 
It has been variously defined by researchers in the field of psychotherapy; however, what 
is common between these definitions is that they all capture the importance of deep 
listening and objective understanding of patients’ experiences (Davis, 1994). Empathy in 
the physician’s communication with their patients was found to have a positive impact on 
overall patient care (Kim, Kaplowitz, & Johnston, 2004; Larson & Yao, 2005). Whereas, 
an indifferent physician-patient relationship was found as one of the factors behind poor 
medication adherence (Osterberg & Blaschke, 2005). There are other verbal behaviors 
known to promote the physician-patient relationship especially among the elderly. 
Physicians’ friendliness, attentive listening, and encouraging patients to ask questions are 
very important attributes of effective communication (Beck, Daughtridge, & Sloane, 
2002; Zachariae et al., 2003).  
 
 
2.1.1 Theoretical Models of Physician-Patient Relationship 
  
Parsons (1951); a sociologist, provided a description of the physician-patient 
relationship. His description was later called “Parsons’ model of sick role and physician’s 
role,” whereby sick people are in need of care that is provided to them by specialized 
personnel. The specialized personnel are in most cases physicians, and because patients 
need that care they must cooperate with their physicians and forgo some of unhealthy 
activities, they were used to in order to recover quickly. According to Parsons’ model, 
patients regardless of their medical conditions, gender, age, ethnicity, and culture, are 
expected to assume the sick role. Parsons also believed physicians should apply their 
clinical skills and knowledge for the benefit and welfare of patients and the whole 
community and not for their narrow financial interests (Parsons, 1951). However, this 
model has received a number of criticisms. The model assumes that the patients will 
voluntarily accept the sick role without any objections and will fully cooperate with their 
physicians. Further, it assumes a consistent physician-patient relationship whereby 
patients from different backgrounds and lifestyles will be treated the same. In addition, it 
puts most of the blame on patients who play the sick role for their illnesses. In reality, 
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physicians’ counseling and advice along with their treatment plan are highly important. 
Parsons’ model may fit acute illnesses (i.e. measles, appendicitis, malaria); however, it 
does not fit chronic medical conditions such as hypertension, hypercholesterolemia, and 
diabetes where patients’ participation in the treatment decision is very important (Jeffery, 
1979; Macintyre, 1994; Morgan, 2003). Existing models that describe this relationship 
fall into one of the following (Charles et al., 1997; Clarke, Hall, & Rosencrance, 2004; 
Emanuel & Emanuel, 2000; Morgan, 2003): 
 
? The Paternalistic (Parsonian) Model: A model in which physicians have 
the upper hand over patients when it comes to the decision making process 
regarding the treatment plan. Many consider this relationship similar to 
one between a parent and child. 
? The Engineering (Informative or Consumerist) Model: In this model 
patients assume the active role, whereby physicians are hired by patients 
to relay the medical facts and information requested by the patient and 
then implement the treatment decision made by patients after explaining 
the variety of treatment options. 
? Interpretive Model: A contractual model in which both patients and 
physicians forge an agreement whereby physicians work with patients as 
partners in the decision making process concerning their health and 
treatment plan provided that their moral integrity is kept intact. The 
principles of autonomy, fidelity, veracity, do no harm, and justice should 
form the basic elements in this contractual relationship. Physicians try to 
understand patients’ values and behavior and come up with individualized 
treatment plans that fit patients’ values and beliefs. This model assumes 
that patients usually are not clear about what would be the best diagnostic 
tests and/or treatment options for them. For this reason, discussions 
between physicians and patients will help patients decide which test or 
treatment would fit them best. 
? Deliberative Model: Instead of trying to understand the patients’ values 
and beliefs in order to devise an individualized treatment plan, physicians 
explain to patients the different diagnostic and treatment options; try to 
persuade the patients about the best options, and finally leave the decision 
to patients. 
When it comes to clinical reality, none of these models will work all the time 
regardless of the medical condition, its urgency, and patients’ backgrounds.  
 
 
2.1.2 Physicians’ Consultation Styles 
 
? Physician-Centered Consultation: Represents the paternalistic 
(Parsonian) model whereby physicians have the upper hand in their 
relationships with their patients. According to this consultation style, 
patients should obey and cooperate with physicians in order to reach the 
desirable outcome. It focuses on the physical aspects of the disease and 
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ignores the feelings and emotions of the patients (Mishler, 1984; Morgan, 
2003). 
? Patient-Centered Consultation: Physicians adopt a less controlling style 
and encourage patients to participate in the consultation. Physicians spend 
more time listening to patients and paying attention to the patients’ 
feelings and emotions. This consultation approach can represent either the 
interpretive or the deliberative contractual (collaborative) models 
(Mishler, 1984; Morgan, 2003).The basic characteristics of this 
consultation style can be summarized in the following (Mead & Bower, 
2000): 
 
? Biopsychosocial Perspective: Physicians are willing to become 
involved in all the difficulties patients are going through and not 
just their medical condition. 
? Patient-as-a-Person: Physicians want to listen and understand 
patients’ medical conditions from the patients’ own perspective 
and use open-ended interview questions. 
? Sharing Power and Responsibility: Patients are treated as a 
partner in this contractual or collaborative relationship with 
physicians; hence, they are encouraged to participate in the 
consultation. 
? Therapeutic Alliance: Patients should be involved in the 
treatment decisions. 
? Physician-as-a-Person: Physicians are human beings and not 
machines so they should recognize and respond to patients’ cues. 
 
2.1.3 Communication with Older Adults  
 
Older adults mostly desire more information about their medical conditions and 
medications from their physicians, however, research has shown that they receive less 
information than younger patients (Beisecker, 1988). This can be partly due to the fact 
that older patients tend to communicate less effectively when they sense that physicians 
are rushed or uninterested (Robinson, White, & Houchins, 2006). This becomes more 
complicated when it is known that the average consultation time is around six minutes 
with the actual length of time between 2 to 20 minutes. This can potentially lead to less 
attention paid to the psychosocial aspects of patients’ disease and more attention to its 
physical nature. Eventually more medications are prescribed and fewer psychological 
problems are identified (Daschle, Domenici, Frist, & Rivlin, 2013; Morgan, 2003).  
 
Older patients revere their physicians and want to spend quality time with them to 
understand their health conditions better and verbalize their concerns. Hence they need an 
attentive physician who makes them feel they are important (Robinson et al., 2006). 
However, one of the most common complaints patients have about physicians is that they 
do not listen and frequently interrupt them (Meryn, 1998). Physicians sometimes avoid 
listening to patients not just because of the time constraints, but also because they do not 
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want to distress themselves by listening to patients’ concerns and do nothing about them 
(Ekdahl, Hellström, Andersson, & Friedrichsen, 2012; Ha & Longnecker, 2010). Older 
patients’ non-adherence to physicians’ advice and prescribed treatment can be greatly 
reduced by attentively listening and reducing the amount of distractions (Dreher, 2001). 
Besides the attentive listening, older patients appreciate the medical advice and 
information conveyed to them by physicians. Given the natural aging process that may 
involve sensory loss, decline of memory, and impaired hearing, physicians need to 
simplify their language by avoiding medical jargon and by talking slowly and loudly 
(Howard, Jacobson, & Kripalani, 2013; Robinson et al., 2006). 
 
 
2.1.4 Factors Influencing Physician-Patient Communication 
 
Factors that can influence physician-patient communication are numerous, but little 
has been published about the potential factors that can be summarized into four domains: 
patient communication style, sociodemographic factors, health-related factors, and 
physician communication style (Morgan, 2003; Street Jr, Gordon, & Haidet, 2007; Strull, 
Lo, & Charles, 1984) (Figure 2-1). Each of these domains has the potential to shape the 
communication between physicians and patients. 
 
2.1.4.1 Patient Communication Style 
  
This domain covers how much information patients want to receive from and discuss 
with physicians about their medical conditions, their willingness to share and express 
their concerns and feelings, and their decision-making preference. Patients with negative 
beliefs about healthcare (i.e., distrust in modern medicine or fear of the healthcare 
system) have a different communication style than those with positive beliefs (Ha & 
Longnecker, 2010). For example, patients with positive views of healthcare tend to be 
more inquisitive and open (i.e., ask questions, assertive about getting answers, and 
express their fears and concerns to their physicians) than those with negative views of 
healthcare. Therefore, patients with positive are more likely to receive supportive, 
informative, and accommodating care (Ha & Longnecker, 2010; Street Jr et al., 2007). 
Further, patients’ preference towards the decision making process (i.e., whether they like 
their physicians to make the decision on their behalf, have a shared decision, or make the 
decision themselves) is another important factor that influences patients’ communication 
style. Patients’ preferences are dependent on factors that fall under the other domains 
such as health literacy, education, and age (Schneider et al., 2006). 
 
2.1.4.2 Patient Sociodemographic Factors 
 
Researchers have shown that as patients age, they become less interested in 
participating in the health decision-making as well as less inclined to engage in effective 
communication with their physicians (Garfield, Smith, Francis, & Chalmers, 2007; 
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Figure 2-1. Factors influencing physician-patient communication. 
 
Source: Reprinted from Social Science and Medicine, 65(3), Street Jr, Gordon & Haidet, 
Physicians' communication and perceptions of patients: is it how they look, how they talk, 
or is it just the doctor?/Figure 1, 586-598, 2007 Jan, with permission from Elsevier. 
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Morgan, 2003; Robinson et al., 2006; Schneider et al., 2006). Paradoxically, one study 
found that older patients are more likely to be satisfied with the care provided (Carlin, 
Christianson, Keenan, & Finch, 2012). Patients of high educational and social status were 
more likely to engage in the consultation by asking questions and inquiring about other 
treatment options in comparison to patients with a lower socioeconomic status (Garfield 
et al., 2007; Morgan, 2003; Schneider et al., 2006). However, highly educated patients 
were also found to be less satisfied with care compared to patients with a lower 
educational status (Carlin et al., 2012). The association between gender and patients’ 
preference for involvement in the decision-making process is variable (Garfield et al., 
2007). Females are more interested than males in having a participatory role as well as 
more satisfied with the care provided (Arora & McHorney, 2000; Carlin et al., 2012; 
Levinson, Kao, Kuby, & Thisted, 2005; Nease Jr, 1995). Other studies show no 
significant association between gender and patients’ preference for decision sharing with 
physicians (Florin, Ehrenberg, & Ehnfors, 2006; McKinstry, 2000). Race is another 
potential factor that can play a major role in patient preference for decision sharing with 
physicians (Strull et al., 1984). Whites are more likely to believe in patients’ autonomy 
than other minorities (Garfield et al., 2007). The role of patients’ insurance status was not 
well described, however, patients enrolled in an HMO (Health Maintenance 
Organization) were found to request more information from their physicians than patients 
with a different type of insurance coverage (Strull et al., 1984). In another study, insured 
patients were more likely to be satisfied with the provided care than those who are 
uninsured (Carlin et al., 2012). 
 
2.1.4.3 Patient Health Related Factors 
 
Patient disease severity was negatively associated with the desire to have an active 
role in both communication and decision sharing with few exceptions (Garfield et al., 
2007). Patients with acute illnesses have been found to seek more information about their 
medical conditions from their physicians, but at the same time preferred a passive role 
when it comes to decision making (Wilkinson, Khanji, Cotter, Dunne, & O’keeffe, 2008). 
Patients with more chronic illnesses report higher satisfaction with the health care 
provided and their physicians’ communication style (Carlin et al., 2012). Further, patients 
vary in their preference for the decision sharing based on their medical condition. Patients 
with heart failure were found to have a passive role in decision-making process, whereas 
older patients with serious mental illness were more likely to be involved in the decision-
making than their younger counterparts (O'Neal et al., 2008; Rodriguez, Appelt, Switzer, 
Sonel, & Arnold, 2008). Furthermore, patients with breast, prostate, colorectal, lung, 
gynecological and other cancers had a strong desire to be involved in the decision-
making process regarding their treatment (Bruera, Sweeney, Calder, Palmer, & Benisch-
Tolley, 2001; Tariman, Berry, Cochrane, Doorenbos, & Schepp, 2010). 
 
2.1.4.4 Physicians’ Communication Style  
 
Some physicians adopt a physician-centered approach where they control the 
direction of the communication during the physician-patient encounter and decide what 
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treatment they deem appropriate with no patient involvement. This model referred to as 
the Parsonian or paternalistic model is widely practiced by many physicians. Others 
practice patient-centered care, where they listen attentively and involve patients in 
treatment decision. In this model, physicians share the treatment decisions with patients 
by explaining different treatment options, and letting the patients decide afterwards what 
treatment option would be the best for them (Morgan, 2003; F. A. Stevenson, Barry, 
Britten, Barber, & Bradley, 2000) (Table 2-1).  However, to understand why physicians 
choose to practice physician-centered or patient-centered care, one has to consider several 
factors that can influence physicians’ communication style. For instance, physicians’ 
prior experiences with patients may influence the physician communication style along 
with gender, cultural background and medical training (Street Jr et al., 2007; Zandbelt, 
Smets, Oort, Godfried, & de Haes, 2006; I Gouni-Berthold MD & Berthold, 2012). 
 
 
2.2  Linking Patient-Centered Care to Health Outcomes 
 
Patient experience with care is increasingly gaining ground to become an integral 
element or even one of the important pillars of the quality of healthcare along with 
patient safety and clinical effectiveness (Doyle, Lennox, & Bell, 2013). Patient-centered 
care has been defined as “the experience (to the extent the informed, individual patient 
desires it) of transparency, individualization, recognition, respect, dignity, and choice in 
all matters, without exception, related to one’s person, circumstances, and relationships in 
health care” (Berwick, 2009, p.560). Currently, there is a sort of consensus among the 
advocates of patient-centered care that a good outcome should be defined based on how 
meaningful and valuable this outcome will be to patients themselves, not solely to 
physicians or policy makers (Guyatt, Montori, Devereaux, Schünemann, & Bhandari, 
2004). Since the provision of patient-centered care encourages patients to participate in 
the discussion with physicians and get involved in their own care, it should be expected 
to see higher adherence, improved quality of life, and better clinical outcomes across a 
wide range of medical conditions (Berwick, 2009; Street Jr, Makoul, Arora, & Epstein, 
2009). However, past research shows inconsistent findings about the impact of patient-
centered care on health outcomes (Lee & Lin, 2010).  
 
In a randomized control study that was conducted more than two decades ago in a 
range of settings in the U.S. and included 252 ulcer, hypertension, diabetes, and breast 
cancer patients, physician-patient communication was assessed by both audiotaping as 
well as questionnaire administration to see if communication style would influence any 
clinical parameters or self-reported health status. A positive association was found 
between an effective physician-patient communication and blood pressure control, blood 
glucose level, and self-reported health status (Kaplan, Greenfield, & Ware Jr, 1989). 
Another study looked at the prevalence as well as the causes and implications for under-
use of opioids medications among 191 veterans who received opioid medications for any 
pain. Under-users of opioids were identified using structured assessments that included 
detailed questions for the participants on how they use their opioid medications on a daily 
basis. Those who took less than the prescribed daily dose or reported having a pain that 
impaired their ability to function normally were considered under-users. Non-adherence 
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Table 2-1. Model of treatment decision-making. 
 
Analytical 
Stages 
 Paternalistic 
(Intermediate) 
Shared 
(Intermediate) 
Informed 
Information 
Exchange 
Flow One way (largely) Two way One way 
(largely) 
  Direction Doctor → Patient Doctor ↔ Patient Doctor → 
Patient 
 Type Medical Medical and 
Personal 
 
 Amount Minimum legally 
required 
 
All relevant for 
decision-making 
 
All relevant 
for decision-
making 
 
Deliberation 
 
 Doctor alone or 
with other doctors 
 
Doctor and patient 
(plus potential 
others) 
 
Patient (plus 
potential 
others) 
 
Deciding on 
treatment to 
implement 
Doctors 
 
Doctor and patient 
 
Patient 
 
 
Source: Reprinted from Sociology as applied to medicine (5th ed., p. 58), Scambler, G., 
& Myfanwy, M., Models of treatment decision-making in a doctor–patient dyad/ Table 
4.3, 49-65, 2003, with permission from Elsevier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
to the prescribed opioids was not different from the non-adherence to any other 
medication regimens and was largely due to poor communication between patients and 
physicians (Lewis, Combs, & Trafton, 2010). The provision of patient-centered care was 
associated with improved medication adherence among patients with breast cancer (Lee 
& Lin, 2010). However, some studies have shown no association between patient 
experiences with care and health outcomes. In a large, multicenter, cross sectional study 
designed to investigate the relationship between clinical performance and patient 
experiences among adult patients (18-64 years) with continuous enrollment in one of five 
participating health plans in Massachusetts for at least a year, no association was found 
between patient experiences and clinical outcomes such as blood pressure, HbA1c, and 
LDL cholesterol level (Odigie & Marshall, 2008). In another cross sectional study 
conducted in the United Kingdom, the relationship between older patients’ (≥ 65 years) 
assessment of primary care and the control of hypertension as well as vaccination against 
influenza was investigated. No significant association between the older patients’ 
assessment of primary care and the aforementioned quality of care measures was found 
(Rao, Clarke, Sanderson, & Hammersley, 2006). All in all, although some studies failed 
to show a significant association between patient-centered care and health outcomes, the 
preponderance of evidence supports a significant association between them (Doyle et al., 
2013). 
 
 
2.3  Assessing the Physician-Patient Relationship 
 
The patient-physician relationship or encounter has been assessed using different 
methods including qualitatively by audiotaping or videotaping the physician-patient 
communication during patient visits. Recordings were analyzed using professional coders 
as well as several software systems to find repetitive themes than can be linked to certain 
communication styles (Hall, Roter, & Katz, 1988; Levinson et al., 1997). The physician-
patient relationship has also been assessed by both audiotaping patient-physician 
encounter and then scoring the encounter using a patient-centered communication score 
tool (Oates, Weston, & Jordan, 2000). Today, a myriad of self-administered 
questionnaires have been developed and validated across multiple patient populations. 
These questionnaires report the fulfillment of patients’ expectations, needs, and wishes 
based on past physician-patient encounters. The Patient-Doctor Relationship 
Questionnaire [PDRQ-9], Health Care Relationship [HCR] Trust Scale, and Consultation 
and Relational Empathy [CARE] measure are a few examples of questionnaires used in 
the primary healthcare field (Eveleigh et al., 2012). These instruments address different 
important attributes of the physician-patient relationship such as patient-centeredness, 
interpersonal communication, cultural sensitivity, and respectfulness. However, some 
instruments were found to be more comprehensive in addressing these attributes of 
primary care in comparison to other instruments. The Primary Care Assessment Survey 
(PCAS) and the Primary Care Assessment Tool (PCAT) are two validated instruments 
with good coverage of the primary health care attributes. Both are available in the public 
domain (Lévesque et al., 2012). 
 
 26 
2.4  Health-Related Quality of Life (HRQoL) 
 
In an era of patient-centered outcomes, patients’ quality of life has become a more 
important outcome measure than proxy clinical parameters such as blood-pressure 
measurements, blood-glucose levels (Carr & Higginson, 2001). The provision of patient-
centered care is expected to improve the quality of life by increasing patients’ 
independence (Poochikian-Sarkissian, Sidani, Ferguson-Pare, & Doran, 2009). However, 
there is no consensus on the definition of patients’ quality of life. It has been defined as 
“the extent to which hopes and ambitions are matched by experience”(Calman, 1984, 
p.124). Further, it has also been defined as the “individuals’ perceptions of their position 
in life taken in the context of the culture and value systems where they live and in 
relation to their goals, expectations, standards, and concerns” (Orley, Kuyken, & de la 
Santé, 1994, p.290). However, some lean towards defining the patients’ quality of life as 
the patients’ assessment of their own functioning against what is considered as being 
ideal functioning level (Carr & Higginson, 2001; Cella & Tulsky, 1990).  
 
Elderliness is a starkly different and variable experience for each patient. Some 
elderly patients view this stage of their life as a relaxing and enjoyable experience; 
however, others describe it as a bad experience (Xavier et al., 2003). In a study that 
investigated the important items influencing elderly patients perception of the quality of 
life, 141 elderly patients were randomly selected, and interviewed in person using an 
open-ended interview structure. The study concluded that patients’ social relations, 
functional ability and activities are the three most important items that influence elderly 
patients’ quality of life as much as their health status (Wilhelmson et al., 2005).  
 
For several generations, the dominant theory in economics and social research that 
describes people’s quality of life is utilitarianism. According to this theory, quality of life 
involves the satisfaction of individuals’ desires and preferences (Cobb, 2000; Torrance & 
Drummond, 2005). There are many quality of life measurement questionnaires, but the 
most important fact to ponder is these instruments are only considered proxies or indirect 
indicators of quality of life. These instruments can never be treated as direct indicators of 
quality of life simply because people cannot observe their happiness or satisfaction 
directly. For example, people may report that they desire having something; however, 
when they have the means to get it, they get something else (Cobb, 2000). These 
instruments vary in their coverage of the quality life attributes (Torrance & Drummond, 
2005). The EuroQol-5D, SF-36 & 12, and Nottingham health profile (NHP) are three 
commonly used and widely validated questionnaires across multiple medical conditions 
and have high reliability coefficient (Cronbach’s Alpha >0.7) (Müller-Nordhorn, Roll, & 
Willich, 2004; Torrance & Drummond, 2005) (Table 2-2). 
 
 
2.4.1 EuroQol-5D (EQ-5D) 
  
The EuroQol-5D is a generic instrument for describing and valuing health, which was 
developed by a consortium of investigators in Western Europe. It includes five attributes 
of quality of life: mobility, self-care, usual activity, pain discomfort, and  
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Source: Coons, Rao, Keininger, & Hays, A Comparative Review of Generic Quality-of-
Life instruments. Pharmacoeconomics 2000 Jan; 17(1): 13-35. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-2. Comparison of quality of life instruments. 
 
 QoL Questionnaires 
Domain SF-36 & SF-
12 
EuroQol (EQ-
5D) 
NHP 
Pain Yes Yes Yes 
Energy or tiredness Yes Not Covered Yes 
Sleep Not Covered Not Covered Yes 
Physical functioning or 
mobility 
Yes Yes Yes 
Daily living activities Yes Yes Yes 
Social interactions Yes Not Covered Yes 
Leisure activities Yes Yes Not 
Covered 
Work Yes Not Covered Not 
Covered 
Emotional wellbeing Yes Yes Yes 
Dependence or independence Not Covered Not Covered Yes 
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anxiety/depression. Each attribute has three levels: no problems, some problems, and 
extreme problems. This instrument is self-administered and respondents can rate their 
overall utility of life on a 0-100 hash-marked vertical visual analog scale (EQ-VAS). The 
EQ-5D has been widely used among the general population as well as patient samples 
and has been translated into more than 130 different languages (Herdman et al., 2011; 
Torrance & Drummond, 2005). However, there is evidence that the EQ-5D can suffer 
from a ceiling effect especially when it is used among a general population with minor 
medical conditions. Thus, there might be issues with its ability to detect small changes in 
health (Bharmal & Thomas III, 2006; Herdman et al., 2011; Huang et al., 2008). 
 
 
2.4.2 Rand-36 (SF-36) 
 
The Short Form Health Survey (SF-36) also known as, Rand-36 is one of the most 
widely used health related quality of life (HRQoL) survey instruments. It consists of 36 
items that assess eight concepts in health: physical functioning, role limitations caused by 
physical health problems, role limitations caused by emotional problems, social 
functioning, emotional well-being, energy/fatigue, and general health perception. These 
concepts can be categorized into two component summaries (the Physical Component 
Summary [PCS-36] & the Mental Component Summary [MCS-36]). Twenty of 36 items 
assess the respondent’s health in the past four weeks. The last item assesses the change in 
the perceived health in the last 12 months, and every item is scored on a scale from 0-100 
(Hays & Morales, 2001). Owing to the length of time the SF-36 takes an individual to 
complete, a new and shorter version of the SF-36 was developed. The SF-12 is a succinct 
form of the SF-36 designed to assess the general self-reported health as well as the 
limitations in everyday activity owing to physical and mental health in the past four 
weeks and has the same two component summary scales (Ware Jr, Kosinski, & Keller, 
1996). The SF-12 was shown to be more sensitive to subtle changes in health than the 
EQ-5D in a relatively healthy population (Johnson & Pickard, 2000). 
 
 
2.4.3 Nottingham Health Profile (NHP) 
 
The NHP was developed in the 1970s by a group of researchers in the Department of 
Community Health at Nottingham University. The instrument was designed to reflect lay 
people’s perception of health as opposed to the medical professional assessment of 
patient health. It was created based on a pool of more than 2000 statements collected 
from in-person interviews that enabled the researchers to identify key concepts. 
Researchers reduced the number of statements to 38 for the first part and seven 
statements for the second part. Statements require a ‘Yes’ or ‘No’ response. The first part 
assesses perceived or subjective health, and statements fall into six domains: sleep, 
physical mobility, energy, pain, emotional reactions and social isolation. The first part is 
scored using weighted values, which results in scores ranging from 0 to 100 for each 
section. The higher the score on any section, the greater the severity of the perceived 
problems in that domain (Coons, Rao, Keininger, & Hays, 2000; Hunt, McEwen, & 
McKenna, 1985). The second part focuses on the domains of the daily life, which are  
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mostly affected by health: paid employment, jobs around the house, social life, personal 
relationships, sex life, hobbies and interests, and holidays (Hunt et al., 1985). The 
developers of the NHP have recommended that the second part should no longer be used 
(Bowling, 1991; Coons et al., 2000).  
 
 
2.5  Medication Adherence 
 
According to the World Health Organization, adherence is defined as “the extent to 
which a person’s behavior (i.e., taking medications, following a diet, or making healthy 
lifestyle changes) corresponds with agreed upon recommendations from a healthcare 
provider” (Sabaté, 2003, p.136). However, medication adherence can also be defined as 
the degree to which patients’ or their caregivers’ medications administration behavior 
coincides with their physicians’ advice with regard to timing, dosage, and frequency of 
administration during the prescribed time window (Osterberg & Blaschke, 2005). 
Adherence to prescribed medications is difficult for patients in general and particularly 
challenging for elderly. Multiple factors influence the elderly patients’ adherence to their 
prescribed treatment regimens. Elderly patients’ sociodemographic (age, race, sex, and 
education), medical (comorbidities, number of medications, and treatment of adverse 
events), psycho-behavioral (beliefs about medicine, understanding of the medical 
condition, and satisfaction with treatment), and economic (type of insurance, co-
payments and coinsurance) characteristics are potential factors that can influence the 
elderly patients’ adherence to their prescribed medications (Gellad, Grenard, & Marcum, 
2011;  MacLaughlin et al., 2005; Sa’ed et al., 2013) (Figure 2-2).  
 
The relationship between each of these factors and medication adherence is far from 
being simple and clear. For instance, older adults are often assumed to have lower 
adherence to their prescribed medications compared to younger adults. However, this is 
not always the case. Some studies have shown that advanced age (≥65 years) is positively 
associated with adherence to prescribed drug regimens (Billups, Malone, & Carter, 
2000). In addition, the number of medical conditions, the prescribed medications patients 
are receiving and their frequency of administration were positively associated with 
medication adherence (Billups et al., 2000; MacLaughlin et al., 2005). Furthermore, 
patient satisfaction with care may affect their adherence to medications (Dang, 
Westbrook, Black, Rodriguez-Barradas, & Giordano, 2013; Krousel-Wood, Muntner, 
Islam, Morisky, & Webber, 2009). Another important aspect of medication use, patients’ 
satisfaction with their treatment regimens, was studied recently in a sample of patients 
with hypertension (HTN), and found to have a positive association with patients’ 
adherence to their treatment regimens. Patients who were overall satisfied with their 
prescribed medications’ effectiveness and convenience were more likely to be adherent to 
their treatment regimens (Sa’ed et al., 2013). In addition, health related quality of life 
(HRQoL) was also associated with medication adherence. Elderly patients with HTN and 
poor HRQoL scores have reported low adherence levels to their antihypertensive 
medications (Holt et al., 2010). 
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Figure 2-2. Factors influencing medication adherence.  
 
Source(s): Gellad, Grenard, & Marcum, A Systematic Review of Barriers to Medication 
adherence in the Elderly: Looking Beyond Cost and Regimen Complexity. The American 
Journal of Geriatric Pharmacotherapy 2011 Feb; 9(1): 11-23. 
MacLaughlin et al, Assessing Medication Adherence in the Elderly: which Tools to Use in 
Clinical Practice? Drugs Aging 2005; 22(3):231-255. 
Sa’ed, Al-Jabi, Sweileh, Morisky, Relationship of treatment satisfaction to medication 
adherence: findings from a cross-sectional survey among hypertensive patients in 
Palestine. Health and Quality of life Outcomes 2013 Nov; 11(1):191.  
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The importance of medication adherence stems from the fact that poor medication 
adherence has been linked to high healthcare costs in comparison to higher levels of 
adherence which were associated with lower healthcare costs. This is particularly true 
among patients with chronic medical conditions that can lead to untoward consequences 
if left uncontrolled (Pittman, Tao, Chen, & Stettin, 2010; Sokol, McGuigan, Verbrugge, 
& Epstein, 2005). HTN is one of the well-known preventable causes of cardiovascular 
disease morbidity and mortality. The utilization of antihypertensive medications has been  
found to reduce the risk of both coronary heart disease (CHD) and stroke by 34% and 
21%, respectively (Mazzaglia et al., 2009). Patients with poor adherence to 
antihypertensive medications were at higher risk of all-cause mortality, stroke, and acute 
myocardial infarction (Esposti et al., 2011). Only 51% of the U.S. hypertensive 
population are considered adherent to their prescribed medications (WHO). Achieving an 
acceptable level of adherence (>80%) entails an open and honest relationship between 
patients and their physicians. 
 
Medication adherence measures can fall into two different categories: direct and 
indirect measurements (Fairman & Matheral, 2000; Farmer, 1999). Direct measurement 
of medication adherence can be done through directly measuring the drug concentration 
in the patients’ blood stream. It can also be done by observing patients and making sure 
that they swallow their pills and documenting that afterwards and by healthcare providers 
administering the medication to patients intravenously (IV), or intramuscularly (IM) and 
documenting the administration. Although direct measurement of adherence is considered 
the most reliable method of measuring adherence, this is impractical, uncommon, and 
rarely used. The indirect measurement of adherence are more commonly used and 
include medication monitoring (electronic monitoring, pills counts), self-report measures 
(diaries, surveys, and interviews), and prescription claims data (length of therapy, 
treatment gaps, medication possession ratio [MPR], and days of coverage) (Fairman & 
Matheral, 2000;  MacLaughlin et al., 2005).  
 
Although there are several methods for measuring medication adherence and each 
one of them has its own advantages and limitations, no one measure of the 
aforementioned methods is perfect (Fairman & Matheral, 2000). The advantage of self-
report measures over other medication adherence methods is that they provide the reason 
for non-adherence from patients’ perspective (Fairman & Matheral, 2000; Lavsa, 
Holzworth, & Ansani, 2010). Self-report measures and scales have differing attributes 
such as the administration time, reliability, specificity and sensitivity, validity, and their 
ability to detect barriers to medication adherence. The new and commonly used self-
report medication adherence scale is the 8-item Morisky Medication Adherence Scale 
(MMAS-8). This scale was validated across a wide spectrum of clinical conditions with 
both high sensitivity (93%) and specificity (53%) towards detecting those with poor 
blood pressure control as well as high reliability (α=0.8) (Lavsa et al., 2010; Morisky, 
Ang, Krousel-Wood, & Ward, 2008). The original 4-items of the Morisky Medication 
Adherence Scale (MMAS-4) is a validated shorter version of the MMAS-8, but has lower 
internal consistency reliability (α=0.61), sensitivity (81%), and specificity (44%) in 
patients with HTN (Lavsa et al., 2010). Brief Medication Questionnaire (BMQ), Self-
efficacy for Appropriate Medication Use Scale (SEAMS), and Medication Adherence 
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Rating Scale (MARS) are widely used questionnaires that assess medication adherence in 
multiple patient populations. The BMQ, SEAMS, and MARS have limited 
generalizability and lower reliability in comparison with MMAS-8 (Lavsa et al., 2010). 
 
 
2.6  Beliefs about Medications 
 
The healthcare delivery in the U.S. and other industrialized countries has been 
following the biomedical model for a long time. This model assumes that illness is linked 
to diseases that results in disturbances in the physiological functions of the body and are 
separate from the psychosocial factors that may affect the disease severity and treatment 
outcome (Annandale, 1998; Horne, 2000). However, in reality these factors are crucial in 
determining the success of any treatment plan, and without considering them it is highly 
unlikely that any disease management strategy would result in favorable outcomes 
(Ogden, 2012). Hence, it is important to assess and understand people’s beliefs and 
attitudes towards disease and medicine.  
 
The self-regulatory model has been proposed as one of the best health behavior 
models to explain the relationship between health beliefs and illness behavior (i.e., 
medication taking behavior). According to this theory, the individual reacts to illness both 
cognitively and emotionally (Figure 2-3) (Cameron & Leventhal, 2003). Understanding 
patients’ beliefs and concerns about their newly diagnosed disease is important. 
However, equally important is patients’ beliefs about the medications that treat these 
illnesses especially those medications that are used on a chronic basis (e.g., 
antihypertensives, antihyperlipidemics, and antiasthmatics). Some patients believe that 
taking medications to treat their medical conditions takes away their sense of control over 
their health. This eventually may affect their expectations of their prescribed medications 
which are also influenced by their past experiences (Dolovich et al., 2008).  
 
Many of the published studies on health sociology focus on identifying barriers to 
healthcare access. However, fewer studies are investigating the patients’ beliefs and 
concerns that may affect their compliance with physicians advice and recommendations 
(Horne, 2000). In an era of patient-centered care, patients are expected to take an active 
role with physicians in the decision making process (Lee & Lin, 2010). Thus, physicians 
need to understand patients’ needs and concerns. This understanding can only be 
achieved through physicians’ candid and frank conversations with patients. To help 
physicians understand these beliefs and concerns, several qualitative and quantitative 
studies have been conducted to identify repeated themes and measure the impact of the 
cultural background on patients’ beliefs about medications in general (Britten, 1994; 
Horne et al., 2004; Lorish, Richards, & Brown, 1990) as well as about disease-specific 
medications (Emilsson et al., 2011; Farmer, Kinmonth, & Sutton, 2006; Lennerling & 
Forsberg, 2012; Paraskevi, 2012).  
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Figure 2-3. Depiction of the self-regulation behavioral model. 
 
Source: Cameron & Leventhal, Anxiety, Cognition, and Responses to Health Threats. 
The Self-regulation of Health and Illness Behavior. 2003 Jan; 157-183. 
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Patients’ beliefs about medications are dynamically changing and are potentially 
formed based on their past experiences, healthcare delivery system, culture, beliefs 
(Dolovich et al., 2008; Phatak & Thomas, 2006). These beliefs are considered by some 
health sociologists as a hidden determinant of any treatment outcome (Horne, 1999). 
They can be classified under “central themes”, such as people’s perceptions about the 
inherent nature of the medications, the likelihood of the medications to do any harm or 
benefit, their tendency to cause addiction, and their likelihood to be overprescribed by 
physicians (Horne, 2000; Horne et al., 2004). The impact of these factors and other 
sociodemographic factors such as age on patient views and beliefs about medications are 
variable and controversial. For example, men were found in one study to have more 
negative beliefs about medications in general compared to women (Horne et al., 2004). In 
another study conducted in Sweden, women expressed negative views about medications 
and their harmful effects more than men (Isacson & Bingefors, 2002). With regard to age, 
older adults were more likely to have positive views about medications than their 
younger counterparts were, and those with lower incomes were more likely to think of 
medications as something necessary but evil at the same time than those with higher 
incomes were. Patients with HTN considered their antihypertensive medications as 
necessary, but evil more than patients with other medical conditions. Patients with a 
psychiatric diagnosis had more positive views about medications than any other patient 
populations (Isacson & Bingefors, 2002). Cultural background was also found to have a 
strong association with medication beliefs. For instance, patients of Asian descent have 
expressed negative views about medications more than those of European descent (Horne 
et al., 2004). Furthermore, in another study among Japanese patients, negative beliefs 
about medications were associated with non-adherence to medications (Iihara et al., 
2004). Patients’ educations were also associated with general beliefs about medications; 
those with lower levels of education were more likely to perceive medications as harmful 
compared to those with higher levels of education (Horne et al., 2004; Horne et al., 1999; 
Isacson & Bingefors, 2002). 
 
Health status also influences patient beliefs about medications. Those with chronic 
medical conditions such as hypertension and diabetes have stronger feelings regarding 
the necessity of medications than those with acute medical conditions (Horne & 
Weinman, 1999). Patients who are currently on prescription medications have more 
positive beliefs about medications than those who are not (Ramstrom et al., 2006). 
Furthermore, believing in herbal/complementary medicine was associated with negative 
views about prescription medications in general. In addition, those who use herbal 
medicine have higher likelihood to think that physicians overprescribe (Horne et al., 
2004; Isacson & Bingefors, 2002; Mårdby, Åkerlind, & Jörgensen, 2007). Another 
important and interesting factor that was found to influence patient beliefs about 
medications is the direct to consumer advertisement (DTCA) (Iosifescu, Halm, McGinn, 
Siu, & Federman, 2008).  Finally, physicians’ communication style was found to have a 
positive impact on patients’ beliefs about medications which in turn resulted in better 
adherence to drug regimens (Bultman & Svarstad, 2000). Overall, patient beliefs about 
medications was shown to influence treatment outcomes in different patient populations. 
Patients who had negative views about medications were found to be less likely to adhere 
to their treatment regimens (Gatti et al., 2009; Iihara et al., 2004; Mårdby et al., 2007). 
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Patients’ beliefs and concerns about medications were identified qualitatively in 
several studies (Britten, 1994;Conrad, 1985; Lorish et al., 1990). However, to measure 
medications beliefs quantitatively Horne, Weinman, and Haskins developed the Beliefs 
about Medicines Questionnaire (BMQ) based on extensive qualitative research that 
identified common themes in medication beliefs (Horne et al., 1999). The BMQ was 
tested for psychometric properties and has been found to be valid and reliable across 
multiple chronic medical conditions including but not limited to asthma, cancer, diabetes, 
and hypertension. The BMQ has two sections (Horne et al., 1999): 
 
? The BMQ-Specific, which assesses patients’ beliefs about medications, 
prescribed for a particular illness from two aspects. The first aspect is the 
necessity of use. The second aspect is concerns about the potential side 
effects that patients may experience upon the use of these medications. 
? The BMQ-General, which assesses the personal views about the 
medications in general, and has two 4-items scales. The first scale is the 
general-overuse scale, which assesses whether patients feel that physicians 
put too much trust in medications and hence overprescribe them. The 
second scale is the general-harm scale, which assesses patients’ beliefs 
about whether they regard medications in general as inherently harmful 
with limited usefulness. 
 
2.7  The Value and Influence of Media Outlets on Patients’ Health Beliefs and 
Behavior 
 
 
2.7.1 Direct to Consumer Advertisement (DTCA) 
 
Multiple media outlets (i.e., TV, Internet, newspapers) that advertise as well as 
educate the public about the signs and symptoms of different medical conditions and the 
medications that treat these conditions surround patients today. This phenomenon, called 
direct to consumer advertisement (DTCA), has grown rapidly in the last two decades. 
DTCA is currently the most noticeable type of health communication that the public 
encounters (Donohue, Cevasco, & Rosenthal, 2007; Rosenthal, Berndt, Donohue, Frank, 
& Epstein, 2002).  
 
However, the public is split on DTCA between opponents who claim that it does 
nothing but harm, and proponents who believe that DTCA has many advantages that 
should not be overlooked. According to the proponents, DTCA informs as well as 
educates the public of certain medical conditions that they might have without them 
knowing about it. This eventually will encourage people to seek help and talk to their 
physicians if they think they have one of the symptoms listed in a medication’s 
advertisement, which will in turn strengthen the patient-physician relationship by 
empowering patients to open up constructive dialogs with physicians. This would reduce 
the healthcare costs by people seeking help earlier before it is too late for medications to 
work. On the other hand, opponents of DTCA say that it misinforms patients. Opponents 
claim that most pharmaceutical companies advocate for the use of their medications by 
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devoting most of their commercial advertisement time to the benefits of taking their 
medications and spend far less time on the possible adverse effects. By doing so, 
pharmaceutical companies overemphasize the benefits of their medications and 
underestimate the potential risks associated with their use. Another issue that critics have 
is the hastiness of the pharmaceutical companies to release their commercial 
advertisements of their new medications in the media without giving the post-marketing 
surveillance an adequate amount of time to check the safety of the medication on a larger 
scale, such as with (Vioxx®, Merck) incident. Opponents also believe that DTCA poses a 
real threat to (a) public health through inappropriate prescribing by some physicians who 
feel pushed sometimes by patients to prescribe a certain medication for them although 
they do not need it, and (b) the economy by exacerbating the rate of rising healthcare 
costs (Ventola, 2011).  
 
Minorities and Internet savvy people are more likely to be in favor of DTCA, while 
people with higher level of education are more likely to oppose DTCA. Overall, DTCA is 
more appealing to many individuals with less power and control given the fact that it 
directly reaches the public without being channeled through the healthcare system 
(Ceccoli & Klotz, 2013). 
 
 
2.7.2 Online Search for Health Information 
 
When it comes to the information sought by patients online and not directly presented 
to them through DTCA, fewer studies have investigated the impact on patient health 
behavior. The development of online health education websites is rapid with the potential 
to influence the way patients interact with their physicians (Sciamanna, Clark, Diaz, & 
Newton, 2003). It has been claimed that 80% of the U.S. adults and 60% of their 
European counterparts use the Internet to seek medical advice (Sillence, Briggs, Harris, 
& Fishwick, 2007). Internet use for health-related activities assessed by the 2002 Pew 
Internet and American Life Project found that 6 out of 10 Americans have access to the 
Internet (Sciamanna et al., 2003).  
 
Unlike the DTCAs that are usually presented to the public in a simple language 
format (i.e., story structure), several issues face consumers and patients alike when they 
search online for information about a medication or a medical device. Patient health 
literacy, the complexity of information or medical jargon, the variability of the content 
quality, and the potential for commercial interests to influence the content of the online 
information are some examples of issues that face patients when they use the Internet to 
look for information about a medical condition or a medication (Winker et al., 2000). In a 
systematic meta-analysis of health-related websites evaluations, 70% of studies reported 
that the quality of websites was an issue (Sillence et al., 2007). Despite these issues, 
many patients turn to the Internet to seek information about health and treatment as well 
as support. According to the National Cancer Institute’s Health Information National 
Trends Survey, 56.5% of the breast cancer patients visited an online website to learn 
more about their clinical condition. They also have reported that the Internet represents 
their second source of information after their physicians. Online information was also 
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found to have a positive effect on the physician-patient relationship (Shaw et al., 2007). 
In another cross-sectional study, patients who do not have Internet access and felt that 
their physicians engaged them in the decision making process were more interested in 
using the Internet for health-related activities compared to those who felt that their 
physicians engaged them less in the decision making process. On the other hand, no 
association was found between having interest to use the Internet for health-related 
activities and physician-patient relationship among those who have access to the Internet. 
This suggests that once people have access to the Internet they no longer view it as filling 
in gaps in their communication with physicians, but as a secondary source of information 
after their physicians’ advice (Sciamanna et al., 2003). In another national survey, the 
access to reliable online health-related websites has been linked to reduced anxiety, a 
feeling of self-efficacy, and reduced utilization of ambulatory healthcare services (Ybarra 
& Suman, 2006). Evidence also suggests that online health information may in fact 
encourage individuals to seek healthcare (Ybarra & Suman, 2006). 
 
Research has shown that most online health information seekers use a general search 
engine (i.e., Yahoo®, Google®) rather than MedlinePlus (Health Information from the 
National Library of Medicine). They typically spend about half an hour browsing two to 
five websites and afterwards do not remember the website’s name from which they 
obtained the information. They usually seek information online to enhance their 
knowledge of their medical conditions, help them diagnose a medical condition, and 
sometimes verify their physician’s diagnosis and medical advice (Ybarra & Suman, 
2006). Minorities have greater interest in using the Internet to seek health information as 
well as to check the appropriateness of their medical treatment because they feel the 
Internet is relatively race neutral (Sciamanna et al., 2003). Adults who are ≥ 65 years of 
age have been found to be the least users of the Internet (Jenkins & Dunn, 2004). 
Whereas middle-aged adults were more likely to use the Internet for health-related 
information, and 41% of the adolescents have reported changing their health behavior as 
result of visiting health educating websites (Ybarra & Suman, 2006). 
 
In a qualitative study that aimed to test how patients trust online health-related 
information, 15 white postmenopausal women with at least high school degree were 
enrolled in a longitudinal study that was conducted between August 2003 and April 2004 
in the United Kingdom. All were keen to learn more about this critical period of their life, 
and have reported visiting women’s health websites at least once a week. The theoretical 
staged model of trust that was proposed for the study was divided into three phases 
(Figure 2-4). In the first phase, each participant attended a two-hour session in an 
Internet café for four weeks. During each session, the participants were given an hour to 
search the Internet for information related to women’s health, followed by a 50-minute 
discussion with a facilitator. In the discussion session, participants were asked about their 
current online information sources, their search strategies, trusted and mistrusted 
websites, their first impressions, and the revisited websites. In the next phase, the 
participants were asked to log their online health search behavior in diaries over the  
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Figure 2-4.  Staged model of trust. 
 
Source: Reprinted from Social Science and Medicine, 64(9), Sillence, Briggs, Harris & 
Fishwick, How do Patients Evaluate and Make Use of Online Health Information?/Figure 
1, 1853-1862, 2007 Feb, with permission from Elsevier. 
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following 6 months. In the final phase, that followed the second phase by one month, the 
participants underwent a structured telephone interview to assess the influence of the 
online sources on participants’ relationships with their physicians as well as their level of 
involvement in the decision-making process. All discussions were recorded and 
transcribed, and then extracts of trust and mistrust were coded. Diaries were analyzed 
based on the thematic analysis, and the interviews according to the emergent themes. The 
participants reported that the design and feel of the website was one of the deciding 
factors on whether they accept or reject a website (i.e., websites with pop-up 
advertisements were more likely to be rejected). Furthermore, websites that belong to 
credible organizations (i.e., reputable healthcare institutions), and reviewed by experts 
were more likely be accepted. The participants also reported that websites that address 
most of their questions, have relevant answers, and have information written by laypeople 
were likely to be revisited. The online search for health-related information increased the 
participants’ feelings of social support, and provided them with an opportunity to explore 
alternative treatment options. In addition, the online information was found to influence 
the patients’ preference for health decision-making without having any negative effect on 
their relationship with their physicians (Sillence et al., 2007). In another study, factors 
such as convenience and anonymity of getting information through online health websites 
were found to be crucial for consumers who browse such websites. In addition, the 
readability of the information presented on the health websites is highly important given 
the fact that the average American reads at 8th grade level and 20% of the Americans read 
at 5th grade level (Jenkins & Dunn, 2004).  
 
Visiting online health-related websites had a positive impact on the patient adherence 
to treatment (Kuppersmith, 2002). It also had several potential benefits with regard to the 
physician-patient relationship by helping patients to make informed healthcare decisions, 
empowering them to collaborate with their physicians, getting them involved in the 
decision-making process, using the time with physicians more efficiently, helping them 
find online support groups, and hearing about other patient experiences with the same 
medical condition or on similar treatment (Wald, Dube, & Anthony, 2007). However, 
patient access to online health-related websites can also have potential disadvantages. In 
a study that investigated the role of the Internet on the physician-patient relationship, 
90% of the people who visit health-related websites frequently felt that they could 
manage their own health issues by themselves, and 82% of them stated that the websites 
provided more useful information on new medications and alternative treatment options 
than their physicians or pharmacists. The lack of attention to details, the personal touch 
that once existed in the physician-patient relationship, and the limited period of time 
patients see physicians were cited as the main reasons behind the findings (Erdem & 
Harrison-Walker, 2006). Access to the websites by patients may also diminish their trust 
in their physicians as well as in the healthcare system creating a real challenge to 
physicians to regain their patients’ trust back again (Wald et al., 2007). Also, patients 
trust in the websites may lead to self-diagnosis, treatment using over-the-counter 
medications, result in misdiagnosis, and inappropriate treatment if incorrect information 
was relied on (Erdem & Harrison-Walker, 2006). Furthermore, health-educating websites 
may exacerbate socioeconomic health disparities due to the fact that some patients do not 
have access to the Internet (Wald et al., 2007). 
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The rapid expansion of online medical information, easier access to online health 
information by patients, and heightened consumer expectations has changed the role of 
the physician drastically. Physicians today must help patients interpret information they 
have gathered, guide them to reliable sources of information, and develop a strategy for 
finding and integrating new information. (Kuppersmith, 2002). Today, patients can go 
online and search for good physicians (i.e., reading people’s reviews and stars ratings) by 
browsing multiple physicians’ rating websites. However, the Internet does not only have 
physician evaluation websites, it also has several medication and medical device rating 
websites. These websites reflect other patient experiences with medications, treatment 
approaches, and medical conditions in general. Assessing and understanding the value of 
these websites to patients is important. 
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CHAPTER 3.    METHODOLOGY 
 
 
3.1  Study Design 
 
The primary purpose of the research study was to explore the value of online ratings 
of medications to the elderly population and evaluate if older adults’ views regarding 
such online websites providing patient feed-backs of their medications varies with their 
sociodemographics, quality of life, beliefs about medication, health literacy, preferences 
for involvement in decision making, and medication adherence. The study main goal was 
to explore the relevance of such online websites to older adults’ care (i.e., facilitating 
physician-patient communication, and encouraging patients to take part in the decision-
making). Further, participants’ views of such online websites (i.e., do they trust the online 
ratings of medications) were also considered. Relevant information thought to impact 
older adults’ opinions of such websites including their sociodemographics, health 
literacy, medication adherence, preference for involvement in health decision-making, 
beliefs about medications, and quality of life were collected using validated 
questionnaires. Seven senior centers in the State of Tennessee were visited and older 
adults (≥60 years of age) were asked to complete Patient Reviews of Medication 
Experiences questionnaire that examines the value of online ratings of medication 
websites. Alongside PROMEX, participants were also asked to complete other validated 
questionnaires that collected information about factors that may affect the elderly 
participants’ opinions of such online websites. Permissions to use these questionnaires 
were received prior to the beginning of the study (Appendix A). 
 
 
3.2  Settings and Subjects 
 
Data were collected in Tennessee at senior centers in Memphis and the surrounding 
areas of Arlington, Bartlett, Cordova, and Somerville. Older adults visit these senior 
centers to socialize with their peers and spend fun time together. Seniors who met the 
following criteria (1) being 60 years of age and older and (2) taking prescription 
medications were asked to participate in the study. Further, those who reported having 
HTN were asked to complete a second part of the PROMEX questionnaire that assessed 
the level of adherence to their antihypertensive medications.  
 
 
3.3  Sampling Plan 
 
A convenience sample of 300 elderly subjects from the senior centers were recruited. 
Both the principal and co-investigator chose this method due to time and resource 
limitations. However, we tried to make our sample as representative as possible by 
recruiting participants from different locations. 
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3.4  Data Collection 
 
The Senior Centers’ coordinators were contacted at least a week prior to the planned 
visit and a date and time was set up. Two research assistants visited the following senior 
centers:, the Orange Mound Senior Center, McWherter Senior Center in Memphis, 
Frayser-Raleigh Senior Center and Bert Ferguson Community Center in Cordova located 
in Memphis; the Bartlett Senior Center in Bartlett, the Somerville Senior Center in 
Somerville, and the Senior Citizens Center in Arlington. In reserved private rooms in 
these Senior Centers, the survey administrators explained to the seniors that their 
participation was voluntary and they could withdraw from the study at any time without 
penalty. Further, the first page of the survey explained the purpose of the study, the rights 
of the participants and asked participants to sign a consent form before starting the 
survey.  
 
The survey consists of two parts: all older adults on prescription medications 
regardless of their medical conditions should complete the first part; however, the second 
part was completed only participants with HTN should since it includes a medication 
adherence questionnaire that measures adherence among those participants. Those who 
completed the survey received a $20 Kroger gift card as an appreciation for their 
participation. Data collection was started in August 2013 and was completed in 
December 2013. 
 
  
3.5  Participant-Reported Outcome Measures 
 
 
3.5.1 Older Adults’ Opinions of the Online Medication Rating Websites 
 
A validated measure that surveys individuals about the usefulness of online reviews 
of medications by patients did not exist. Therefore, a questionnaire was created to address 
important aspects of the online medications rating websites that are important to the older 
adults. The Patient Reviews of Medication Experience (PROMEX) questionnaire has two 
domains: 
 
I. The value of such websites in general as well as in facilitating patient-
physician communication. 
II. The trustworthiness and the influence of online patients reviews of 
medications on the participant’s medication preference. 
The first proposed domain consists of four questions with a five-point Likert scale, in 
which the first question inquires about the usefulness of such websites in general from the 
perspective of older adults. Further, to explore the usefulness of the online patients’ 
medications reviews, the participants were asked about the likelihood they would 
mention it to their physicians/prescribers. The third question inquired about the likelihood 
such online reviews would facilitate communication with their physicians. The final 
question inquired about the probability that physicians would be upset if the participants 
brought up the online reviews. 
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The second proposed domain contains three questions with a Likert scale of five 
points. The first question in this domain inquired about the trustworthiness of such 
websites to participants. To examine how much older adults trust such websites that show 
them medications reviews, we asked them about the likelihood they would provide their 
own comments and ratings of their prescribed medications. The final question inquired 
about the influence of the online patient reviews of medications on the participants’ 
medication preference. The total number of questions in both domains is seven with 
proposed maximum points of 35 and a minimum of seven. The higher the score, the more 
likely older adults believe that these online websites are useful in general as well as in 
facilitating their communication with physicians. 
 
Since the PROMEX questionnaire was newly created and recently used, it was 
validated using Principal Component Analysis and Varimax Rotation methods to test for 
its construct validity. To test for reliability, the internal consistency (Cronbach’s Alpha) 
method was used. 
 
 
3.5.2 Patient-Centered Practice Attributes 
 
The Primary Care Assessment Survey (PCAS) is a validated 51-item, self-report 
questionnaire which is designed to operationalize the formal definitions of primary care. 
The PCAS measures seven domains of primary care through 11 validated summary 
Likert-scaled measures which perform consistently well across population subgroups 
defined based on age, sex, education, race, household income, and health status. Each 
scale ranges from 0 to 100 with higher scores indicating more of the underlying attribute 
(Safran et al., 1998). 
 
The Communication and the Interpersonal Treatment are two validated scales within 
the Primary Care Assessment Survey (PCAS) (Safran et al., 1998).  Both the 
Communication and the Interpersonal Treatment summary scales have excellent 
reliability with high Cronbach’s Alpha (0.95) (Nunnally, 2010; Safran et al., 1998). In the 
communication scale of the PCAS, participants were asked to rate their physicians on six 
important aspects of primary care that are aligned with the Institute of Medicine (IOM) 
definition of primary care. These aspects are: the thoroughness of the questions being 
asked about their symptoms, attention to what they have to say, explanations provided 
about their medical conditions and treatment, instructions about symptoms to report and 
when to seek help, advice and help in making decisions about their own care, and finally 
whether they leave their Physicians’ offices with unanswered questions (Care, 
Donaldson, Yordy, & Vanselow, 1994; Safran et al., 1998). The interpersonal treatment 
scale addresses another five aspects of primary care that are also aligned with the IOM 
definition of primary care; participants were asked to rate their physicians on the amount 
of time spent with them, patience with their questions, friendliness and warmth received, 
care and concern, and finally the level of showed respect to them (Safran et al., 1998). 
 
Each of the covered items in both the communication and the interpersonal treatment 
scales have six possible answers based on the Likert scale. Each one of them is assigned a 
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value (i.e., Very poor=1, Poor=2, Fair=3, Good=4, Very good=5, Excellent=6; or 
Always=1, Almost always=2, A lot of the time=3, Some of the time=4, Almost never=5, 
Never=6). The Communication scale has six questions with six possible answers for each 
question. The highest possible score of 36, the lowest possible score is six, and the 
possible raw score range is 30. The interpersonal treatment scale has five questions with 
six possible answers. The highest possible score is 30, the lowest possible score is 5, and 
the possible raw score range is 25. The higher the scores of both the PCAS-
Communication and PCAS-interpersonal treatment scales, the higher the satisfaction of 
the respondents of both their physicians’ communication and interpersonal treatment. 
 
 
3.5.3 Health-Related Quality of Life 
 
Participants’ Health-Related Quality of Life (HRQoL) was measured using the Short 
Form Health Survey (SF-12v2). The SF-12v2 is a validated generic questionnaire 
(Cronbach’s Alpha>0.7), which assesses the general self-reported health as well as 
limitations in everyday activity owing to physical and mental health in the past four 
weeks(Ware Jr et al., 1996). It has two component summary scales, the Physical 
Component Summary (PCS-12) and the Mental Component Summary (MCS-12) with 
higher scores (ranges between 0 to 100) indicating better quality of life (Ware Jr et al., 
1996). 
 
 
3.5.4 Patients’ Beliefs about Medications 
 
The patients’ beliefs about medications were assessed using the Beliefs about 
Medicine Questionnaire (BMQ). The BMQ was developed by Horne in the United 
Kingdom and has been validated across multiple health conditions (Horne et al., 1999). It 
consists of two sections, one general and one specific. The general section contains eight 
statements that can be broken down into two themes. The first theme is the “General-
Harm”, which comprised beliefs about the intrinsic nature of medications and the extent 
to which they are perceived as harmful. The second theme is the “General-Overuse”, 
which is comprised of beliefs about the way medications are used and in particular, 
whether physicians overprescribe them. The second section consists of ten statements that 
can be broken down into two themes. The first theme is the “necessity”, which focuses on 
the perceived necessity of the medication to maintain and improve the health. The second 
theme is the “concerns”, which focuses on the perceived concerns of the potential adverse 
effects of the medications. Respondents can indicate their level of agreement with each 
statement on a five-point Likert scale (Horne et al., 1999). Since seniors who were taking 
prescribed medications were surveyed about their opinions of the online reviews of 
medications, and were not focusing on a certain disease, the general BMQ was used. 
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3.5.5 Medication Adherence 
 
Medication adherence was measured using Morisky Medication Adherence Scale 
(MMAS-8) among those who reported having hypertension. The MMAS-8 is a validated 
self-report questionnaire that consists of eight questions. An alpha reliability of 0.83 was 
computed among 1367 patients who were diagnosed with essential HTN by primary care 
providers in an outpatient clinic of a large teaching hospital and was significantly 
associated with blood pressure control (p<0.05). The underpinning theory of this 
questionnaire was that failure to adhere to treatment regimen could stem from several 
factors such as forgetfulness and complexity of the treatment regimen. The MMAS-8 
questions were phrased in a way to avoid the “yes-saying” bias, which is usually the 
patients’ tendency to give positive answers to healthcare providers. The questions address 
patient medication taking behavior but not medication adherence determinants; with a 
dichotomous response (yes/no) to 7 out of 8 questions and 5-point Likert response for the 
last question. The total scale has a range between zero and eight with higher scores 
indicating better adherence. A cutpoint of <6 is used to identify patients with poor 
adherence to an antihypertensive treatment regimen with 93% sensitivity and 53% 
specificity. Each question was given a score of either zero or one. If the participant 
answered questions 1, 2, 3, 4, 6, and 7 with “Yes”, a score of zero was assigned to each 
response; and if their answers was “No” a score of one will be assigned to their 
responses. However, in question five, if participants answered the question with “Yes”, a 
score of one was assigned to their response, and zero if their answer was “No”. In 
question eight which has 5-point Likert response scale, a score of one was assigned to 
participants’ response if they chose “Never”, 0.75 if “Once in a while”, 0.5 if 
“Sometimes”, 0.25 if “Usually”, and 0 if “All the time” was selected. The predictive 
validity of this scale has been assessed through association with blood pressure readings, 
attitude, social support, coping techniques with stress, knowledge about their medical 
condition and treatment, and patients’ satisfaction with the provided care (Krousel-Wood 
et al., 2009; Morisky, Ang, Krousel?Wood, & Ward, 2008; Morisky & DiMatteo, 2011).  
 
 
3.5.6 Older Adults’ Evaluation of Their Antihypertensive Medication Regimens 
 
To further understand the value of PROMEX and examine the association between 
participants’ evaluations of their own medications and medication adherence as well as 
other participant-reported outcomes (PROs) such as the quality of life, a simulation of 
PROMEX was created at the end of survey. We asked the participants who reported 
taking medications for HTN to rate their medications on a scale from 1 to 5 on five 
different medication use aspects (i.e., effectiveness, side effects, ease of use, cost, and 
food interactions) and give an overall rating for each medication. Four medication-rating 
tables were provided in case the participant was taking more than one medication for 
HTN.  A specific score was created for each participant by taking the average of each 
participant’s antihypertensive medication regimen ratings for every single medication use 
aspect as well as the overall rating. Both the overall rating score of the participants’ 
antihypertensive medication regimens as well as the specific medication use aspects 
rating scores were reported. 
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3.6  Participants’ Characteristics 
 
 
3.6.1 Sociodemographics 
 
Participants were asked to report their age, gender, race, and years of education, 
marital status, and the household member(s) they live with via either filling in the blanks 
or checking off the answer that best describes their situation. The participants’ age was 
categorized into four groups (i.e., 50-60, 61-70, 71-80, and >80 years of age). Further, the 
participants’ mean age ± standard deviation was compared across senior centers. Race 
was categorized into four groups (i.e., African Americans, Caucasians, Hispanics, and 
Others). Marital status was dichotomized into two groups (i.e., married vs. unmarried)1 . 
Education was categorized into three groups based on the number of years spent in school 
or higher education (i.e., high school or less, college degree, post-graduate degree). 
Living status was dichotomized into two groups (i.e., alone vs. not alone)2.  
 
 
3.6.2 Health Decision Sharing Preference 
 
Patients’ engagement in their own health care has been associated with both lower 
health costs and hospital admissions (Hibbard & Greene, 2013). Research shows patients 
in general want to be involved in their health care (Bernabeo & Holmboe, 2013). 
However, understanding the factors that influence patients’ decision sharing preference is 
still elusive (Légaré & Witteman, 2013). Therefore, many like to describe the patients’ 
preference for involvement in the health care decision making as patient-specific 
(Bernabeo & Holmboe, 2013). Thus, a validated question was included that assessed the 
participant’s preference for engagement in their health care (Lawler, 1998).  Participants 
were asked the following question (Lawler, 1998, p.1549; Ray, 1997): 
 
“What do you prefer for involvement in decisions about your health care? Would you 
prefer to: 
 
? Keep control in your own hands? 
? Have an equal partnership with the doctor? 
? Leave it in the doctor’s hands?” 
The health care decision sharing preferences across the different senior centers were 
compared. However, to know whether the health decision sharing preference had any 
impact on participants’ views of PROMEX, they were categorized into two groups. Even 
though response options I and III were distinctly different, they share one thing, a health 
decision non-sharing preference. Therefore, they were labeled as a healthcare decision 
                                                 
 
1 Unmarried includes all those who reported being widowed, divorced, separated, and single. 
2 Not alone includes all participants who reported living with a spouse, friend, community center, family 
members…etc.  
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non-sharing group. The second group includes those who preferred to have an equal 
partnership with their physicians. 
  
 
3.6.3 Health Literacy 
 
Health literacy is variable among different patient populations and has a significant 
impact on several health outcomes such as medication adherence (Kripalani, Gatti, & 
Jacobson, 2010; Kutner, Greenberg, & Baer, 2005). Therefore, controlling for this 
important variable is crucial in understanding the relationship between any two 
participant-reported outcome measures. There are several validated questionnaires that 
have been widely used to assess patients’ health literacy level such as the Test of 
Functional Health Literacy in Adults (TOFHLA) (Parker, Baker, & Williams, 1995). 
However, due to the length of the questionnaires, new and shorter versions of the same 
health literacy assessment tools have been developed (Baker, Williams, Parker, 
Gazmararian, & Nurss, 1999). Further, health literacy screening questions with high Area 
under the Receiver Operating Characteristic (AUROC) have been created and validated 
to assess patients’ health literacy with only one question (Wallace, Rogers, Roskos, 
Holiday, & Weiss, 2006). Thus, the following question was used “How confident are you 
filling out medical forms by yourself?” (Extremely, quite a bit, somewhat, a little bit, or 
not at all) with an AUROC of 0.79 (95% CI=0.74 to 0.83) when plotted against the Rapid 
Estimate of Adult Literacy in Medicine (REALM). The “somewhat” response was 
recommended as the optimal cutoff point to identify participants with limited or marginal 
health literacy skills (Chew, Bradley, & Boyko, 2004; Wallace et al., 2006, p.874). Thus, 
the respondents were dichotomized into two groups: marginal/limited and good health 
literacy.  
 
 
3.6.4 Medical Conditions 
 
Senior participants were asked to identify diseases they had from a list of more than 
14 medical conditions prevalent among the U.S. population in general and among the 
U.S. elderly population in particular (Ward, 2013). The list included the following: 
 
1. Hypertension. 
2. Angina pectoris or coronary artery disease (CAD). 
3. Congestive Heart Failure (CHF). 
4. Myocardial infarction or heart attack. 
5. Stroke. 
6. Asthma, emphysema or COPD (Chronic Obstructive Pulmonary Disease). 
7. Diabetes. 
8. Arthritis or any kind of rheumatism. 
9. Chronic back pain or sciatica. 
10. Depression. 
11. Gastroesophageal Reflux Disease (i.e. chronic heartburn “GERD) or 
ulcers. 
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12. Cancer (other than skin cancer). 
13. Sexual dysfunction. 
14. Irritable bowel syndrome or indigestion. 
Further, the participants were asked to write down the number of prescription 
medications that they were currently taking. In addition, those who had HTN were asked 
to write down the number of years since they were diagnosed with HTN as well as the 
number of medications they were taking. 
 
 
3.7  Statistical Analysis 
 
 
3.7.1 Sample Size Estimation 
 
The estimated minimum sample size for a medium effect size at a power=0.80 and 
α=0.05 for multiple regression analysis and for eight independent variables based on the 
Cohen statistical power analysis method is 107 participants (Cohen, 1992). In addition to 
the Cohen statistical power analysis method, the GPOWER software was also used to 
estimate the minimum sample size using the same criteria and determined 127  
participants were needed for twelve explanatory (i.e., independent) variables (Erdfelder, 
Faul, & Buchner, 1996). In this research project, 300 seniors have participated and 
completed the survey. 
 
 
3.7.2 Descriptive Statistics 
 
Frequencies and means were reported for sociodemographic and medical history 
variables. Means and standard deviations were reported for continuous variables. For 
ordinal and nominal variables, percentages were reported. The comparisons between the 
groups were made with the use of a two-sided student’s t-test for continuous data and chi-
square test for categorical data. Further, one-way analysis of variance (ANOVA) was 
used to test the difference in the means between the different categorical variables 
(Tabachnick & Fidell, 2001). 
 
 
3.7.3 Assessing PROMEX Reliability 
 
The reliability of PROMEX was computed using the Cronbach’s alpha (Seibert et al., 
1999). Cronbach’s alpha is a measure of internal consistency that is commonly used in 
questionnaires’ reliability validation (Thorndike & Hagen, 1961). A questionnaire with 
Cronbach’s alpha of ≥0.7 is considered to be internally consistent (Cronbach, 1951). 
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3.7.4 Principal Component Analysis 
 
Principal Component Analysis was used to identify the underlying factor structure of 
the Patient Reviews of Medication Experiences (PROMEX) questionnaire. Although two 
factors or domains have been hypothesized to be the underlying construct of PROMEX, 
the Principal Component Analysis was conducted to verify the hypothesis (Suhr, 2005). 
An eigenvalue greater than or equal to one along with the results of the scree plot were 
used to determine the number of possible factors or domains that can be extracted from 
PROMEX. Further, varimax rotation was also used to determine the loading of each 
variable on each potential factor (Jolliffe, 2005). 
 
 
3.7.5 Path Analysis 
 
Wanting to examine the association between different participant-reported outcomes 
such as quality of life and medication adherence with the participants’ views of 
PROMEX, the running of simple linear regression models where potentially more than 
one dependent variable can exist was not possible. Therefore, using path analyses in 
which multiple dependent variables can coexist is more plausible. As an extension of 
multiple regression (Streiner, 2005). Path models have several advantages over multiple 
regression. Firstly, it is a powerful technique in which complex models with multiple 
dependent variables as well as chains of influence can coexist may be more plausible in 
certain research settings like ours (Streiner, 2005). Secondly, the path analysis approach 
is more flexible than the ordinary least square method as the structure of the path models 
can be modified to increase the model’s fitness (Nazim & Ahmad, 2014). Thirdly, it 
enables one to disentangle complex interrelationships among variables and eventually 
identify the most significant pathway in predicting the outcome (i.e., dependent) variable 
(Lleras, 2005). 
 
3.7.5.1 The Association between the Older Adults’ Views of the Online Reviews of 
Medications and Their Satisfaction with Physician Communication 
 
In order to determine whether the association between participant satisfactions with 
their physicians’ communication and their views of the online rating of medications, a 
path model based on the evidence based predictors of patients’ satisfaction with 
physicians’ quality of care was created. The model created represented the evidence 
based sociodemographic and health status predictors of the satisfaction with physicians’ 
communication. Age, education, marital status, health literacy, comorbidities, race, and 
gender are significant predictors of patients satisfactions with physicians (Hall & Dornan, 
1990; LaVeist & Nuru-Jeter, 2002; Moy & Bartman, 1995; Tucker & Kelley, 2000). 
Then, the association of the Primary Care Assessment Survey (PCAS) the 
Communication scale and the participant’s views of the online rating of medications 
(PROMEX) was looked at. 
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3.7.5.2 The Association between the Older Adults’ Views of the Online Reviews of 
Medications and Their Quality of Life 
 
Any path model that tests the Health related Quality of Life (HRQoL) effect on any 
outcome variable, should take into consideration the significant predictors of HRQoL. 
Therefore, a path model was tested taking into account the sociodemographic factors, 
health status, and interpersonal treatment as well as effective healthcare communication 
with participants that were significant predictors of HRQoL (Felce, 1997; Low & 
Molzahn, 2007; Odigie & Marshall, 2008; Xavier et al., 2003). 
 
3.7.5.3  The Association between the Older Adults’ Views of the Online Reviews of 
Medications and Their Beliefs about Medications 
 
In order to examine the influence of participants’ beliefs about medications on their 
views of the online reviews of medications, the evidence-based predictors of participants’ 
beliefs about medications must be accounted for in a path model. Then, the effect of 
beliefs about medications on participants’ views of online rating of medications can be 
examined in the same model. Physicians’ communication style, participants’ age, culture 
or ethnicity, education, gender, and the number of prescription medications the 
participants take on a daily basis are considered significant predictors of participants’ 
beliefs of medications (Bultman & Svarstad, 2000; Horne et al., 2004; Iihara et al., 2004; 
Isacson & Bingefors, 2002; Mårdby et al., 2007). 
 
3.7.5.4 The Association between the Older Adults’ Views of the Online Reviews of 
Medications and Their Adherence to Antihypertensive Medications 
 
In order to examine the effect of medication adherence on the participants’ views of 
online medication reviews (PROMEX), a path model was constructed based on evidence-
based predictors of medication adherence. Age, gender, race, beliefs about medications, 
health literacy, satisfaction with physicians’ communication, education, the number of 
prescription medications, comorbidities, and overall rating of antihypertensive treatment 
regimen were included in the model (Gellad et al., 2011; Krousel-Wood et al., 2009; 
Morisky et al., 2008; Sa’ed et al., 2013). 
 
3.7.5.5 The Association between the Older Adults’ Views of the Online Reviews of 
Medications and Their Satisfaction with Physicians’ Communication, Beliefs 
about medications, and Health-Related Quality of Life 
 
The association between participants’ views of online medication rating websites 
(PROMEX) and their satisfaction with physicians’ communication, beliefs about 
medications, and health-related quality of life was examined in one model in which most 
of the evidence-based predictors for each of the included participant-reported outcomes 
were controlled for in this overarching model.  
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In this model, race, gender, marital status, and health literacy were specified as direct 
predictors of the participants’ satisfaction with their physicians’ communication, which 
was measured by the PCAS-Communication scale (Hall & Dornan, 1990; LaVeist & 
Nuru-Jeter, 2002; Moy & Bartman, 1995; Tucker & Kelley, 2000). With regard to 
participants’ beliefs about medications, which was measured by the BMQ-general, the 
number of prescription medications participants reported taking, participants’ satisfaction 
with their physicians’ communication, gender, and race were specified as direct 
predictors participants’ beliefs about prescription medications (Horne et al., 2004). 
Further, the participants’ health-related quality of life scores measured by the PCS-12 and 
MCS-12 of the SF-12v2 were included in the model with the number of chronic health 
conditions, age, number of prescription medications, health literacy, marital status, and 
education specified as direct predictors of these two health-related quality of life scales 
(Felce, 1997; Low & Molzahn, 2007; Odigie & Marshall, 2008; Xavier et al., 2003). 
Moreover, even though some variables, which were collected in the study, and may 
predict certain participant-reported outcomes, such as health literacy and BMQ-general, 
were not specified as direct predictors of these outcomes, these variables were controlled 
for indirectly since all of the sociodemographic and medical factors that were collected 
from the participants in this study were included in this model.  
 
Finally, the PCS-12, MCS-12, and the health decision sharing preference were 
specified as direct predictors of the participants’ views of online medication rating 
websites, which was measured by PROMEX. These three variables were specified as 
direct predictors of PROMEX for several reasons. The health-related quality of life is a 
multidimensional concept that is influenced by an array of factors. Therefore, the 
specified predictors of both the PCS-12 and MCS-12 in the model captured most of the 
variables, and hence the impact of other variables on PROMEX can be indirectly 
examined. In addition, the health decision sharing preference was specified as a direct 
predictor of PROMEX since it is participant-specific (Bernabeo & Holmboe, 2013). 
 
 
3.7.6 Regression Analysis 
 
In addition to the path analysis, multiple linear regression analysis was conducted to 
assess the relationship between the perceived value of the online patients’ reviews of 
medications by older adults and each of the aforementioned participant-reported 
outcomes. The dependent variable of interest was the total score of PROMEX. The 
independent variables of interest were the scores of the communication domain of the 
PCAS, Mental and Physical Component Summaries (MCS & PCS) of the SF-12v2, 
Beliefs about Medicines Questionnaire (BMQ) General Overuse and Harm domains, and 
Morisky Medication Adherence Scale (MMAS-8). Other independent variables were age, 
gender, race (i.e. African Americans, Caucasians, Hispanic, and others), years of 
education, number of chronic medical conditions, number of prescription medications, 
and health literacy. The model adequacy was checked through diagnostic tools such as 
the normality of the residuals. 
 
 52 
I. The Regression Model for the Association between the Older Adults’ 
Views of the Online Reviews of Medications and Their Satisfaction 
with Physician Communication: 
PROMEX =βº +β1 (PCAS-Communication) +β2 (Age) + β3 (Comorbidities) 
+ β4 (Education) + β5 (Race) + β6 (Health Literacy) + β7 (Gender) + β8 
(Gender) + β9 (Marital Status) +ε. 
 
II. The Regression Model for the Association between the Older Adults’ 
Views of the Online Reviews of Medications and Their Quality of 
Life: 
PROMEX =βº +β1 (PCS-12) +β2 (MCS-12) + β3 (PCAS-Communication) + 
β4 (Age) + β5 (Comorbidities) + β6 (Education) + β7 (Race) + β8 (Health 
Literacy) + β9 (Gender) + β10 (Marital Status) +ε. 
 
III. The Regression Model for the Association between the Older Adults’ 
Views of the Online Reviews of Medications and Their Beliefs about 
Medications: 
PROMEX =βº +β1 (BMQ-Overuse) +β2 (BMQ-Harm) + β3 (PCAS-
Communication) + β4 (Age) + β5 (Number of Prescription Medications) + 
β6 (Education) + β7 (Race) + β8 (Gender) + ε. 
 
IV. The Regression Model for the Association between the Older Adults’ 
Views of the Online Reviews of Medications and Their Adherence to 
Antihypertensive Medications: 
PROMEX =βº +β1 (MMAS-8) +β2 (PCAS-Communication) + β3 (BMQ-
Overuse) + β4 (BMQ-Harm) + β5 (Overall Rating of HTN Medications) + 
β6 (Age) + β7 (Comorbidities) + β8 (Race) + β9 (Health Literacy) + β10 
(Gender) + β11 (Number of Prescription Medications) + β12 (Marital 
Status) + ε. 
 
 
3.7.7 The Association between Participants’ Rating of Their Antihypertensive 
Medication Regimens and Participant-Reported Outcomes (PROs) 
 
Since online rating of medications is an evaluation of patients’ medications 
experiences, participants who reported having HTN were asked to complete the Morisky 
Medication Adherence Scale (MMAS-8) and rate their antihypertensive medications that 
reported taking. Multiple linear regression analyses were done to examine the association 
between each participant-reported outcome and participants’ evaluation of their 
antihypertensive medications. The dependent variables were the scores of the 
communication domain of the PCAS, Mental and Physical Component Summaries (MCS 
& PCS) of the SF-12v2, Beliefs about Medicines Questionnaire (BMQ) General Overuse 
and Harm domains, and Morisky Medication Adherence Scale (MMAS-8). The main 
independent variable of interest was the participant-specific overall rating score of the 
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antihypertensive medication regimen. The other independent variables were age, gender, 
race (i.e. African Americans, Caucasians, Hispanic, and others), years of education, 
number of chronic medical conditions, number of prescription medications, and health 
literacy. All statistical analyses were conducted using SAS® 9.4 (SAS Institute, Inc., 
Cary, NC, USA). 
 
I. The Regression Model for the Association between the Overall Rating 
of Antihypertensive Medication Regimen and Satisfaction with 
Physician Communication: 
PCAS-Communication =βº + β1 (Overall Rating of HTN Medications) + β2 
(Age) + β3 (Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health 
Literacy) + β7 (Gender) + β8 (Number of Prescription Medications) + β9 
(Marital Status) + ε.  
 
II. The Regression Model for the Association between the Overall Rating 
of Antihypertensive Medication Regimen and the Quality of Life: 
 
i. Regression Model for the Association between the Overall Rating of 
Antihypertensive Medication Regimen and the PCS-12: 
PCS-12 =βº + β1 (Overall Rating of HTN Medications) + β2 (Age) + β3 
(Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health Literacy) + β7 
(Gender) + β8 (Number of Prescription Medications) + β9 (Marital Status) 
+ ε.  
 
ii. Regression Model for the Association between the Overall Rating of 
Antihypertensive Medication Regimen and the MCS-12: 
MCS-12 =βº + β1 (Overall Rating of HTN Medications) + β2 (Age) + β3 
(Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health Literacy) + β7 
(Gender) + β8 (Number of Prescription Medications) + β9 (Marital Status) 
+ ε.  
 
III. The Regression Model for the Association between the Overall Rating 
of Antihypertensive Medication Regimen and the Beliefs About 
Medication: 
 
i. Regression Model for the Association between the Overall Rating of 
Antihypertensive Medication Regimen and the BMQ-Overuse: 
BMQ-overuse =βº + β1 (Overall Rating of HTN Medications) + β2 (Age) + 
β3 (Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health Literacy) + 
β7 (Gender) + β8 (Number of Prescription Medications) + β9 (Marital 
Status) + ε.  
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ii. Regression Model for the Association between the Overall Rating of 
Antihypertensive Medication Regimen and the BMQ-Harm: 
BMQ-Harm =βº + β1 (Overall Rating of HTN Medications) + β2 (Age) + β3 
(Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health Literacy) + β7 
(Gender) + β8 (Number of Prescription Medications) + β9 (Marital Status) 
+ ε. 
 
IV. The Regression Model for the Association between the Overall Rating 
of Antihypertensive Medication Regimen and Medication Adherence: 
MMAS-8 =βº + β1 (Overall Rating of HTN Medications) + β2 (Age) + β3 
(Comorbidities) + β4 (Education) + β5 (Race) + β6 (Health Literacy) + β7 
(Gender) + β8 (Number of Prescription Medications) + β9 (Marital Status) 
+ ε.  
 
 
3.8  Consideration of Human Subjects 
 
The study was granted an expedited status by the institutional review board (IRB) at 
the University of Tennessee Health Science Center (Appendix B). Although, it was not 
necessary for the participants to sign the consent form since no personal identifiers or 
access to medical records was asked for, a cover letter was included that served as 
consent form as well as an explanation of the research project. All completed surveys 
were securely maintained. 
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CHAPTER 4.    RESULTS 
 
 
4.1  Study Sample Characteristics 
 
Three hundred participants were recruited for the study from seven senior centers in 
and around Memphis, Tennessee. Out of those, 298 participants completed the PROMEX 
questionnaire. The number of eligible participants who were aged 60 years and over as 
well as reported taking one or more prescription medications was 286 participants. The 
participant-reported characteristics are listed in Table 4-1. The mean age of the 
participants was 72 years. Seventy-seven percent of the participants were female. Sixty-
three percent of the participants were married3.  Forty-four percent of the participants 
were living alone. Forty-five percent of the participants had a high school degree or less, 
about 41% had some college degree, and 13% had a post-graduate degree (i.e., master or 
PhD).  Seventy-two percent of the participants had good health literacy level based on 
their response to the question, “How confident are you filling out medical forms by 
yourself?” The majority of the participants (i.e., >80%) reported taking at least two 
prescription medications daily.  The mean number of diseases that each participant had 
from the listed 14 comorbidities common among the elderly was three. Almost 76% of 
the study participants reported having hypertension. The self-reported race was 55% 
Caucasians/white, 40% African Americans/black, 2% Hispanics, and 3% others4. With 
regard to the participants’ preference to share the healthcare decision with their 
physicians’, 79.1% preferred to share their decision. The participants’ Short Form Health 
Questionnaire (SF-12v2) mental and physical component summaries (MCS-12 & PCS-
12) scores, Primary Care Assessment Survey (PCAS) communication and interpersonal 
treatment scales scores, and Beliefs about Medicine Questionnaire general overuse and 
harm domains scores are listed in Table 4-2. The mean scores of the PCS-12 and MCS-
12 of the SF-12v2 were 45.8 and 52.3, respectively. Further, the mean scores for the 
PCAS communication and interpersonal treatment scales were 72.8 and 72.6, 
respectively. Finally, the mean scores for both the BMQ-overuse and BMQ-Harm for the 
study sample were 12.6 and 9.03, respectively.  
 
 
4.2  Item Analysis and Reliability of Patient Reviews of Medication Experiences 
(PROMEX) 
 
An item analysis was performed on the seven questions of Patient Reviews of 
Medication Experiences (PROMEX) questionnaire. The initial Cronbach’s alpha was 
0.76. Table 4-2 lists item means, standard deviations, and the minimum and maximum 
possible score for each item. Further, the inter-item correlation was examined to 
determine items that did not correlate well with one another. Table 4-3 shows that item-7 
had a poor inter-item correlation (p≥0.05) with items-1, 4, and 5. In addition, item-7 had 
a negative inter-item correlation with the other items on the questionnaire. Thus, item-7 
                                                 
 
3 The unmarried comprised of the single, divorced, widowed, separated …etc. 
4 Others were comprised of Asians and Alaska Natives.  
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Table 4-1. Baseline characteristics of the participants across the senior centers. 
 
 
Characteristics 
 Senior centers  
Total 
(n=300) 
 
p-Value Frayser-
Raleigh 
(n=50) 
Orange-
Mound 
(n=94) 
Arlington 
(n=24) 
Bartlett 
(n=48) 
Bert 
Ferguson 
(n=21) 
McWherter 
(n=41) 
Somerville 
(n=22) 
Age-yrs.  
(Mean ± SD) 
74.98±8.32 68.25±25 73.13±7.76 72.81±7.71 74.21±6.96 73.63±9.71 72.3±8.58 71.95±8.65 0.001* 
Sex 
Female  37(74%) 75(80.7%) 15(62.5%) 42(87.5%) 18(85.7%) 27(65.9%) 17(77.3%) 231(77.3%) 0.100 
Male 13(26%) 18(19.4%) 9(37.5%) 6(12.5%) 3(14.3%) 14(34.2%) 5(22.7%) 68(22.7%) 
Marital status 
Married 20(40%) 24(25.8%) 16 (66.7%) 17(35.4%) 10(47.6%) 15 (36.6%) 8(36.4%) 189(63.2%) 0.017* 
Unmarried 30(60%) 69(74.2%) 8 (33.3%) 31(64.5%) 11(52.4%) 26(63.4%) 14(63.6%) 110(36.8%) 
Education 
≤High school  
(1-12 yrs.) 
23(46%) 42(44.7%) 13(54.2%) 21(43.8%) 4(19.1%) 15(36.6%) 18(81.8%) 136(45.3%) 0.014* 
Some college 
degree (13-16 yrs.) 
19(38%) 43(45.7%) 9(37.5%) 18(37.5%) 11(52.4%) 20(48.8%) 4(18.2%) 124(41.3%) 
Post-graduate 
degree (≥17 yrs.) 
8(16%) 9(9.6%) 2(8.3%) 9(18.8%) 6(28.6%) 6(14.6%) 0(0%) 40(13.3%) 
Race 
Caucasians 40(80%) 0(0%) 24(100%) 43(91.5%) 21(100%) 32(78.1%) 4(18.2%) 164(54.9%) <0.001* 
African Americans 8(16%) 88(93.6%) 0(0%) 0(0%) 0(0%) 6(14.6%) 18(81.8%) 120(40.1%) 
Hispanics 1(2%) 2(2.1%) 0(0%) 1(2.13%) 0(0%) 2(4.9%) 0(0%) 6(2.01) 
Others 1(2%) 4(4.3%) 0(0%) 3(6.4%) 0(0%) 1(2.4%) 0(0%) 9(3.01%) 
Health literacy 
Good  42(84%) 62(66%) 0(0%) 41(85.5%) 14(66.7%) 33(80.5%) 8(36.4%) 200(72.5%) 0.001* 
Marginal/limited 8(16%) 32(34%) 0(0%) 7(14.6%) 7(33.3%) 8(19.5%) 14(63.6%) 76(27.5) 
Healthcare 
decision sharing 
         
Yes 43(87.8%) 74(78.7%) 18(75%) 38(80.8%) 18(85.7%) 29(72.5%) 15(68.2%) 235(79.1%) 0.450 
No 6(12.2%) 20(21.3%) 6(25%) 9(19.2%) 3(14.3%) 11(27.5%) 7(31.8%) 62(20.9%) 
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Table 4-1. Continued. 
 
 
Characteristics 
Senior centers  
Total 
(n=300) 
 
p-Value Frayser-
Raleigh 
(n=50) 
Orange-
Mound 
(n=94) 
Arlington 
(n=24) 
Bartlett 
(n=48) 
Bert 
Ferguson 
(n=21) 
McWherter 
(n=41) 
Somerville 
(n=22) 
Stroke 5(10%) 5(5.4%) 1(4.2%) 6(12.5%) 1(4.8%) 3(7.3%) 5(22.7%) 26(8.7%) 0.181 
HTN 38(76%) 75(80.7%) 24(100%) 34(70.8%) 34(70.8%) 28(68.3%) 13(59.1%) 226(75.6%) 0.020* 
Angina Pectoris 
or CAD 
10(20%) 10(10.8%) 4(16.7%) 2(4.2%) 1(4.8%) 4(9.8%) 3(13.6%) 34(11.4%) 0.238 
CHF 6(12%) 5(5.4%) 0(0%) 3(6.3%) 1(4.8%) 2(4.9%) 2(9.1%) 19(6.35%) 0.547 
Myocardial 
Infarction (MI) 
7(14%) 5(5.4%) 1(4.2%) 2(4.2%) 0(0%) 3(7.3%) 2(9.1%) 20(6.7%) 0.320 
Asthma, 
emphysema or 
COPD 
5(10%) 13(13.9%) 4(16.7%) 6(12.5%) 2(9.5%) 4(10%) 3(13.6%) 37(12.4%) 0.972 
Diabetes 16(32%) 40(43.01%) 2(8.3%) 13(27.1%) 1(4.8%) 11(26.8%) 11(50%) 94(31.4%) 0.001* 
Arthritis or any 
kind of 
rheumatism 
32(64%) 48(51.6%) 13(54.2%) 25(52.1%) 13(61.9%) 22(53.7%) 13(59.1%) 166(55.5%) 0.834 
Chronic back 
pain or sciatica 
12(24%) 18(19.4%) 7(29.2%) 17(35.4%) 3(14.3%) 4(9.8%) 7(31.8%) 68(22.7%) 0.076 
Depression 7(14%) 15(16.1%) 2(8.3%) 12(25%) 2(9.5%) 6(14.6%) 3(13.6%) 47(15.7%) 0.550 
Chronic heart 
burn 
4(8%) 12(12.9%) 4(16.7%) 7(14.6%) 0(0%) 5(12.2%) 7(31.8%) 39(13.04%) 0.073 
Any cancer 
(other than skin 
cancer) 
9(18%) 8(8.6%) 8(33.3%) 12(25%) 2(9.5%) 4(9.8%) 3(13.6%) 46(15.4%) 0.024* 
Sexual 
dysfunction 
3(6%) 7(7.5%) 2(8.3%) 1(2.1%) 2(9.5%) 1(2.4%) 2(9.1%) 18(6.02%) 0.721 
IBS or stomach 
ulcer or 
indigestion 
10(20%) 12(12.9%) 5(20.8%) 10(20.8%) 2(9.5%) 5(12.2%) 3(13.6%) 47(15.7%) 0.712 
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Table 4-1. Continued. 
 
 
Characteristics 
Senior centers  
Total 
(n=300) 
 
p-Value Frayser-
Raleigh 
(n=50) 
Orange-
Mound 
(n=94) 
Arlington 
(n=24) 
Bartlett 
(n=48) 
Bert 
Ferguson 
(n=21) 
McWherter 
(n=41) 
Somerville 
(n=22) 
Comorbidity 
score 
3.3±2.30 2.94±1.98 3.21±1.56 3.13±2.03 2.09±1.51 2.47±1.96 3.50±2.87 2.97±2.07 0.162 
Living status 
Alone 25(50%) 39(42.9%) 4(16.7%) 26(54.2%) 9(42.9) 20(50%) 9(40.9%) 132(44.6%) 0.098 
Not alone 25(50%) 52 (57.1%) 20(83.3%) 22(45.8%) 12(57.1%) 20(50%) 13(59.1%) 164(55.4%)  
Number of  
prescription 
medications 
0-1 12(24%) 23(24.5%) 0(0%) 5(10.4%) 3(14.3%) 8(19.5%) 4(18.2%) 55(18.3%) 0.047* 
2-4 16(32%) 43(45.7%) 14(58.3%) 19(39.6%) 15(71.4%) 20(48.8%) 9(40.9%) 136(45.3%) 
5-7 16(32%) 22(23.4%) 7(29.2%) 21(43.8%) 3(14.3%) 10(24.39%) 5(22.7%) 84(28%) 
≥8 6(12%) 6(6.4%) 3(12.5%) 3(6.3%) 3(6.3%) 3(7.3%) 4(18.2%) 25(8.3%) 
 
Notes: Unmarried= single, divorced, widowed, and separated. Others = Asians and Alaska Natives. (*)=p-value below 0.05. Not alone 
includes all participants who reported living with a spouse, friend, community center, family members…etc.
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Table 4-2. Item means, standard deviations, and minimum and maximum 
scores for each PROMEX item. 
 
Item Mean  SD  Min  Max 
How trustworthy do you find PROMEX? 
(Item-1) 
3.315  0.932  1.00  5.00 
How likely is it for you to provide your ratings 
and reviews for PROMEX? (Item-2) 
3.161  1.107  1.00  5.00 
Would you ask your doctor to prescribe the 
most highly recommended medication from 
PROMEX? (Item-3) 
3.053  1.084  1.00  5.00 
How useful do you find PROMEX? (Item-4) 3.600  1.325  1.00  5.00 
If you came across PROMEX like the example 
above how likely, is it for you to mention it to 
your doctor? (Item-5) 
3.553  1.121  1.00  5.00 
Do you believe that PROMEX will facilitate 
communication with your doctor? (Item-6) 
3.456  1.180  1.00  5.00 
How likely is it for your doctor to get upset if 
you mention PROMEX? (Item-7) 
3.526  0.992  1.00  5.00 
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Table 4-3. Pearson correlation coefficients between PROMEX items 
and p-values. 
 
Item 1  2  3  4  5  6  7 
1 1.00  0.462  0.409  0.508  0.508  0.627  −0.089 
<0.001  <0.001  <0.001  <0.001  <0.001  0.124 
2 0.462  1.00  0.477  0.420  0.377  0.471  −0.138 
<0.001  <0.001  <0.001  <0.001  <0.001  0.016 
3 0.409  0.477  1.00  0.371  0.509  0.525  −0.126 
<0.001  <0.001  <0.001  <0.001  <0.001  0.028 
4 0.554  0.420  0.371  1.00  0.371  0.508  −0.113 
<0.001  <0.001  <0.001  <0.001  <0.001  0.050 
5 0.508  0.377  0.509  0.625  1.00  0.627  −0.093 
<0.001  <0.001  <0.001  <0.001  <0.001  0.106 
6 0.627  0.471  0.525  0.508  0.627  1.00  −0.128 
<0.001  <0.001  <0.001  <0.001  <0.001  0.026 
7 −0.089  −0.138  −0.126  −0.113  −0.093  −0.128  1.00 
0.124  0.016  0.028  0.050  0.106  0.026  
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was considered for removal. Moreover, the item-total statistics were examined to 
determine whether removing item-7 would result in an improvement in the Cronbach’s 
alpha of the instrument. Table 4-4 shows that item-7 has a low and negative item-total 
correlation (i.e., −0.15). Further, the Cronbach’s alpha of the instrument improved from 
0.77 to 0.85 when item-7 was deleted. Therefore, item-7 was deleted. 
 
Principal Component Analysis was also performed to determine the number of 
constructs or factors that can be extracted from the questionnaire. The Kaiser's Meyer-
Okin Measure of Sampling Adequacy (KMO) was 0.83, which indicates that the sample 
size was large enough to extract a factor or factors from this questionnaire (Cortina, 
1993). According to Kaiser-Guttman rule, the number of factors to be extracted should be 
equal to the number of factors having an eigenvalue (i.e., variance) greater than one 
(Kaiser, 1960). Table 4-5 shows that only one factor has an eigenvalue greater than one. 
In addition, the scree plot in Figure 4-1 helps illustrates the rate of change in the 
magnitude of the eigenvalues. As can be shown in Figure 4-1, only one factor has an 
eigenvalue greater than one, and there was a significant drop in the second factor 
eigenvalue to less than one. Therefore, only one factor was extracted. The loading of each 
item on the extracted factor is shown in Table 4-6.   
 
The final PROMEX instrument consists of six items after deleting item-7 due to its 
lack of inter-item correlation with some of the instrument items, negative and low total-
item correlation. Further, the questionnaire’s Cronbach’s alpha was significantly 
improved after deleting item-7 (i.e.,0.85) (Field, 2009). Varimax rotation was not 
performed because only one factor was extracted (Hatcher, 2005). This factor was named 
the “value of online medication rating websites to older adults”. The minimum possible 
score of PROMEX is six and the maximum possible score is 30 after excluding item-7. 
The higher the score of PROMEX, the more useful participants believe online medication 
rating websites are.  
 
 
4.3  Patient Reviews of Medication Experiences (PROMEX) 
 
The mean scores of PROMEX for the different sociodemographic groups are listed in 
Table 4-7. The overall mean and standard deviation scores of PROMEX for study 
participants was 20.14±5.16 and participants from the different age groups did not have 
significantly different PROMEX mean scores (p=0.921). Therefore, participants from the 
different age groups viewed the online medication rating websites similarly. Likewise, 
male and female participants did not have significantly different PROMEX mean scores 
(p=0.511). Thus, male and female participants viewed the online medication rating 
websites in a similar way. Further, the number of prescription medications that 
participants take daily did not influence their views of online medication rating websites. 
The study participants with one or no medical condition (i.e., comorbidity score≤1) did 
not have a significantly different PROMEX mean score than those with more than one 
medical condition (i.e., comorbidity score >1) (p=0.270). Hence, the number of medical 
conditions or the comorbidity score for each participant did not influence their views of  
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Table 4-4. Cronbach coefficient alpha with deleted PROMEX item. 
 
 
Deleted item 
Raw item  Standardized item 
Correlation 
with total 
Alpha  Correlation 
with total 
Alpha 
How trustworthy do you find PROMEX? (Item-1) 0.655 0.725  0.646 0.707 
How likely is it for you to provide your ratings and reviews 
for PROMEX? (Item-2) 
0.530 0.744  0.527 0.733 
Would you ask your doctor to prescribe the most highly 
recommended medication from PROMEX? (Item-3) 
0.559 0.739  0.555 0.727 
How useful do you find PROMEX? (Item-4) 0.616 0.724  0.614 0.714 
If you came across PROMEX like the example above how 
likely, is it for you to mention it to your doctor? (Item-5) 
0.684 0.712  0.671 0.702 
Do you believe that PROMEX will facilitate communication 
with your doctor? (Item-6) 
0.695 0.707  0.695 0.696 
How likely is it for your doctor to get upset if you mention 
PROMEX? (Item-7) 
−0.151 0.853  −0.150 0.856 
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Table 4-5. Eigenvalues of the correlation matrix. 
 
Factor Eigenvalue Difference Proportion Cumulative 
1 3.505 2.779 0.584 0.584 
2 0.725 0.122 0.121 0.705 
3 0.602 0.093 0.101 0.805 
4 0.509 0.132 0.084 0.890 
5 0.376 0.095 0.062 0.953 
6 0.280  0.046 1.000 
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Figure 4-1. Scree plot of the possible number of factors that can be extracted 
from the 6-items PROMEX questionnaire. 
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Table 4-6. Loading of each item of PROMEX on the extracted factor. 
 
Items Factor-1 
Item 6: Do you believe that PROMEX will facilitate communication 
with your doctor? 
0.830 
Item 5: If you came across PROMEX like the example above how 
likely, is it for you to mention it to your doctor? 
0.804 
Item 1: How trustworthy do you find PROMEX?  0.783 
Item 4: How useful do you find PROMEX? 0.762 
Item 3: Would you ask your doctor to prescribe the most highly 
recommended medication from PROMEX? 
0.709 
Item 2: How likely is it for you to provide your ratings and reviews for 
PROMEX? 
0.685 
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Table 4-7. Patient Reviews of Medication Experiences (PROMEX) scores of 
different sociodemographic subgroups (n=298). 
 
 PROMEX score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 6 21.0 20.80±5.85 30 0.921 
61-70 yrs. 117 7 21.0 20.12±5.12 30  
71-80 yrs. 97 7 21.0 20.07±5.03 30  
>80 yrs. 54 7 20.5 19.96±5.15 28  
Number of prescription  
medications 
       
0-1 55 7 21.0 19.98±5.73 29 0.744 
2-4 136 6 21.0 19.89±5.11 30  
5-7 82 7 20.0 20.39±4.73 30  
≥8 25 9 21.0 21.00±5.61 30  
Sex 
Male 68 7 21.0 20.50±5.46 30 0.511 
Female 229 6 21.0 20.03±5.08 30  
Living status 
Alone 131 6 21.0 20.09±5.45 30 0.879 
Not alone 163 7 21.0 20.18±4.97 29  
Marital status 
Unmarried 187 6 21.0 20.21±5.41 30 0.759 
Married 110 7 20.0 20.02±4.75 29  
Comorbidity score 
≤1 74 7 21.0 19.57±5.72 29 0.270 
>1 224 6 21.0 20.33±4.95 30  
Race 
Caucasians 163 6 20.0 19.57±4.91 30 0.205 
African Americans 119 7 21.0 20.87±5.32 30  
Hispanics 6 9 22.0 19.67±6.00 27  
Others 9 8 21.0 21.00±6.66 29  
Education 
≤High school 
(1-12 yrs.) 
135 7 21.0 20.45±4.66 30 0.617 
Some college degree  
(13-16 yrs.) 
124 6 20.0 19.82±5.49 30  
Post-graduate degree  
(≥17 yrs.) 
39 8 21.0 20.08±5.73 29  
Health literacy 
Marginal/limited 76 9 21.0 20.30±5.18 29 0.813 
Good 199 6 21.0 20.14±5.24 30  
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Table 4-7. Continued. 
 
 PROMEX score  
Characteristics n Min Median Mean ±SD Max p-Value 
Healthcare decision 
sharing 
       
No 61 6 20.0 19.07±5.18 30 0.080 
Yes 234 7 21.0 20.36±5.13 30  
Healthcare decision  
sharing preference 
       
Keep control in my  
own hand 
34 6 20.0 19.38±5.38 30 0.187 
Have an equal  
partnership 
234 7 21.0 20.36±5.13 30  
Leave it in the doctor’s 
hands 
27 9 19.5 18.67±4.99 30  
 
Note: (*) =p<0.05. 
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online rating of medication websites. In addition, the PROMEX mean scores were not 
significantly different across the different marital and living status groups (p=0.879). 
Moreover, PROMEX mean scores were not significantly different between the different 
education, health literacy and racial subgroups (p≥0.05). Finally, the PROMEX mean 
scores were not significantly different between the different health decision sharing and 
preference groups (p=0.08). 
 
 
4.4  The Health-Related Quality of Life (HRQoL) 
 
 
4.4.1 The SF-12v2 Physical Component Summary (PCS-12)  
 
The number of the participants who completed the Physical Component Summary 
(PCS-12) section of the SF-12v2 survey was 298 participants. The mean scores of the 
PCS-12 for the different sociodemographic subgroups are listed in Table 4-8. As the 
number of prescription medications a participant took daily increased, the PCS-12 mean 
score decreased. Participants who were taking one or more prescription medications had 
significantly lower PCS-12 mean scores than participants on one prescription medication 
or not on any prescription medications (p<0.001). Therefore, participants who were 
taking multiple prescription medications report lower physical health or physical HRQoL 
than participants taking only one medication or not taking any prescription medications. 
Similarly, participants with more than one medical condition had a significantly lower 
PCS-12 mean score than participants with no medical conditions or with only one 
medical condition (p<0.001). Hence, participants with multiple comorbidities had lower 
physical health or physical HRQoL than those with one or no comorbidities. Participants 
with some college or post-graduate degrees had significantly higher PCS-12 mean scores 
than those with high school diploma or lower (p=0.011). Thus, participants with higher 
educations (i.e., some college or post-graduate degrees) reported better physical health or 
physical HRQoL than participants with lower educations (i.e., high school diploma or 
lower). The mean scores of the PCS-12 were not significantly different across age, sex, 
marital status, living status, racial, health literacy, and health decision sharing preference 
subgroups (p≥0.05).  
 
 
4.4.2 The SF-12v2 Mental Component Summary (MCS-12) 
 
The number of participants who completed the Mental Component Summary (MCS-
12) section of the SF-12v2 survey was 298 participants. The mean scores of the SF-12v2 
Mental Component Summary (MCS-12) for the different sociodemographic subgroups 
are listed in Table 4-9. The mean scores of the MCS-12 for the study participants aged 
61 years and above were significantly higher than those aged 60 or less years (p=0.001). 
Participants whose age was between 71 and 80 years had the highest mental health or 
mental HRQoL compared to the other age subgroups. Further, married participants had a 
significantly higher MCS-12 mean score compared to the unmarried participants 
(p=0.039). In addition, the mean score of the MCS-12 for participants with good health 
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Table 4-8. SF-12v2 Physical Component Summary (PCS-12) scores of 
different sociodemographic subgroups (n=298). 
 
 PCS-12 score  
Characteristics n Min  Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 26 46.3 47.16±9.62 60 0.285 
61-70 yrs. 117 24 48.9 46.84±10.3 67 
71-80 yrs. 97 22 45.0 45.12±9.47 63 
>80 yrs. 54 13 44.3 43.99±11.3 61 
Number of prescription  
medications 
0-1 55 28 55.9 52.04±8.54 63 <0.001* 
2-4 136 13 46.5 45.70±9.44 61 
5-7 82 22 44.3 44.11±10.4 67 
≥8 25 26 38.8 38.47±9.51 53 
Sex 
Male 68 24 44.8 44.73±9.45 63 0.298 
Female 229 13 47.2 46.19±10.4 67 
Living status 
Alone 131 21 48.9 46.89±9.82 63 0.095 
Not alone 163 13 44.9 44.9±10.37 67 
Marital status 
Unmarried 187 13 47.1 46.24±10.3 67 0.396 
Married 110 24 46.2 45.20±9.91 61 
Comorbidity score 
≤1 74 30 53.8 51.56±7.49 63 <0.001* 
>1 224 13 43.8 43.94±10.2 67 
Race 
Caucasians 163 21 48.0 46.15±10.2 30 0.781 
African Americans 119 13 45.1 45.40±9.92 30 
Hispanics 6 33 46.0 47.14±11.5 27 
Others 9 22 44.7 43.17±12.8 29 
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Table 4-8. Continued. 
 PCS-12 score  
Characteristics n Min  Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
135 13 43.5 44.18±9.65 61 0.011* 
Some college degree  
(13-16 yrs.) 
124 21 51.1 47.88±10.2 67 
Post-graduate degree 
(≥17 yrs.) 
39 24 47.8 45.03±10.7 61 
Health literacy  
Marginal/limited 76 21 44.2 44.68±9.18 67 0.121 
Good 199 13 48.9 46.78±10.4 63 
Healthcare decision  
sharing   
No 61 26 45.7 45.46±9.21 61 0.668 
Yes 234 13 47.2 46.08±10.3 67 
Healthcare decision 
sharing preference  
Keep control in my own 
hand 
34 28 49.6 47.25±9.27 59 0.273 
Have an equal partnership 234 13 47.2 46.08±10.3 67 
Leave it in the doctor’s 
hands 
27 26 43.0 43.21±8.80 61 
 
Note: (*) =p<0.05. 
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Table 4-9. SF-12v2 Mental Component Summary (MCS-12) scores of different 
sociodemographic subgroups (n=298). 
 
 MCS-12 score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 26 47.5 45.63±9.80 58 0.001* 
61-70 yrs. 117 30 55.5 52.05±9.88 68 
71-80 yrs. 97 29 58.5 54.99±9.13 72 
>80 yrs. 54 33 53.4 52.49±8.46 73 
Number of prescription 
medications 
      
0-1 55 30 54.8 52.78±8.87 72 0.763 
2-4 136 29 54.4 51.69±9.61 73 
5-7 82 26 55.2 53.07±9.72 69 
≥8 25 25 56.7 52.35±12.9 67 
Sex 
Male 68 25 53.0 50.11±11.3 72 0.053 
Female 229 26 55.8 53.04±9.21 73 
Living status 
Alone 131 25 53.1 51.68±9.64 69 0.235 
Not alone 163 26 55.8 53.04±9.87 73 
Marital status 
Unmarried 187 25 53.0 51.47±9.91 73 0.039* 
Married 110 29 56.8 53.90±9.41 72 
Comorbidity score 
≤1 74 30 56.6 52.95±8.98 67 0.530 
>1 224 25 54.3 52.12±10.1 73 
Race 
Caucasians 163 25 56.9 53.53±9.13 72 0.067 
African Americans 119 26 52.4 51.02±10.4 73 
Hispanics 6 34 46.5 46.02±9.82 58 
Others 9 36 51.7 51.50±11.9 69 
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Table 4-9. Continued. 
 MCS-12 score  
Characteristics n Min Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
135 26 52.7 51.04±10.5 73 0.077 
Some  college degree  
(13-16 yrs.) 
124 25 56.2 53.0±9.24 72 
Post-graduate degree 
(≥17 yrs.) 
39 31 55.3 54.64±8.42 68 
Health literacy 
Marginal/limited 76 26 48.1 48.02±10.5 69 <0.001 
Good 199 25 55.6 53.23±9.13 73 
Healthcare decision  
sharing   
No 61 25 51.8 50.29±11.3 72 0.060 
Yes 234 29 55.8 52.93±9.28 73 
Healthcare decision  
sharing preference  
Keep control in my own 
hand 
34 25 53.9 50.91±11.7 72 0.147 
Have an equal partnership 234 29 55.8 52.93±9.28 73 
Leave it in the doctor’s 
hands 
27 26 48.1 49.51±11.0 65 
 
Note: (*) =p<0.05. 
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literacy was significantly higher than the one for participants with limited health literacy 
(p<0.001). Finally, the mean scores of the MCS-12 were not significantly different across 
the different sex, comorbidities, number of prescription medications, living status, 
educations, racial, and health decision sharing preference subgroups (p≥0.05).  
 
 
4.5  Satisfaction with Physician Communication and Interpersonal Treatment 
 
 
4.5.1 The Primary Care Assessment Survey-Communication Scale (PCAS-
Communication) 
 
The number of the study participants who completed the Primary Care Assessment 
Survey Communication domain (PCAS-Communication) was 300. The PCAS-
Communication scale mean scores for the different sociodemographic groups are listed in 
Table 4-10. The mean score of the PCAS-Communication for female participants was 
significantly higher than the score for male participants (p=0.048). Female participants 
were more satisfied with the physician communication than their male counterparts were. 
Married participants also had a significantly higher PCAS-Communication mean score 
than the unmarried participants (p=0.013). Married participants were more satisfied with 
the physician communication compared to the unmarried participants. Further, the mean 
score of the PCAS-Communication for Caucasians was significantly higher than the 
scores for African Americans, Hispanics, and other racial subgroups (p=0.041). The 
Caucasian participants had the highest satisfaction level with the physician 
communication among the other racial subgroups. Hispanics had the lowest satisfaction 
level with the physician communication among the other racial subgroups. In addition, 
participants with good health literacy level had a significantly higher PCAS-
Communication mean score than participants with limited health literacy (p=0.001). 
Finally, the mean scores of PCAS-Communication scores across the different age, 
number of prescription medications, living status, comorbidity score, education, 
healthcare decision sharing, and healthcare decision sharing preference subgroups were 
not significantly different (p≥0.05). 
 
 
4.5.2 The PCAS-Interpersonal Treatment Scale  
 
The number of the study participants who completed the Primary Care Assessment 
Survey Interpersonal Treatment domain (PCAS-Interpersonal Treatment) was 300. The 
PCAS-interpersonal treatment scale mean scores for the different sociodemographic 
subgroups are listed in Table 4-11. Married participants had a significantly higher PCAS-
interpersonal treatment mean score than the unmarried participants did (p=0.029). 
Therefore, the married participants’ level of satisfaction with the physician interpersonal 
treatment was significantly higher than the level of satisfaction for the unmarried. 
However, the mean scores of the PCAS-interpersonal treatment did not significantly 
differ across the age, education, living status, number of prescription medications, sex, 
comorbidities, race, health literacy, healthcare decision sharing, and healthcare decision  
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Table 4-10. Primary Care Assessment Survey (PCAS-Communication) scale 
(n=300). 
 
 PCAS-Communication scale score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 10 68.0 68.53±21.4 100 0.133 
61-70 yrs. 117 28 76.7 73.85±16.9 100 
71-80 yrs. 98 20 75.0 74.95±16.8 100 
>80 yrs. 55 30 66.7 69.33±17.1 100 
Number of prescription  
medications 
0-1 55 10 76.7 73.78±17.7 100 0.295 
2-4 136 30 73.3 71.55±16.9 100 
5-7 84 20 76.7 75.27±17.8 100 
≥8 25 40 70.0 69.07±17.6 100 
Sex 
Male 68 30 66.7 69.11±16.5 100 0.048* 
Female 231 10 73.3 73.85±17.6 100 
Living status 
Alone 132 10 70.0 70.93±18.4 100 0.092 
Not alone 164 28 76.7 74.37±16.5 100 
Marital status 
Unmarried 189 10 70.0 70.87±18.2 100 0.013* 
Married 110 30 80.0 76.04±15.6 100 
Comorbidity score 
≤1 74 20 75.0 73.53±17.9 100 0.676 
>1 226 10 73.3 72.55±17.3 100 
Race 
Caucasians 164 30 76.7 74.59±17.5 100 0.041* 
African Americans 120 10 73.3 71.77±17.3 100 
Hispanics 6 43 60.0 60.56±14.9 87 
Others 9 37 60.0 62.59±12.3 80 
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Table 4-10. Continued. 
 PCAS-Communication scale score  
Characteristics n Min Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
136 28 70.0 71.66±16.2 100 0.346 
Some college degree 
(13-16 yrs.) 
124 20 73.3 72.94±17.9 100 
Post-graduate degree  
(≥17 yrs.) 
40 10 80.0 76.22±19.5 100 
Health literacy 
Marginal/limited 76 30 66.7 66.77±15.8 97 0.001* 
Good 200 10 76.7 74.97±17.5 100 
Healthcare decision  
sharing  
No 62 36 67.3 70.61±18.4 100 0.263 
Yes 235 10 73.3 73.41±17.2 100 
Healthcare decision 
sharing preference 
Keep control in my own 
hand 
34 36 67.3 67.88±16.9 100 0.213 
Have an equal partnership 235 10 73.3 73.41±17.2 100  
Leave it in the doctor’s 
hands 
28  40 70.0 73.93±19.8 100 
 
Note: (*) =p<0.05. 
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Table 4-11. Primary Care Assessment Survey (PCAS-Interpersonal Treatment) 
scale (n=300). 
 
 PCAS-Interpersonal Treatment scale score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 40 68.0 71.96±20.3 100 0.618 
61-70 yrs. 117 27 76.0 72.84±18.9 100 
71-80 yrs. 98 27 76.0 74.31±17.8 100 
>80 yrs. 55 35 72.0 70.27±16.3 100 
Number of prescription  
medications 
0-1 55 40 76.0 73.36±21.1 100 0.605 
2-4 136 27 72.0 71.75±17.3 100 
5-7 84 27 76.0 74.37±17.7 100 
≥8 25 28 68.0 69.60±18.4 100 
Sex 
Male 68 27 74.0 69.35±17.6 100 0.084 
Female 231 27 76.0 73.68±18.3 100 
Living status 
Alone 132 27 72.0 70.87±18.8 100 0.099 
Not alone 164 27 76.0 74.37±17.6 100 
Marital status 
Unmarried 189 27 72.0 70.95±18.6 100 0.029* 
Married 110 28 80.0 75.69±17.2 100 
Comorbidity score 
≤1 74 27 72.0 72.00±19.8 100 0.742 
>1 226 27 76.0 72.80±17.7 100 
Healthcare decision  
sharing 
      
No 62 28 72.0 71.77±18.9 100 0.668 
Yes 235 27 76.0 72.90±18.1 100  
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Table 4-11. Continued. 
 PCAS-Interpersonal Treatment scale score  
Characteristics n Min Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
136 28 72.0 71.53±17.2 100 0.205 
College degree 
(13-16 yrs.) 
124 27 76.0 72.26±19.6 100 
Post-graduate degree 
(≥17 yrs.) 
40 40 80.0 77.30±16.9 100 
Race 
Caucasians 164 35 76.0 73.85±18.3 100 0.059 
African Americans 120 27 75.5 72.57±18.1 100 
Hispanics 6 44  60.0 62.67±18.4 88 
Others 9 40 60.0 59.22±12.9 76 
Health literacy 
Marginal/limited 76 28 72.0 69.37±17.4 100 0.056 
Good 200 27 76.0 74.04±18.4 100 
Healthcare decision  
sharing preference 
Keep control in my own 
hand 
34 40 66.0 68.53±19.3 100 0.278 
Have an equal partnership 235 27 76.0 72.90±18.1 100 
Leave it in the doctor’s 
hands 
28 28 74.0 75.71±18.2 100 
 
Note: (*) =p<0.05. 
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sharing preference subgroups (p≥0.05). 
 
 
4.6  The General Domains of Beliefs about Medicines Questionnaire (BMQ) 
 
 
4.6.1 BMQ-Overuse Scale 
 
The number of the participants who completed the Beliefs about Medicine 
Questionnaire-Overuse scale was 297. The BMQ-Overuse scale mean scores across the 
different sociodemographic subgroups are listed in Table 4-12. Participants who reported 
taking zero or only one prescription medication had significantly higher BMQ General-
Overuse mean scores than other participants who reported taking multiple prescription 
medications (p=0.016). As the number of prescription medications participants were 
taking increased, their belief that medications are overprescribed or overused decreased. 
Female participants had a significantly higher BMQ General-Overuse mean score than 
their male counterparts (p=0.009). Hence, female participants’ beliefs about medications 
being overused or overprescribed were stronger than their male counterparts. Further, the 
mean scores of the BMQ General-Overuse for participants who liked to be involved in 
the health decision along with the physicians or have an equal partnership, and those who 
liked to keep the health decision in their own hands were significantly higher than the 
participants who liked to keep the health decision in the physicians’ hands (p=0.017). 
Participants who liked to be involved with physicians’ in the health decision or have an 
equal partnership held the strongest beliefs that medications are overprescribed or 
overused; however, participants who liked to leave the health decision in the physicians’ 
hands had the weakest beliefs than medications are overprescribed or overused. Finally, 
the mean scores of the BMQ General-Overuse for the different age, education, marital 
and living status, comorbidities, race, and health literacy groups were not significantly 
different (p≥0.05). 
 
 
4.6.2 BMQ-Harm Scale  
 
The number of the participants who completed the Beliefs about Medicine 
Questionnaire-Harm scale was 298. The BMQ-Harm scale mean scores across the 
different sociodemographic subgroups are listed in Table 4-13. The participants who 
reported taking zero or one prescription medication had the highest BMQ-Harm mean 
score compared to the mean scores of those taking multiple medications (p=0.038). As 
the number of prescription medications taken by the participants increased, their belief 
that prescription medications are inherently harmful decreased. The Caucasian/white 
participants had the lowest BMQ-Harm mean score in comparison to the other racial 
groups (p=0.014). Hence, the Caucasian participants’ beliefs that prescription 
medications are generally harmful were not as strong as the beliefs of other racial groups. 
On the other hand, Asians and Alaska Natives (i.e., Others) held the strongest beliefs that 
medications are generally harmful in comparison to other racial groups (p=0.014). The 
mean scores of BMQ-Harm across other sociodemographic, comorbidities, health  
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Table 4-12. Beliefs about Medicines Questionnaire-Overuse (BMQ-Overuse) 
scale scores of different sociodemographic subgroups (n=297). 
 
 BMQ-Overuse score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 4 13.0 12.48±3.74 19 0.592 
61-70 yrs. 116 4 13.0 12.62±2.77 18 
71-80 yrs. 98 5 13.0 12.91±3.20 20 
>80 yrs. 53 6 12.0 12.23±2.46 18 
Number of prescription  
medications 
      
0-1 55 4 14.0 13.49±3.65 20 0.016* 
2-4 134 4 13.0 12.66±2.80 20 
5-7 83 6 13.0 12.23±2.63 17 
≥8 25 4 12.0 11.40±3.21 16 
Sex 
Male 68 4 12.0 11.78±2.96 16 0.009* 
Female 228 4 13.0 12.86±2.96 20 
Living status 
Alone 131 4 13.0 12.81±3.12 20 0.277 
Not Alone 162 4 13.0 12.43±2.90 20 
Marital status 
Unmarried 86 4 13.0 12.80±2.98 20 0.149 
Married 110 4 12.0 12.28±2.99 20  
Comorbidity score 
≤1 74 4 13.0 12.93±3.13 19 0.257 
>1 223 4 13.0 12.48±2.96 20  
Race 
Caucasians 162 5 12.5 12.56±2.84 20 0.895 
African Americans 120 4 13.0 12.65±3.21 19 
Hispanics 5 7 12.0 11.60±4.16 16 
Others 9 7 13.0 12.56±2.60 18 
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Table 4-12. Continued. 
 BMQ-Overuse score  
Characteristics n Min Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
133 4 12.0 12.32±3.19 20 0.313 
College degree 
(13-16 yrs.) 
124 4 13.0 12.89±2.95 19 
Post-graduate degree 
(≥17 yrs.) 
40 7 12.5 12.58±2.45 17 
Health literacy  
Marginal/limited 76 4 13.0 12.79±3.40 20 0.480 
Good 198 4 13.0 12.48±2.78 18 
Healthcare decision  
sharing   
No 60 4 12.5 11.93±3.80 20 0.118 
Yes 235 5 13.0 12.76±2.76 20 
Healthcare decision  
sharing preference  
Keep control in my 
own Hand 
34 4 13.5 12.65±3.76 20 0.017* 
Have an equal partnership 235 5 13.0 12.76±2.76 20 
Leave it in the doctor’s 
hands 
26 4 10.5 11.0±3.71 17 
 
Note: (*) =p<0.05. 
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Table 4-13. Beliefs about Medicines Questionnaire-Harm (BMQ-Harm) scale 
scores of different sociodemographic subgroups (n=298). 
 
 BMQ-Harm score  
Characteristics n Min Median Mean ±SD Max p-Value 
Age 
50-60 yrs. 25 4 10.0 9.92±3.38 17 0.062 
61-70 yrs. 115 4 9.0 9.35±2.91 18 
71-80 yrs. 98 4 8.0 8.71±2.62 14 
>80 yrs. 55 4 8.0 8.45±2.79 18 
Number of prescription 
medications 
0-1 55 4 9.0 9.80±3.00 18 0.038* 
2-4 135 4 9.0 8.99±2.79 17 
5-7 84 4 8.5 8.92±2.72 17 
≥8 24 4 7.5 7.83±3.06 16 
Sex 
Male 67 4 9.0 8.66±2.36 13 0.177 
Female 230 4 9.0 9.13±2.99 18 
Living Status 
Alone 131 4 9.0 9.02±2.94 17 0.963 
Not Alone 163 4 9.0 9.03±2.84 18 
Marital Status 
Unmarried 187 4 9.0 8.98±2.79 17 0.756 
Married 110 4 9.0 9.09±3.00 18 
Comorbidity Score 
≤1 74 4 9.0 9.15±2.77 18 0.673 
>1 224 4 9.0 8.99±2.89 18 
Race 
Caucasians 164 4 8.0 8.55±2.60 16 0.014* 
African Americans 118 4 9.0 9.53±3.01 18 
Hispanics 6 4 9.0 9.17±4.96 13 
Others 9 5 11.0 10.44±2.46 18 
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Table 4-13. Continued.  
 BMQ-Harm score  
Characteristics n Min Median Mean ±SD Max p-Value 
Education 
≤High school  
(1-12 yrs.) 
134 4 9.0 9.37±2.74 18 0.148 
College degree  
(13-16 yrs.) 
124 4 9.0 8.81±2.93 18 
Post-graduate degree 
(≥17 yrs.) 
40 4 8.0 8.55±2.95 16 
Health literacy 
Marginal/limited 76 4 9.5 9.51±3.00 17 0.115 
Good 198 4 8.5 8.90±2.83 18 
Healthcare decision 
sharing  
No 62 4 9.0 9.52±3.43 18 0.185 
Yes 233 4 9.0 8.89±2.69 18 
Healthcare decision  
sharing preference 
Keep control in my  
own hand 
34 4 9.5 9.74±3.49 18 0.248 
Have an equal partnership 233 4 9.0 8.89±2.69 18 
Leave it in the doctor’s 
hands 
28 4 9.0 9.25±3.40 16 
 
Note: (*) =p<0.05. 
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literacy, and health decision sharing preference groups were not significantly different 
(p≥0.05). 
 
 
4.7  The Hypertensive Study Sample Characteristics 
 
The number of participants who reported having hypertension was 226 (75.3%). Out 
of this sample, 218 reported taking prescription medications for hypertension. The 
sociodemographic characteristics of the hypertensive study sample who reported taking 
antihypertensive medications are listed in Table 4-14. The mean age of this sample was 
72 years, 76.6% of the study sample were female; 63.8% were unmarried; 54% had either 
some college or postgraduate degrees. The self-reported race of the sample was 55% 
Caucasians/white, 40% African Americans/black, 2% Hispanics, and 3% Others (i.e., 
Asians and Alaska Natives). Forty-four percent were living alone, while 56% were not. 
Finally, more than 90% of the participants were taking more than two prescription 
medications. 
 
 
4.8 Medication Adherence Levels among the Hypertensive Sample 
 
Adherence to antihypertensive medication regimens were categorized into three 
distinct categories based on Morisky Medication Adherence Scale (MMAS-8) scores. 
High medication adherence level is achieved when the MMAS-8 score is eight. However, 
medium and low adherence levels are achieved when the MMAS-8 scores are between 
six and less than eight, and less than six, respectively  (Krousel-Wood et al., 2009; 
Morisky et al., 2008; Morisky & DiMatteo, 2011). The adherence levels to 
antihypertensive medication regimens among the hypertensive sample across the seven 
senior centers are listed in Table 4-15. The proportion of the sample with high, medium, 
and low adherence levels to their antihypertensive medication regime was 49%, 30%, and 
21%, respectively. Further, the hypertensive participants were categorized into adherent 
and non-adherent based on their MMAS-8 scores. If the MMAS-8 score is eight, then 
participant was considered adherent to his/her antihypertensive medication regimen, 
however, if the MMAS-8 score is less than eight, then the participant  was considered 
non-adherent to his/her antihypertensive medication regimen (Wong et al., 2014). The 
adherence levels across the different sociodemographic and medical groups are listed in 
Table 4-16. The proportion of adherent participants among the hypertensive sample 
significantly increased as their age increased (p<0.001). The majority of the participants 
aged 71 years and above were adherent to their antihypertensive medication regimens 
(i.e., >60%); however, less than 33% of the participants aged 70 years and less were 
adherent. In addition, the proportion of adherent participants among the Caucasians was 
significantly higher than the non-adherent participants (p=0.021). Further, most of the 
Caucasians/white participants were adherent to their antihypertensive medication 
regimens (i.e., 58%) in comparison to 40% of the African Americans, 20% of Hispanics, 
and 29% of other racial subgroups (i.e., Asians and Alaska Natives). Finally, the 
proportions of adherent participants were not significantly different across the remaining 
sociodemographic and medical subgroups (p≥0.05). 
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Table 4-14. Baseline characteristics of the hypertensive participants (n=218). 
 
 Senior centers   
Characteristics Frayser-
Raleigh 
(n=36) 
Orange-
Mound 
(n=71) 
Arlington 
(n=24) 
Bartlett 
(n=33) 
Bert 
Ferguson 
(n=14) 
McWherter 
(n=28) 
Somerville 
(n=12) 
Total 
 (n=218) 
p-Value 
Age-yrs. 
(Mean ± SD) 
76.25±8.35 69.43±8.51 73.13±7.76 72.13±7.32 75.38±7.25 72.96±10.68 70.17±6.59 72.25±8.65 0.005* 
Sex 
Female 25(69.4%) 56(78.9%) 15(62.5%) 29(87.9%) 13(92.9%) 20(71.4%) 9(75%) 167(76.6%) 0.188 
Male 11(30.6%) 15(21.1%) 9(37.5%) 4(12.1%) 1(7.1%) 8(28.6%) 3(25%) 51(23.4%) 
Marital status 
Married 13(36.1%) 16(22.5%) 16 (66.7%) 12(36.4%) 7(50%) 10(35.7%) 5(41.7%) 79(36.2%) 0.010* 
Unmarried 23(63.9%) 55(77.5%) 8(33.3%) 21(63.6%) 7(50%) 18(64.3%) 7(58.3%) 139(63.8%) 
Education 
≤High school  
(1-12 yrs.) 
17(47.2%) 35(49.3%) 13(54.2%) 16(48.5%) 2(14.3%) 9(32.1%) 9(75%) 101(46.3%) 0.075 
Some college 
degree  
(13-16 yrs.) 
15(41.7%) 30(42.3%) 9(37.5%) 12(36.4%) 7(50%) 16(57.1%) 3(25%) 92(42.2%) 
Post-graduate 
degree 
(≥17 yrs.)  
4(11.1%) 6(8.5%) 2(8.3%) 5(15.2%) 5(35.7%) 3(10.7%) 0(0%) 25(11.5%) 
Race 
Caucasians 29(80.6%) 0(0%) 24(100%) 29(87.9%) 14(100%) 21(75%) 2(16.7%) 119(54.6%) <0.001* 
African 
Americans 
5(13.9%) 66(92.9%) 0(0%) 0(0%) 0(0%) 6(21.4%) 10(83.3%) 87(39.9%) 
Hispanics 1(2.8%) 2(2.8%) 0(0%) 1(3%) 0(0%) 1(3.6%) 0(0%) 5(2.3%) 
Others 1(2.8%) 3(4.2%) 0(0%) 3(9.1%) 0(0%) 0(0%) 0(0%) 7(3.2%) 
Living status  
Alone 20(55.6%) 31(44.3%) 4(16.7%) 16(48.5%) 6(42.9%) 13 (48.1%) 5(41.7%) 95(43.98%) 0.136 
Not alone 
 
16(44.4%)  39(55.7%) 20(83.3%) 17(51.5%) 8(57.1%)  14 (51.9%) 7(58.3%) 121(56.02%) 
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Note: (*) =p<0.05. 
 
 
  
 
 
 
 
 
 
 
 
 
Table 4-14. Continued. 
  
 Senior centers   
Characteristics Frayser-
Raleigh 
(n=36) 
Orange-
Mound 
(n=71) 
Arlington 
(n=24) 
Bartlett 
(n=33) 
Bert 
Ferguson 
(n=14) 
McWherter 
(n=28) 
Somerville 
(n=12) 
Total 
(n=218) 
p-Value 
Number of  
prescription  
medications 
0-1 4(11.1%) 8(11.3%) 0(0%) 0(0%) 1(7.1%) 3(10.7%) 1(8.3%) 17(7.8%) 0.116 
2-4 13(36.1%) 38(53.5%) 14(58.3%) 13(39.4%) 10(71.4%) 12(42.9%) 4(33.3%) 104(47.7%) 
5-7 15(41.7%) 20(28.2%) 7(29.2%) 17(51.5%) 3(21.4%) 10(35.7%) 3(25%) 75(34.4%) 
≥8 4(11.1%) 5(7.0%) 3(12.5%) 3(9.1%) 0(0%) 3(10.7%) 4(33.3%) 22(10.1%) 
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Table 4-15. Morisky Medication Adherence Scale (MMAS-8) levels among the hypertensive sample (n=218). 
 
 Senior centers   
Adherence 
level 
Frayser-
Raleigh 
(n=36) 
Orange-
Mound 
(n=71) 
Arlington 
(n=24) 
Bartlett 
(n=33) 
Bert 
Ferguson 
(n=14) 
McWherter 
(n=28) 
Somerville 
(n=12) 
Total 
(n=218) 
p-Value 
High 
(MMAS-8 
score= 8) 
21(58.3%) 28(39.4%) 10(41.7%) 20(60.6%) 9(64.3%) 12(42.9%) 7(58.3%) 107(49.1%) 0.005* 
Medium 
(MMAS-8 
score = 6-<8) 
10(27.8%) 21(29.6%) 9(37.5%) 10(30.3%) 5(35.7%) 7(25%) 4(33.3%) 66(30.3%) 
Low 
(MMAS-8 
score <6) 
5(13.9%) 22(31.0%) 5(20.8%) 3(9.1%) 0(0%) 9(32.14%) 1(8.3%) 45(20.6%) 
 
Note: (*) =p<0.05. 
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Table 4-16. Morisky Medication Adherence Scale (MMAS-8) levels across the 
hypertensive subgroups. 
 
Characteristics Non-adherent  
(MMAS-8 <8) 
(n) 
Adherent 
(MMAS-8 =8) 
(n) 
p-Value 
Age 
50-60 yrs. 13(72.2%) 5(27.8%) <0.001* 
61-70 yrs. 55(66.3%) 28(33.7%) 
71-80 yrs. 28(38.4%) 45(61.6%) 
>80 yrs. 12(29.3%) 29(70.7%) 
Number of prescription 
medications 
   
0-1 8(47.1%) 9(52.9%) 0.951 
2-4 55(52.9%) 49(47.1%)  
5-7 37(49.3%) 38(50.7%)  
≥8 11(50%) 11(50%)  
Sex    
Male 29(56.9%) 22(43.1%) 0.331 
Female 82(49.1%) 85(50.9%)  
Living status 
Alone 51(53.7%) 44(46.3%) 0.401 
Not alone 58(47.9%) 63(52.1%) 
Marital status    
Unmarried 72(51.8%) 67(48.2%) 0.729 
Married 39(49.4%) 40(50.6%)  
Comorbidity score 
≤1 11(39.3%) 17(60.7%) 0.187 
>1 100(52.6%) 90(47.4%) 
Health literacy 
Marginal/limited 29(61.7%) 18(38.3%) 0.065 
Good 68(46.3%) 79(53.7%) 
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Table 4-16. Continued. 
Characteristics Non-adherent 
(MMAS-8 <8) 
(n) 
Adherent 
(MMAS-8 =8) 
(n) 
p-Value 
Healthcare decision  
sharing 
No 22(50%) 22(50%) 0.864 
Yes 89(51.45%) 84(48.55%)  
Education 
≤High school (1-12 yrs.) 53(52.5%) 48(47.5%) 0.509 
College degree (13-16 yrs.) 48(52.2%) 44(47.8%) 
Post-graduate degree (≥17 yrs.) 10(40%) 15(60%) 
Race 
Caucasians 50(42.02%) 69(57.9%) 0.021* 
African Americans 52(59.8%) 35(40.2%) 
Hispanics 4(80%) 1(20%) 
Others 5(71.4%) 2(28.6%) 
Healthcare decision sharing  
preference 
Keep control in my own hand 12(52.2%) 11(47.8%) 0.941 
Have an equal partnership 89(51.45%) 84(48.55%) 
Leave it in the doctor’s hands 10(47.6%) 11(52.4%) 
Satisfaction with the  
antihypertensive regimen 
Dissatisfied 1(100%) 0(0%) 0.100 
 Not satisfied 2(100%) 0(0%) 
Somewhat satisfied 9(75%) 3(25%) 
Satisfied 35(54.7%) 29(45.3%) 
Very satisfied 62(45.3%) 75(54.7%) 
 
Note: (*) =p<0.05. 
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4.9  Participant Rating of Antihypertensive Medication Regimens 
 
The hypertensive participants were asked to rate their satisfaction with each 
antihypertensive medication they reported taking on a 5-point Likert scale (i.e., 1-low to 
5-high) in terms of their side effects, effectiveness, ease of use, cost of medication, and 
food interactions. Further, participants were asked to provide an overall rating of each 
antihypertensive medication. Then, participant-specific satisfaction with the overall 
antihypertensive medication regimen was calculated by taking the mean score of each 
rated aspect of medication use (i.e., side effects, effectiveness, etc...) for every 
hypertensive participant. The number of study participants who rated their 
antihypertensive medications was 193 participants. The participant-specific mean scores 
of each rated medication use aspect for the antihypertensive medication regimen across 
the seven senior centers are listed in Table 4-17.  
 
Table 4-18 presents the correlation matrix of the rated aspects of medication use. All 
of the rated medication use aspects for the antihypertensive medication regimens were 
positively and significantly correlated with each other (p<0.05). Further, the instrument’s 
internal consistency (i.e., Cronbach’s alpha) was measured and found to be adequate (i.e., 
α=0.82). In addition, the medication-specific average rating of the antihypertensive 
medications that were rated by ten or more hypertensive participants are listed in 
Table 4.19. Ten or more participants rated the following antihypertensive medications: 
Atenolol, Amlodipine, Hydrochlorothiazide (HCTZ), Lisinopril, Losartan, Metoprolol, 
and Valsartan. All of the rated antihypertensive medications had high rating scores; 
however, they slightly differ (Figure 4-2). For example, Losartan had the highest 
effectiveness rating among the other rated antihypertensive medications, and Valsartan 
had the lowest rating (Figure 4-3). Likewise, Losartan had the highest rating in terms of 
medication ease of use, and amlodipine had the lowest rating (Figure 4-4). With regard 
to medication cost, Hydrochlorothiazide (HCTZ) had the highest rating, whereas, 
Amlodipine had the lowest rating (Figure 4-5). Similarly, HCTZ had the highest rating in 
terms of medication food interactions, and Atenolol had the lowest rating (Figure 4-6); 
while HCTZ had the highest rating in terms of medication side effects, and Lisinopril had 
the lowest rating (Figure 4-7). Finally, Lisinopril had the highest overall rating, whereas, 
Valsartan had the lowest rating (Figure 4-8). 
 
 
4.10 Pearson Correlation Coefficients between Participant-Reported Outcomes 
(PROs) 
 
The Pearson correlation coefficients between the Patient Reviews of Medication 
Experiences (PROMEX) and the Primacy Care Assessment Survey (PCAS) 
communication and interpersonal treatment scales, Beliefs about Medicines 
Questionnaire (BMQ) general harm and overuse scales, the Mental and Physical 
Component Summaries (MCS-12 and PCS-12) of the Short Form Health Questionnaire 
(SF-12v2), and the Morisky Medication Adherence Scale (MMAS-8) for hypertensive 
participants are listed in Table 4-20. PROMEX was not associated with any of the 
participant-reported outcomes (p≥0.05). The PCAS-Communication and 
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Table 4-17. Participants’ evaluations of their antihypertensive medications (n=193).  
 
 Senior centers   
Medication 
use aspect 
Frayser-
Raleigh 
(n=33) 
Orange-
Mound 
(n=59) 
Arlington 
(n=21) 
Bartlett 
(n=34) 
Bert 
Ferguson 
(n=13) 
McWherter 
(n=26) 
Somerville 
(n=7) 
Total 
(n=193) 
p-Value 
Effectiveness 4.43±0.82 4.15±1.18 4.78±0.41 4.57±0.70 4.38±0.87 4.32±0.81 4.70±0.67 4.40±0.91 0.073 
Side effects 3.43±1.54 2.98±1.65 2.95±1.88 4.15±1.42 3.86±1.61 3.01±1.73 3.63±1.77 3.33±1.67 0.025* 
Ease of use 4.44±1.06 4.27±1.13 4.84±0.47 4.57±0.85 4.69±0.63 4.62±0.92 4.75±0.46 4.51±0.95 0.217 
Cost  4.32±1.07 3.82±1.34 4.23±1.20 4.17±1.16 4.26±1.04 4.02±1.47 3.25±1.98 4.04±1.29 0.269 
Food 
interaction 
4.09±1.39 3.81±1.48 3.82±1.56 4.15±1.39 4.03±1.32 3.69±1.74 4.00±1.41 3.93±1.47 0.880 
Overall 4.49±0.83 4.27±1.01 4.77±0.40 4.59±0.88 4.69±0.63 4.46±0.86 4.71±0.49 4.49±0.86 0.255 
 
Notes: Participants were asked to evaluate each aspect of their antihypertensive medication regimens in a scale from one to five. The 
higher the score, the more satisfied the participants are with their medications. (*) =p<0.05. 
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Table 4-18. Pearson correlation coefficients between the participants’ rated antihypertensive medication use aspects and 
their p-values (n=193). 
 
Medication use 
aspect 
Effectiveness Side 
effects 
Ease of 
use 
Cost of 
medication 
Food 
interactions 
Overall 
rating 
Total 
correlation 
Effectiveness 1.00 0.251 0.589 0.408 0.249 0.591 0.603 
0.001* <0.001* <0.001* 0.001* <0.001* 
Side effects 0.251 1.00 0.290 0.363 0.564 0.349 0.405 
0.001* <0.001* <0.001* <0.001* <0.001* 
Ease of use 0.589 0.290 1.00 0.460 0.447 0.571 0.649 
<0.001* <0.001* <0.001* <0.001* <0.001* 
Cost of 
medication 
0.408 0.363 0.460 1.00 0.514 0.498 0.610 
<0.001* <0.001* <0.001* <0.001* <0.001* 
Food interactions 0.249 0.564 0.447 0.514 1.00 0.408 0.575 
0.001* <0.001* <0.001* <0.001* <0.001* 
Overall rating 0.591 0.349 0.571 0.498 0.408 1.00 0.669 
<0.001* <0.001* <0.001* <0.001* <0.001* 
 
Note: (*) =p<0.05. 
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Table 4-19. Antihypertensive medication rating (medication-specific) (n=148). 
 
 
 
Medication 
name 
Effectiveness  Ease of use  Cost of 
medication 
 Food 
interaction 
 Side effects  Overall 
n Mean± SD  n Mean± SD  n Mean± SD  n Mean± SD  n Mean± SD  n Mean± SD 
Atenolol 14 4.58±0.67  10 4.55±0.70  10 4.36±0.84  10 3.64±1.66  9 3.40±1.66  10 4.55±0.70 
Amlodipine 35 4.31±0.72  34 4.41±1.08  32 3.91±1.30  33 3.88±1.52  34 2.94±1.86  32 4.50±0.76 
Hydro-
chlorothiazide 
(HCTZ) 
14 4.85±0.29  12 4.92±0.29  12 4.92±0.29  12 4.85±0.39  12 4.08±1.15  12 4.77±0.39 
Lisinopril 35 4.56±0.84  28 4.77±0.65  28 4.27±1.12  28 3.93±1.52  29 2.81±1.80  27 4.79±0.40 
Losartan 14 5.00±0.00  13 5.00±0.00  13 4.50±1.33  12 4.15±1.68  13 3.86±1.79  13 4.71±1.11 
Metoprolol 26 4.76±0.45  24 4.69±0.87  23 4.32±0.99  22 3.83±1.69  23 3.44±1.78  23 4.44±0.99 
Valsartan 10 4.11±0.82  10 4.88±0.41  10 4.56±0.76  10 4.14±1.74  10 3.14±1.99  10 4.38±0.82 
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Figure 4-2. Antihypertensive medication ratings. 
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Figure 4-3. Rating of antihypertensive medications’ effectiveness. 
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Figure 4-4. Rating of antihypertensive medications’ ease of use. 
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Figure 4-5. Rating of antihypertensive medications’ cost.  
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Figure 4-6. Rating of antihypertensive medications’ food interactions.  
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Figure 4-7. Rating of antihypertensive medications’ side effects. 
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Figure 4-8. Overall rating of antihypertensive medications. 
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Table 4-20. Pearson correlation coefficients between the participant-reported outcomes (PROs) and their p-values 
(n=298). 
 
PRO variable PROMEX  PCAS-
Communication 
PCAS-
Interpersonal 
MCS-12 PCS-12 BMQ-
Overuse 
BMQ-
Harm 
MMAS-8 
PROMEX 1.00 0.048 0.030 −0.110 −0.106 −0.080 −0.042 −0.066 
0.407 0.604 0.055 0.066 0.168 0.470 0.327 
PCAS-
Communication 
0.048 1.00 0.872 0.161 0.134 −0.164 −0.231 0.204 
0.407 <0.001* 0.005* 0.020* 0.004* <0.001* 0.002* 
PCAS-
Interpersonal 
0.030 0.872 1.00 0.148 0.100 −0.155 −0.209 0.193 
0.604 <0.001* 0.010* 0.082 0.007* 0.001* 0.004* 
MCS-12 −0.110 0.161 0.148 1.00 −0.056 0.056 −0.142 0.180 
0.055* 0.005* 0.010* 0.328 0.335 0.014* 0.007* 
PCS-12 −0.106 0.134 0.100 −0.056 1.00 0.086 0.041 0.120 
0.066 0.020* 0.082 0.328 0.135 0.471 0.076 
BMQ-Overuse −0.080 −0.164 −0.155 0.056 0.086 1.00 0.460 −0.108 
0.168 0.004* 0.007* 0.335 0.135 <0.001 0.112 
BMQ-Harm −0.042 −0.231 −0.209 −0.142 0.041 0.460 1.00 −0.089 
0.470 <0.001* 0.001* 0.014* 0.471 <0.001* 0.190 
MMAS-8 −0.066 0.204 0.193 0.180 0.120 −0.108 −0.089 1.00 
0.327 0.002* 0.004* 0.007* 0.076 0.112 0.190 
 
Note: (*) =p<0.05. 
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PCAS-interpersonal treatment were associated with each other (r=0.872; p<0.001). 
Further, the PCAS-Communication was associated with both the MCS-12 (r=0.162; 
p=0.005) and PCS-12 (r=0.134; p=0.020) of the SF-12v2. In addition, the PCAS-
Communication was associated with both the BMQ-overuse (r= −0.164; p=0.004) and 
BMQ-Harm (r=−0.231; p<0.001). Moreover, the PCAS-Communication was associated 
with MMAS-8 (r=0.204; p=0.002). Likewise, the PCAS-Interpersonal treatment was 
associated the MCS-12 (r=0.148; p=0.010) but not with the PCS-12 (p≥0.05). Further, the 
PCAS-interpersonal treatment was associated with both the BMQ-overuse (r=−0.155; 
p=0.007) and BMQ-Harm (r=−0.209; p=0.001). In addition, the PCAS-interpersonal 
treatment was associated with the MMAS-8 (r=0.193; p=0.004). The MCS-12 was 
associated with BMQ-Harm (r=−0.142; p=0.014) and with the MMAS-8 (r=0.180; 
p=0.007). Finally, the BMQ-overuse and BMQ-Harm were associated with each other 
(r=0.460; p<0.001). 
 
 
4.11 Pearson Correlation Coefficients between the Participant-Specific Ratings of 
Antihypertensive Medication Regimens and PROs 
 
The correlation coefficients between participant-specific ratings of antihypertensive 
medication regimens and participant-reported outcomes are listed in Table 4-21. The 
participant-specific rating of antihypertensive medication regimen effectiveness was 
associated with both the PCAS-Communication (r=0.192; p=0.006) and interpersonal 
treatment (r=0.189; p=0.007) scales. Further, the participant-specific rating of 
antihypertensive medication regimen effectiveness was associated with the PCS-12 
(r=0.178; p=0.012). Likewise, the participant-specific antihypertensive medication 
regimen ease of use rating was associated with the PCAS-Communication (r=0.157; 
p=0.030). The participant-specific antihypertensive medication regimen cost, side effects, 
and food interactions ratings were not associated with any of the measured participant-
reported outcomes (p≥0.05). Finally, the participant-specific overall antihypertensive 
medication regimen rating was associated with PCAS-Communication (r=0.280; 
p=0.001), PCAS-interpersonal treatment (r=0.223; p=0.002), and the BMQ-Harm 
(r=−0.184; p=0.012) scales. 
 
 
4.12 Older Adult Participants’ Views of Online Medication Rating Websites and 
Their Satisfaction with Physician Communication 
 
 
4.12.1 Path Model for the Association between PROMEX and PCAS-
Communication 
 
A path model was built to examine the association between participants’ satisfaction 
with physician communication and their views of online medication rating websites. The 
PCAS-Communication scale was used to assess participant satisfaction with physician 
communication, whereas, PROMEX was used to assess participant views of online 
medication rating websites. Education, gender, age, health literacy, race, marital status, 
and comorbidities were treated as exogenous variables  that influence the
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Table 4-21. Pearson correlation coefficients between the participant-specific rating of antihypertensive medication 
regimens and participant-reported outcomes (PROs) variables. 
 
Medication 
use aspect 
PROMEX PCAS-
Communication 
PCAS-
Interpersonal 
MCS-12 PCS-12 BMQ-
Overuse 
BMQ-
Harm 
MMAS-8 
Effectiveness −0.010 0.192 0.189 0.096 0.178 −0.082 −0.133 0.131 
0.887 0.006* 0.007* 0.180 0.012* 0.250 0.062 0.066 
Side effects −0.070 −0.073 −0.052 −0.021 0.085 0.036 −0.052 0.024 
0.337 0.315 0.475 0.771 0.245 0.622 0.475 0.742 
Ease of use 0.005 0.157 0.138 0.044 0.094 −0.073 −0.122 0.115 
0.944 0.030* 0.055 0.545 0.195 0.314 0.093 0.111 
Cost 0.036 0.108 0.116 −0.059 0.106 −0.075 −0.129 0.094 
0.617 0.139 0.112 0.421 0.146 0.308 0.078 0.198 
Food 
interaction 
−0.002 0.071 0.096 −0.062 0.074 0.005 −0.092 −0.045 
0.975 0.339 0.197 0.408 0.324 0.946 0.217 0.544 
Overall  −0.089 0.280 0.223 0.134 0.124 −0.128 −0.184 0.107 
0.229 0.001* 0.002* 0.069 0.095 0.082 0.012* 0.148 
 
Note: (*) =p<0.05. 
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participant satisfaction with physician communication (i.e., PCAS-Communication). The 
PCAS-Communication was treated as both an endogenous variable in which it is 
influenced by the exogenous variables, as well as an exogenous variable in which it 
influences participant views of online medication rating websites (i.e., PROMEX).  The 
results of the path analysis are presented in Figure 4-9 and Table 4-22. Participant views 
of online medication rating websites (i.e., PROMEX) were not influenced by participant 
satisfaction with physician communication (i.e., PCAS-Communication) (p≥0.05). 
Further, their views were not influenced by other exogenous variables (i.e., age, race, 
education, etc.) (p≥0.05). However, participant satisfaction with physician 
communication (i.e., PCAS-Communication) was positively influenced by marital status 
(β=0.119; p=0.049), health literacy (β=0.18; p=0.002), and gender (β=0.123; p=0.038), 
and negatively influenced by race (β=−0.14; p=0.019).  An analysis of the fit indices 
indicated adequate model fit (comparative fit index=1.00, adjusted goodness of fit 
index=0.99, root mean square error of approximation= 0.00, and standardized root mean 
square residual=0.020). 
 
 
4.12.2 Multiple Linear Regression for the Association between PROMEX and 
PCAS-Communication 
 
In addition to the path analysis, a multiple linear regression analysis was completed to 
examine the association between PROMEX and the PCAS-Communication controlling 
for the same sociodemographic factors in the path model as well as comorbidities.  As 
with the path analysis, no significant association was found between PROMEX and 
PCAS-Communication (p≥0.05) (Table 4-23). 
 
 
4.13 Older Adult Participants’ Satisfaction with Physician Communication and 
Overall Rating of Their Antihypertensive Medication Regimens 
 
The results of the multiple linear regression analysis that examined the association 
between the Primary Care Assessment Survey communication scale (PCAS-
Communication) and participants’ overall rating of their antihypertensive medication 
regimens are listed in Table 4-24. The higher the overall rating of antihypertensive  
medication regimen score, the higher the score of the PCAS-Communication (β=5.031; 
p=0.005). Hypertensive participants with high overall rating of their antihypertensive 
medication regimens were more likely to have high PCAS-Communication score 
compared to participants with low overall rating of their antihypertensive medication 
regimens controlling for their age, comorbidities, race, education, and gender, marital 
status, number of prescription medications, and health literacy level. Health literacy also 
influenced the satisfaction with physician communication; participants with good health 
literacy level were more likely to have higher PCAS-Communication scores (β=9.965; 
p=0.007). Age, comorbidities, race, education, gender, number of prescription 
medications, and marital status were not associated with the PCAS-Communication 
(p≥0.05).
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Figure 4-9. Path analysis: Association between PROMEX and PCAS-Communication. 
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Table 4-22. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
PCAS-Communication (n=286). 
 
Outcome variables R2 Predictor 
variables 
Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.002 PCAS-
Communication 
0.045 0.00 0.045 0.465 
Age 0.00 −0.002 −0.002 0.606 
Education 0.00 0.001 0.001 0.727 
Marital status 0.00 0.005 0.005 0.494 
Health literacy 0.00 0.008 0.008 0.478 
Comorbidities 0.00 −0.002 −0.002 0.546 
Race 0.00 −0.006 −0.006 0.486 
Gender 0.00 0.005 0.005 0.491 
PCAS-Communication 0.11 Age −0.04 0.00 −0.04 0.466 
Education 0.024 0.00 0.024 0.692 
Marital status 0.119 0.00 0.119 0.049* 
Health literacy 0.181 0.00 0.181 0.002* 
Comorbidities −0.06 0.00 −0.06 0.283 
Race −0.14 0.00 −0.14 0.019* 
Gender 0.123 0.00 0.123 0.038* 
 
Notes: R-Square= 0.01. (*)=p<0.05. 
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Notes: R-Square= 0.02. (*)=p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-23. Multiple linear regression: The association between PROMEX and 
PCAS-Communication (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
PCAS-
Communication 
0.023 0.230 −0.01 0.062 
Age 0.001 0.973 −0.08 0.084 
Comorbidity 
score 
0.215 0.164 −0.08 0.520 
Education −0.02 0.831 −0.29 0.235 
Race 0.747 0.167 −0.31 1.810 
Health literacy −0.06 0.937 −1.57 1.458 
Gender −0.89 0.276 −2.49 0.718 
Marital status 0.083 0.906 −1.31 1.486 
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Table 4-24. Multiple linear regression: The association between hypertensive 
participants’ PCAS-Communication scale scores and overall ratings of their 
antihypertensive medication regimens (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
5.031 0.005* 1.513 8.550 
Age −0.026 0.884 −0.391 0.337 
Comorbidity 
score 
0.318 0.695 −1.290 1.928 
Education 0.582 0.340 −0.621 1.787 
Race −1.490 0.523 −6.094 3.113 
Health literacy 9.965 0.007* 2.648 17.282 
Gender 3.285 0.358 −3.755 10.325 
Number of 
prescription 
medications 
−0.662 0.343 −2.039 0.714 
Marital status 3.012 0.344 −3.263 9.287 
 
Notes: R-Square= 0.17. (*)=p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 108 
4.14 Older Adults’ Views of Online Medication Rating Websites and Their 
Quality of Life 
 
 
4.14.1 Path Model for the Association between PROMEX and MCS-12 
 
The results of the path model that tested the association between participants’ views 
of online medication rating websites (i.e., PROMEX) and their mental health quality of 
life (MCS-12) are presented in Figure 4-10 and Table 4-25. The participants’ views of 
online medication rating websites (i.e., PROMEX) were not influenced by their mental 
health quality of life (i.e., MCS-12) (p≥0.05). Further, their views were not influenced by 
other exogenous variables (i.e., age, race, education…etc.) (p≥0.05). However, the older 
adults’ mental health quality of life (MCS-12) was positively influenced by their age 
(β=0.219; p=0.001), education (β=0.144; p=0.014), and health literacy (β=0.243; 
p=<0.001), and negatively influenced by their comorbidities (β=−0.178; p=0.001). An 
analysis of the fit indices indicated adequate model fit (comparative fit index=1.00, 
adjusted goodness of fit index=0.99, root mean square error of approximation= 0.00, and 
standardized root mean square residual=0.015). 
 
 
4.14.2 Path Model for the Association between PROMEX and PCS-12 
 
The results of the path model that tested the association between participants’ views 
of online medication rating websites (i.e., PROMEX) and their physical health quality of 
life (PCS-12) are presented in Figure 4-11 and Table 4-26. The participants’ views of 
online medication rating websites (i.e., PROMEX) were significantly influenced by their 
physical health quality of life (i.e., PCS-12) (β=−0.126; p=0.040). Participants with low 
PCS-12 scores were more likely to have favorable views of online medication rating 
websites. However, their views were not influenced by other exogenous variables (i.e., 
age, race, education…etc.) (p≥0.05). The participants’ physical health quality of life 
(PCS-12) was positively influenced by their satisfaction with physician communication 
(i.e., PCAS-Communication) (β=0.125; p=0.035). However, it was negatively influenced 
by their age (β=−0.120; p=0.048) and comorbidities (β=−0.360; p<0.001). An analysis of 
the fit indices indicated adequate model fit (comparative fit index=1.00, adjusted 
goodness of fit index=0.99, root mean square error of approximation= 0.00, and 
standardized root mean square residual=0.015). 
 
 
4.14.3 Multiple Linear Regression for the Association between PROMEX and Both 
PCS-12 and MCS-12  
 
In addition to the path analyses, we did multiple linear regression analyses to examine 
the association between PROMEX and the quality of life scales (i.e., PCS-12 and MCS-
12) controlling for the same variables in the path analyses. In the first regression model, 
we examined the association between the mental quality of life (i.e., MCS-12) and 
participants’ views of online medication rating websites (i.e., PROMEX). As with the
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Figure 4-10. Path analysis: The association between PROMEX and MCS-12. 
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Table 4-25. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
MCS-12 (n=286). 
 
Outcome variables R2 Predictor 
variables 
Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.012 MCS-12 −0.111 0.00 −0.111 0.071 
PCAS-
Interpersonal 
Treatment 
0.00 −0.01 −0.01 0.188 
Age 0.00 −0.024 −0.024 0.107 
Education 0.00 −0.016 −0.016 0.147 
Marital status 0.00 −0.011 −0.011 0.209 
Health literacy 0.00 −0.027 0.099 0.099 
Comorbidities 0.00 0.019 0.019 0.118 
Race 0.00 −0.004 −0.004 0.561 
Gender 0.00 −0.012 −0.012 0.194 
MCS-12 0.189 PCAS-
Interpersonal 
Treatment 
0.11 0.00 0.111 0.052 
Age 0.219 0.00 0.219 0.001* 
Education 0.144 0.00 0.144 0.014* 
Marital status 0.103 0.00 0.103 0.078 
Health literacy 0.243 0.00 0.243 <0.001* 
Comorbidities −0.178 0.00 −0.178 0.001* 
Race 0.037 0.00 0.037 0.539 
Gender 0.108 0.00 0.108 0.060 
 
Notes: R-Square= 0.01. (*)=p<0.05. 
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Figure 4-11. Path analysis: The association between PROMEX and PCS-12. 
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Table 4-26. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
PCS-12 (n=286). 
 
Outcome variables R2 Predictor 
variables 
Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.016 PCS-12 −0.126 0.00 −0.126 0.040* 
PCAS-
Communication 
0.00 −0.015 −0.015 0.142 
Age 0.00 0.015 0.015 0.156 
Education 0.00 −0.001 −0.001 0.939 
Marital Status 0.00 0.013 0.013 0.167 
Health Literacy 0.00 −0.001 −0.001 0.977 
Comorbidities 0.00 0.045 0.045 0.051 
Race 0.00 0.007 0.007 0.369 
Gender 0.00 0.002 0.002 0.786 
PCS-12 0.174 PCAS-
Communication 
0.125 0.00 0.125 0.035* 
Age −0.120 0.00 −0.120 0.048* 
Education 0.004 0.00 0.004 0.939 
Marital Status −0.110 0.00 −0.110 0.061 
Health Literacy 0.001 0.00 0.001 0.977 
Comorbidities −0.360 0.00 −0.360 <0.001* 
Race −0.061 0.00 −0.061 0.317 
Gender −0.015 0.00 −0.015 0.784 
 
Notes: R-Square=0.01. (*)=p<0.05.  
 
 
 
 113 
path analysis, the MCS-12 did not influence PROMEX (p≥0.05) (Table 4-27). In the 
second regression model, we examined the association between the physical quality of 
life (i.e., PCS-12) and participants’ views of online medication rating websites (i.e., 
PROMEX). Contrary to the path analysis, the PCS-12 did not influence PROMEX 
(p≥0.05) (Table 4-28). In the third regression model, we included both the PCS-12 and 
the MCS-12 to examine the effects of both HRQoL measures on participants’ views of 
online medication rating websites; however, no significant association was found 
between either PCS-12 or MCS-12 and PROMEX (p≥0.05) (Table 4-29). 
 
 
4.15 The Health-Related Quality of Life and the Overall Rating of 
Antihypertensive Regimens 
 
 
4.15.1 The Association between the MCS-12 and the Overall Rating of 
Antihypertensive Regimens 
 
The results of the multiple regression analysis that examined the association between 
the MCS-12 and the overall rating of antihypertensive medication regimens are presented 
in Table 4-30. The participants’ overall rating of antihypertensive medication regimens 
did not influence their mental health quality of life (i.e. MCS-12) (p≥0.05).  However, 
age and health literacy were positively associated the MCS-12, and participants’ 
comorbidities was negatively associated with MCS-12 (p<0.05).  
 
 
4.15.2 The Association between the PCS-12 and the Overall Rating of 
Antihypertensive Regimens 
 
The results of the multiple regression analysis that examined the association between 
the PCS-12 and the overall rating of antihypertensive medication regimens are presented 
in Table 4-31. The participants’ overall rating of antihypertensive medication regimens 
significantly influenced their physical health quality of life (i.e., PCS-12) (β=2.740; 
p=0.005). The higher the overall rating of antihypertensive medication regimens, the 
more likely participants will have high PCS-12 scores controlling for their age, 
comorbidities, race, education, and gender, marital status, number of prescription 
medications, and health literacy level. Further, comorbidities also influenced participants’ 
physical health quality of life (i.e., PCS-12) (β=−1.202; p=0.008). The more diseases 
participants have, the more likely they will have lower PCS-12 scores. 
 
 
 
 
 
 
 
 114 
Table 4-27. Multiple linear regression: The association between PROMEX and 
HRQoL (MCS-12) (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
MCS-12 −0.057 0.127 −0.130 0.016 
PCAS-
Communication 
0.025 0.189 −0.012 0.064 
Age 0.015 0.714 −0.069 0.100 
Comorbidity 
score 
0.170 0.277 −0.138 0.480 
Education 0.003 0.980 −0.262 0.269 
Race 0.776 0.150 −0.284 1.837 
Health literacy 0.229 0.772 −1.330 1.790 
Gender −0.741 0.366 −2.358 0.874 
Marital status 0.206 0.773 −1.201 1.614 
 
Note: R-Square= 0.03. 
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Table 4-28. Multiple linear regression: The association between PROMEX and 
HRQoL (PCS-12) (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
PCS-12 −0.059 0.089 −0.129 0.009 
PCAS-
Communication 
0.028 0.157 −0.010 0.067 
Age −0.007 0.861 −0.090 0.076 
Comorbidity 
score 
0.112 0.497 −0.213 0.438 
Education −0.027 0.837 −0.289 0.235 
Race 0.690 0.200 −0.370 1.751 
Health literacy −0.058 0.939 −1.571 1.455 
Gender −0.914 0.262 −2.517 0.689 
Marital status −0.057 0.935 −1.464 1.349 
 
Note: R-Square=0.03. 
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Table 4-29. Multiple linear regression: The association between PROMEX and 
HRQoL (PCS-12 and MCS-12) (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
PCS-12 −0.067 0.056 −0.137 0.001 
MCS-12 −0.065 0.079 −0.139 0.007 
PCAS-
Communication 
0.031 0.115 −0.007 0.070 
Age 0.008 0.850 −0.076 0.092 
Comorbidity 
score 
0.047 0.777 −0.284 0.380 
Education 0.009 0.944 −0.255 0.274 
Race 0.716 0.183 −0.340 1.773 
Health literacy 0.277 0.725 −1.275 1.830 
Gender −0.745 0.361 −2.353 0.862 
Marital status 0.066 0.926 −1.341 1.473 
 
Note: R-Square= 0.04. 
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Table 4-30. Multiple linear regression: The association between hypertensive 
participants’ MCS-12 scores and overall ratings of their antihypertensive 
medication regimens (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
0.410 0.636 −1.300 2.120 
Age 0.329 0.001* 0.152 0.507 
Comorbidity 
score 
−1.299 0.001* −2.082 −0.515 
Education 0.375 0.210 −0.213 0.965 
Race 1.191 0.295 −1.051 3.434 
Health literacy 5.230 0.004* 1.672 8.788 
Gender 2.193 0.207 −1.228 5.616 
Number of 
prescription 
medications 
0.591 0.082 −0.077 1.260 
Marital status 1.402 0.365 −1.650 4.454 
 
Notes: R-Square: 0.20. (*)=p<0.05. 
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Table 4-31. Multiple linear regression: The association between hypertensive 
participants’ PCS-12 scores and overall ratings of their antihypertensive 
medication regimens (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
2.740 0.005* 0.809 4.672 
Age −0.071 0.481 −0.271 0.128 
Comorbidity 
score 
−1.202 0.008* −2.087 −0.318 
Education 0.064 0.848 −0.600 0.730 
Race −2.123 0.099 −4.655 0.409 
Health 
literacy 
−3.972 0.052 −7.989 0.044 
Gender −0.558 0.775 −4.422 3.305 
Number of 
prescription 
medications 
−0.540 0.159 −1.296 0.214 
Marital status −0.598 0.731 −4.044 2.846 
 
Notes: R-Square=0.15. (*)=p<0.05. 
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4.16 Older Adult Participants’ Views of Online Medication Rating Websites and 
Their Beliefs about Medications 
 
 
4.16.1 Path Model for the Association between PROMEX and BMQ-Overuse Scale 
 
The results of the path analysis that examined the association between participants’ 
views of online medication rating websites and BMQ-overuse are presented in  
Figure 4-12 and Table 4-32. The participants’ views of online medication rating 
websites (i.e., PROMEX), were not influenced by the beliefs that medications are 
generally overused or overprescribed (i.e., BMQ-overuse) (p≥0.05). Further, PROMEX 
was not influenced by the other exogenous variables (i.e., age, gender, education, etc.). 
However, BMQ-overuse was negatively influenced by PCAS-Communication 
(β=−0.194; p=0.001), and the number of prescription medications taken (β=−0.202; 
p=0.001), and positively influenced by gender (β=0.175, p=0.001). Participants who were 
satisfied with their physician communication were less likely to believe that medications 
are overused or overprescribed. Further, the higher the number of prescription 
medications taken by participants, the less likely they believe medications are 
overprescribed or overused. On the other hand, women were more likely than men to 
believe that medications are overprescribed or overused. An analysis of the fit indices 
indicated adequate model fit (comparative fit index=1.00, adjusted goodness of fit 
index=0.999, root mean square error of approximation= 0.00, and standardized root mean 
square residual=0.017). 
 
 
4.16.2 Path Model for the Association between PROMEX and BMQ-Harm Scale 
 
The results of the path analysis that examined the association between participants’ 
views of online medication rating websites and BMQ-Harm are presented in Figure 4-13 
and Table 4-33. The participants’ views of online medication rating websites (i.e., 
PROMEX), were not influenced by the beliefs that medications are inherently harmful 
(i.e., BMQ-overuse) (p≥0.05). Further, PROMEX was not influenced by the other 
exogenous variables (i.e., age, gender, education, etc.). However, the BMQ-Harm was 
negatively influenced by the PCAS-Communication (β=−0.221; p<0.001), age 
(β=−0.177; p=0.002), education (β=−0.124; p=0.030), and number of prescription 
medications taken (β=−0.185; p=0.001). Participants who were satisfied with their 
physician communication were less likely to believe that medications are harmful. 
Further, the older the participants, the less likely they believe that medications are 
harmful. In addition, participants with higher levels of education were less likely to 
believe medications are harmful. Moreover, the higher the number of prescription 
medications taken by participants, the less likely they believe medications are harmful. 
An analysis of the fit indices indicated adequate model fit (comparative fit index=0.993, 
adjusted goodness of fit index=0.999, root mean square error of approximation=0.01, and 
standardized root mean square residual=0.021). 
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Figure 4-12. Path analysis: The association between PROMEX and BMQ-Overuse. 
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Table 4-32. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
BMQ-Overuse (n=286). 
 
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.005 BMQ-Overuse −0.070 0.00 −0.070 0.236 
PCAS-
Communication 
0.00 0.013 0.013 0.264 
Age 0.00 0.002 0.002 0.606 
Education 0.00 −0.00 −0.00 0.426 
Number of 
prescription 
medications 
0.00 0.014 0.014 0.261 
Race 0.00 0.004 0.004 0.447 
Gender 0.00 −0.01 −0.01 0.269 
BMQ-Overuse 0.111 PCAS-
Communication 
−0.194 0.00 −0.194 0.001* 
Age −0.034 0.00 −0.034 0.567 
Education 0.063 0.00 0.063 0.282 
Number of 
prescription 
medications 
−0.202 0.00 −0.202 0.001* 
Race −0.059 0.00 −0.059 0.321 
Gender 0.175 0.00 0.175 0.001* 
 
Notes: R-Square=0.01. (*)=p<0.05. 
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Figure 4-13. Path analysis: The association between PROMEX and BMQ-Harm. 
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Table 4-33. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
BMQ-Harm (n=286). 
 
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.003 BMQ-Harm −0.052 0.00 −0.052 0.379 
PCAS-
Communication 
0.00 0.011 0.011 0.391 
Age 0.00 0.009 0.009 0.398 
Education 0.00 0.006 0.006 0.415 
Number of 
prescription 
medications 
0.00 0.009 0.009 0.395 
Race 0.00 −0.001 −0.001 0.667 
Gender 0.00 −0.003 −0.003 0.471 
BMQ-Harm 0.140 PCAS-
Communication 
−0.221 0.00 −0.221 <0.001* 
Age −0.177 0.00 −0.177 0.002* 
Education level −0.124 0.00 −0.124 0.030* 
Number of 
prescription 
medications 
−0.185 0.00 −0.185 0.001* 
Race 0.028 0.00 0.028 0.623 
Gender 0.070 0.00 0.070 0.208 
 
Notes: R-Square= 0.01. (*)=p<0.05. 
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4.16.3 Multiple Linear Regression for the Association between PROMEX and Both 
BMQ-Overuse and BMQ-Harm 
 
In addition to the path analyses, a multiple linear regression analysis was performed 
to examine the association between PROMEX and beliefs about medications (i.e., BMQ-
overuse & BMQ-Harm) controlling for the same variables as in the path analyses. The 
results of this multiple linear regression in which both BMQ-overuse and BMQ-Harm 
were included are presented in Table 4-34. Neither BMQ-overuse nor BMQ-Harm 
influenced PROMEX (i.e., participants’ views of online medication rating websites) 
(p≥0.05). 
 
 
4.17 Beliefs about Medications and the Overall Rating of Antihypertensive 
Regimens 
 
 
4.17.1 The Association between BMQ-Overuse and the Overall Rating of 
Antihypertensive Regimens 
 
The results of the regression analysis that examined the association between BMQ-
Overuse and the overall rating of antihypertensive medication are presented in  
Table 4-35. The overall rating of antihypertensive medication regimens did not 
significantly influence the BMQ-Overuse controlling for age, race, education, and health 
literacy, number of prescription medications, comorbidities, gender, and marital status 
(p≥0.05). Female participants were more likely to have high BMQ-Overuse score 
compared to male participants (β=1.204, p=0.024), controlling for their age, race, 
education, and health literacy, number of prescription medications, comorbidities, and 
marital status.  On the other hand, the number of prescription medication negatively 
influenced the BMQ-Overuse score (β=−0.256, p=0.014), controlling for their age, race, 
education, and health literacy, comorbidities, overall rating of antihypertensive 
medication regimens, gender, and marital status. 
 
 
4.17.2 The Association between BMQ-Harm and the Overall Rating of 
Antihypertensive Regimens 
 
The results of the regression analysis that examined the association between BMQ-
Harm and the overall rating of antihypertensive medication are presented in Table 4-36. 
The overall rating of antihypertensive medication regimens significantly influenced the 
BMQ-Harm (β=−0.601; p=0.035). The higher overall rating of antihypertensive 
medication regimens, the less likely participants believe medications are harmful 
controlling for age, race, education, health literacy, number of prescription medications, 
comorbidities, gender, and marital status. Further, age (β=−0.077; p=0.009), and 
education (β=−0.219; p=0.024), significantly influenced the BMQ-Harm score. The older 
the participants, and the lower their level of education the less likely they believe that 
medications are harmful controlling for race, health literacy, number of prescription  
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Table 4-34. Multiple linear regression: The association between PROMEX and 
BMQ-Overuse and BMQ-Harm (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence Limits 
Lower Upper 
BMQ-Overuse −0.02 0.855 −0.26 0.221 
BMQ-Harm −0.04 0.707 −0.30 0.209 
PCAS-
Communication 
0.023 0.208 −0.01 0.060 
Age −0.01 0.756 −0.09 0.067 
Number of 
prescription 
medications 
0.146 0.227 −0.09 0.385 
Education −0.02 0.834 −0.28 0.230 
Race 0.856 0.100 −0.16 1.879 
Gender −0.60 0.427 −2.09 0.891 
 
Notes: R-Square= 0.02. (*)=p<0.05. 
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Table 4-35. Multiple linear regression: The association between hypertensive 
participants’ overall ratings of their antihypertensive medication regimens and 
BMQ-Overuse (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
−0.514 0.053 −1.036 0.007 
Age −0.005 0.849 −0.059 0.048 
Comorbidity 
score 
0.048 0.688 −0.190 0.287 
Education 0.070 0.434 −0.107 0.249 
Race −0.050 0.883 −0.733 0.632 
Health literacy −0.036 0.946 −1.121 1.048 
Gender 1.204 0.024* 0.160 2.248 
Number of 
prescription 
medications 
−0.256 0.014* −0.461 −0.052 
Marital status −0.208 0.659 −1.138 0.722 
 
Notes: R-Square=0.12. (*)=p<0.05. 
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Table 4-36. Multiple linear regression: The association between hypertensive 
participants’ overall ratings of their antihypertensive medication regimens and 
BMQ-Harm (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
−0.601 0.035* −1.161 −0.042 
Age −0.077 0.009* −0.135 −0.019 
Comorbidity 
score 
−0.041 0.747 −0.298 0.214 
Education −0.219 0.024* −0.411 −0.028 
Race −0.041 0.909 −0.767 0.683 
Health literacy −0.002 0.997 −1.163 1.158 
Gender 0.529 0.354 −0.598 1.657 
Number of 
prescription 
medications 
−0.143 0.207 −0.366 0.080 
Marital status 0.246 0.626 −0.752 1.244 
 
Notes: R-Square= 0.13. (*)=p<0.05. 
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medications, comorbidities, gender, and marital status. Further, age (β=−0.077; p=0.009), 
and education (β=−0.219; p=0.024), significantly influenced the BMQ-Harm score. The 
older the participants, and the lower their level of education the less likely they believe 
that medications are harmful controlling for race, health literacy, number of prescription 
medications, comorbidities, overall rating of antihypertensive medication regimens, 
gender, and marital status. 
 
 
4.18 Older Adult Participants’ Views of Online Medication Rating Websites and 
Adherence to Antihypertensive Medication Regimens 
 
 
4.18.1 Path Model for the Association between PROMEX and Morisky Medication 
Adherence Scale (MMAS-8) 
 
The results of the path analysis that examined the association between participants’ 
views of online medication rating websites (i.e., PROMEX) and adherence to 
antihypertensive medication regimens are presented in Figure 4-14 and Table 4-37. The 
Morisky Medication Adherence scale (MMAS-8) (i.e., medication adherence) was not 
associated with participants’ views of the online medications rating websites (i.e., 
PROMEX) (p≥0.05). Moreover, none of the other exogenous variables (i.e., age, 
education, gender, etc.) were associated with PROMEX (p≥0.05). However, participants’ 
satisfaction with physician communication (i.e., PCAS-Communication) was positively 
associated with medication adherence (β=0.22; p=0.003). Participants with high levels of 
satisfaction with physician communication (i.e., high PCAS-Communication score) were 
more likely to have high adherence levels to their antihypertensive medication regimens. 
Further, age was also positively associated with medication adherence (β=0.26; p=0.001). 
Adherence to antihypertensive medication regimens increased as the age of the 
participants increased. In addition, the overall rating of regimens were positively 
associated with medication adherence (β=0.21; p=0.003). The higher the overall rating of 
regimens, the more likely participants will be adherent to the regimens. Education, 
gender, age, comorbidities, the number of prescription medications, Beliefs about 
Medicine (BMQ) General-Overuse domain, and race were not associated with medication 
adherence (p≥0.05). Further, BMQ-Harm was negatively associated with participants’ 
overall rating of their regimens (β=−0.18; p=0.018). Older adults who did not believe 
medications are generally harmful were more likely to give a high overall rating to their 
regimens. Health literacy was also positively associated with the overall rating of 
regimens (β=0.24; p=0.001). Participants with good health literacy level were more likely 
to give high overall rating to their regimens. On the other hand, the number of 
prescription medications taken was not associated with the overall rating of 
antihypertensive medications (p≥0.05). An analysis of the fit indices indicated adequate 
model fit (comparative fit index=0.985, adjusted goodness of fit index=0.995, root mean 
square error of approximation=0.02, and standardized root mean square residual=0.035).  
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Figure 4-14. Path analysis: The association between PROMEX and MMAS-8 (adherence). 
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Table 4-37. Path analysis: Standardized direct, indirect, and total effects of the variables evaluated on PROMEX and 
MMAS-8 (n=286). 
 
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.018 Medication Adherence −0.13 0.00 −0.13 0.079 
Age 0.00 −0.03 −0.03 0.118 
BMQ-Overuse 0.00 0.002 0.002 0.836 
BMQ-Harm 0.00 0.005 0.005 0.208 
Race 0.00 0.011 0.011 0.355 
Overall Rating HTN Meds 0.00 −0.02 −0.02 0.134 
Communication 0.00 −0.03 −0.03 0.136 
Comorbidities 0.00 −0.00 −0.00 0.933 
Gender 0.00 −0.01 −0.01 0.280 
Health Literacy 0.00 −0.006 −0.006 0.176 
Number of Prescription 
Medications 
0.00 −0.00 −0.00 0.241 
Education 0.00 0.011 0.011 0.353 
Medication adherence 
(MMAS-8) 
0.211 BMQ-Overuse −0.01 0.00 −0.01 0.835 
Gender 0.100 0.00 0.100 0.168 
Overall Rating of HTN 
Meds 
0.207 0.00 0.207 0.003* 
Communication 0.218 0.00 0.218 0.003* 
Age 0.260 0.00 0.260 0.001* 
Education −0.08 0.00 −0.08 0.272 
Comorbidities −0.006 0.00 −0.006 0.933 
Race −0.08 0.00 −0.08 0.275 
Overall rating of 
hypertension (HTN) 
medication regimen 
0.123 BMQ-Harm −0.17 0.00 −0.17 0.018* 
Health Literacy 0.237 0.00 0.237 0.001* 
Number of Prescription 
Medications (RX number) 
0.142 0.00 0.142 0.056 
 
Notes: R-Square=0.01. (*)=p<0.05.
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4.18.2 Regression Model for the Association between PROMEX and Morisky 
Medication Adherence Scale ( MMAS-8) 
 
The results of the regression model that examined the association between PROMEX 
and MMAS-8 are presented in Table 4-38. Medication adherence to antihypertensive 
medication regimens did not influence participants’ views of online medication rating 
websites (i.e., PROMEX) (p≥0.05), however, comorbidity score did influence PROMEX 
(β=0.492; p=0.045). Hypertensive participants with multiple comorbidities or diseases 
were more likely to have favorable views of online medication rating websites controlling 
for their medication adherence, satisfaction with physician communication, beliefs about 
medications, overall rating of antihypertensive medication regimens, age, education, race, 
health literacy, gender, the number of prescription medications, and marital status. 
 
 
4.19 Medication Adherence and the Overall Rating of Antihypertensive Regimens 
 
The results of the regression model that examined the association between medication 
adherence and the overall rating of antihypertensive medication regimens are presented in 
Table 4-39. As with path analysis, the overall rating of antihypertensive medication 
regimens was positively associated with Morisky Medication Adherence Scale Score 
(MMAS-8) (β=0.408; p=0.004). The higher the overall rating of antihypertensive 
medication regimens, the higher the adherence level to these medication regimens 
controlling for age, comorbidities, education, race, health literacy, gender, number of 
prescription medications, and marital status. Further, age was positively associated with 
medication adherence to the regimens controlling for the overall rating of these 
medication regimens, comorbidities, education, race, health literacy, gender, the number 
of prescription medications, and marital status (β=0.049; p=0.001).  
 
 
4.20 An Overarching Path Model of the Association between Older Adults’ Views 
of Online Medication Rating Websites and Participant-Reported Outcomes 
 
The results of the path model that examined the association of participants’ online 
medication rating websites (i.e., PROMEX), health-related quality of life (i.e., PCS-12 
and MCS-12), and beliefs about medications (i.e., BMQ-Harm and BMQ-Overuse) are 
presented in Figure 4-15 and Table 4-40. The healthcare decision sharing preference was 
positively associated with PROMEX (β=0.179; p=0.003). Participants who like to have 
an equal partnership with their physicians concerning their healthcare were likely to have 
favorable views of the online medication rating websites compared to those who like to 
either keep their healthcare decision in their own hands or leave it in the doctors’ hands. 
Further, both PCS-12 (β=−0.129; p=0.033) and MCS-12 (β=−0.130; p=0.032) of the SF-
12v2 were negatively associated with PROMEX. Participants with poor physical and 
mental HRQoL were more likely to have favorable views of the online medication rating 
websites compared to those with good quality of life. In addition, comorbidity score was 
positively associated with PROMEX (β=0.059; p=0.007). Participants with multiple 
diseases or comorbidities were more likely to view the online medication rating websites 
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Table 4-38. Multiple linear regression: The association between participants’ 
medication adherence (MMAS-8 Score) and PROMEX (n=286). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
MMAS-8 
(adherence) 
−0.460 0.146 −1.084 0.163 
PCAS-
Communication 
0.040 0.125 −0.011 0.092 
BMQ-Overuse 0.078 0.670 −0.284 0.441 
BMQ-Harm 0.082 0.633 −0.257 0.422 
Overall rating 
of HTN 
medications 
−0.425 0.446 −1.529 0.677 
Age 0.030 0.608 −0.085 0.146 
Comorbidity 
score 
0.492 0.045* 0.009 0.975 
Education −0.069 0.715 −0.445 0.306 
Race 0.953 0.171 −0.416 2.322 
Health literacy 0.406 0.720 −1.831 2.644 
Gender −1.321 0.235 −3.513 0.869 
Number of 
prescription 
medications 
−0.020 0.927 −0.454 0.414 
Marital status −0.073 0.939 −1.963 1.817 
 
Notes: R-Square= 0.09. (*)=p<0.05. 
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Table 4-39. Multiple linear regression: The association between overall ratings 
of antihypertensive medication regimens and MMAS-8 score (n=193). 
 
 
Variable 
 
Beta (β) estimate 
 
p-Value 
95% Confidence limits 
Lower Upper 
Overall rating 
of HTN 
medications 
0.408 0.004* 0.131 0.684 
Age 0.049 0.001* 0.020 0.078 
Comorbidity 
score 
0.020 0.749 −0.119 0.133 
Education −0.053 0.268 −0.143 0.046 
Race −0.124 0.502 −0.503 0.220 
Health literacy 0.478 0.102 −0.103 1.047 
Gender 0.403 0.153 −0.107 0.999 
Number of 
prescription 
medications 
−0.010 0.851 −0.113 0.103 
Marital status 0.269 0.282 −0.235 0.752 
 
Notes: R-Square=0.19. (*)=p<0.05. 
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Figure 4-15. Path analysis: The association between PROMEX and PROs. 
 
Notes: Dashed lines represent the indirect relationships. Continuous lines represent direct 
relationships. 
 
 
 
 
 
 
 
 
 
 135 
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Table 4-40. Standardized direct, indirect, and total effects of the variables evaluated on PROMEX, PCS-12, MCS-12, 
BMQ-Harm and BMQ-Overuse, and PCAS-Communication scales (n=286). 
 
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
Patient Reviews of 
Medication Experiences 
(PROMEX) 
0.063 Healthcare decision 
sharing 
0.179 0.00 0.179 0.003* 
SF-12v2 Physical 
Component Summary 
(PCS-12) 
−0.129 0.00 −0.129 0.033* 
SF-12v2 Mental 
Component Summary 
(MCS-12) 
−0.130 0.00 −0.130 0.032* 
PCAS-Communication 0.00 −0.02 −0.02 0.057 
Age 0.00 −0.01 −0.01 0.319 
Comorbidities 0.00 0.059 0.059 0.007* 
Education 0.00 −0.01 −0.01 0.177 
Race 0.00 0.003 0.003 0.168 
Gender 0.00 −0.00 −0.00 0.155 
Health literacy 0.00 −0.037 −0.037 0.034* 
Marital status 0.00 −0.01 −0.01 0.141 
Number of prescription 
medications 
0.00 −0.02 −0.02 0.113 
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Table 4-40. Continued. 
 
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
SF-12v2 Mental 
Component Summary 
(MCS-12) 
0.179 Marital status 0.089 0.00 0.089 0.124 
PCAS-Communication 0.068 0.00 0.068 0.251 
Age 0.212 0.00 0.212 0.001* 
Education 0.158 0.00 0.158 0.007* 
Health literacy 0.259 0.00 0.259 <0.001* 
Comorbidities −0.183 0.00 −0.183 0.001* 
Gender 0.00 0.008 0.008 0.312 
Race 0.00 −0.00 −0.00 0.319 
SF-12v2 Physical 
Component Summary 
(PCS-12) 
0.176 Age −0.076 0.00 −0.076 0.193 
PCAS-Communication 0.136 0.00 0.136 0.017* 
Number of prescription 
Medications 
−0.159 0.00 −0.159 0.017* 
Comorbidities −0.275 0.00 −0.275 <0.001* 
Education −0.007 0.00 −0.007 0.904 
Race 0.00 −0.01 −0.01 0.125 
Gender 0.00 0.017 0.017 0.110 
Health literacy 0.00 0.028 0.028 0.052 
Marital status 0.00 0.018 0.018 0.104 
PCAS-Communication 0.1 Race −0.123 0.00 −0.123 0.043* 
Gender 0.131 0.00 0.131 0.030* 
Health literacy 0.206 0.00 0.206 0.001* 
Marital status 
 
 
 
 
0.135 0.00 0.135 0.025* 
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Table 4-40. Continued. 
  
Outcome variables R2 Predictor variables Standardized 
direct effect (β) 
Standardized 
indirect effect (β) 
Standardized 
total effect (β) 
p-Value 
BMQ-Harm 0.1 PCAS-Communication −0.21 0.00 −0.21 0.001* 
Race 0.136 0.00 0.136 0.014* 
Number of prescription 
medications 
−0.17 0.00 −0.17 0.003* 
Gender 0.00 −0.02 −0.02 0.064 
Health literacy 0.00 −0.044 −0.044 0.013* 
Marital status 0.00 −0.02 −0.02 0.058 
BMQ-Overuse 0.1 PCAS-Communication −0.178 0.00 −0.178 0.002* 
Gender 0.143 0.00 0.143 0.009* 
Number of prescription 
medications 
−0.206 0.00 −0.206 0.001* 
Race 0.00 0.022 0.022 0.095 
Health literacy 0.00 −0.03 −0.03 0.025* 
Marital status 0.00 −0.02 −0.02 0.074 
 
Notes: (*) =p<0.05 
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favorably compared to the healthy participants. Further, health literacy was negatively 
associated with PROMEX (β=−0.037; p=0.034). Participants with good health literacy 
were less likely to view the online medication rating websites favorably than those with 
limited health literacy. Age, education, and health literacy were positively associated with 
the MCS-12, whereas, the comorbidity score was negatively associated with it (p<0.05). 
The PCAS-Communication was positively associated with the PCS-12, however, the 
number of prescription medication and the comorbidity score were negatively associated 
with it (p<0.05). Gender, health literacy, and marital status were positively associated the 
PCAS-Communication, whereas, race was negatively associated with it (p<0.05). Race 
was positively associated with BMQ-Harm; however, the PCAS-Communication, health 
literacy, and the number of prescription medications were negatively associated with it 
(p<0.05). Finally, health literacy, number of prescription medications, and the PCAS-
Communication were negatively associated with BMQ-Overuse; however, gender was 
positively associated with it. An analysis of the fit indices indicated adequate model fit 
(comparative fit index=0.977, adjusted goodness of fit index=0.994, root mean square 
error of approximation=0.03, standardized root mean square residual=0.03). 
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CHAPTER 5.    DISCUSSION 
 
 
5.1  Overview 
 
The advent of the Internet has revolutionized health care delivery (Campbell & Nolfi, 
2005). Today, patients can go online to browse an immense amount of educational 
information about a variety of health conditions and treatment options. Further, patients 
can go online and read other patients’ feedback about different physicians and health 
products to make informed decisions before choosing a certain physician or over-the-
counter (OTC) medication (Emmert, Meier, et al., 2013; Faber et al., 2009). Medication 
rating websites are a new frontier in the online health-related websites market. Currently, 
patients can go online and post their feedback about the medications they are taking for 
others to read. These websites ask patients who want to share their medication 
experiences with others to rate these medications in terms of their effectiveness, side 
effects, cost, etc… The online medication rating websites have the potential as other 
online health-related information websites, to empower patients to ask more questions 
during their physician office visits, adopt healthy lifestyle habits, follow their physicians’ 
advice more closely, and improve their health outcomes (Iverson, Howard, & Penney, 
2008; Lau, Campbell, Tang, Thompson, & Elliott, 2014). These potential benefits of the 
online medication rating websites are needed especially among the U.S. elderly (≥65 
years).  
 
According to Pew Internet and American Life Project, six in ten or 59% of U.S. 
seniors reported using the Internet in 2013 (i.e. 59%) (Duggan & Smith, 2013). Older 
adults are more likely to have chronic diseases (i.e., diabetes and hypertension) than their 
younger counterparts (N. C. o. Aging, 2014). Additionally, more than 80% of U.S. older 
adults take at least one prescription medication, and about one third take five or more 
prescription medications daily (Qato et al., 2008). Further, infirm patients such as elderly 
are prone to medication side effects due to their diminished physiological reserve 
(Wasson, 2008).  Moreover, several studies that examined the appropriateness of 
physician prescribing patterns among elderly have found multiple prescribing patterns 
that were inconsistent with evidence-based practice (Goulding, 2004; Spinewine et al., 
2007). Therefore, older adults are well poised to evaluate the usefulness of the online 
medication rating websites.  
 
The aim of this study was to examine the association between older adults’ views of 
the online medication rating websites in terms of facilitating patient-physician 
communication and participant-reported outcomes, i.e., and their satisfaction with 
physician communication, health-related quality of life, beliefs about medications, and 
medication adherence. Further, the association between older adults’ actual overall 
rating/evaluation of their antihypertensive medications and each of the aforementioned 
participant-reported outcomes was examined. The final sample of this study was 286 
participants that examined the association between the value of online medication rating 
websites to older adults (i.e., PROMEX) and each of the participant-reported outcomes 
with the exception of medication adherence. The sample size for both path and regression 
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analyses that examined the association between PROMEX and medication adherence 
among hypertensive participants was 193. Finally, the sample size for the regression 
analyses that examined the association between each of the participant-reported outcomes 
and the overall rating of antihypertensive medications among the hypertensive 
participants was 193. 
 
 
5.2  Patient Reviews of Medication Experiences (PROMEX) 
 
In order to assess older adults’ views of online medication rating websites, we 
developed a self-report questionnaire, Patient Reviews of Medication Experiences 
(PROMEX). First, participants were presented with a table that included five commonly 
prescribed antihypertensive medications that were rated online by anonymous users. 
Then, participants were asked to answer seven questions that explored their views of 
online medication rating websites like the example in table. After refining this 
instrument, the final questionnaire includes six questions with a Cronbach’s alpha of 
0.85. Although we proposed two domains or constructs within this questionnaire, only 
one construct was extracted from it.  We named this construct the “value of online 
medication rating websites to older adults”. Therefore, PROMEX is sufficiently reliable 
to measure the value of online medication rating websites in terms of facilitating 
physician-patient communication among this surveyed sample of older adults (Field, 
2009).  
 
 
5.3  PROMEX and Participant-Reported Outcomes (PROs) 
 
Participants’ views of online medication rating websites (i.e., PROMEX) were not 
influenced by the sociodemographic factors (Table 4-7). Further, PROMEX was not 
associated with participants’ health-related quality of life or HRQoL, satisfaction with 
physician communication, beliefs about medications, and medication adherence 
(Table 4-21). However, in the path analyses that we conducted to determine the causal 
effects among the variables of participants’ views of online medication rating websites 
(PROMEX), HRQoL (PCS-12 and MCS-12), satisfaction with physician communication 
(PCAS-Communication), and beliefs about medications (BMQ-Overuse and BMQ-
Harm) several variables directly or indirectly influenced PROMEX.  
 
The Physical Component Summary (PCS-12) of the SF-12v2 that measured the 
physical quality of life of the older adult participants in the past four weeks was 
significantly associated with their views of online medication rating websites (PROMEX) 
(p<0.05) (Figure 4-11 and Table 4-27). Participants with poor physical HRQoL were 
more likely to have favorable views of online medication rating websites than those with 
good physical HRQoL (β= −0.13, p=0.040). Further, older adults with poor physical 
HRQoL were more likely to be unsatisfied with their physician communication than 
those with good physical HRQoL (β= 0.13, p=0.035). Additionally, participants with 
poor physical HRQoL were more likely to have multiple comorbidities (i.e., chronic 
diseases) than those with good physical HRQoL (β= −0.36, p<0.001). Moreover, older 
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participants were more likely to have poor physical HRQoL (β= −0.12, p=0.048). 
Further, participants with poor physical HRQoL were more likely to be on multiple 
prescription medications than those with good physical HRQoL (β= −0.16, p=0.017) 
(Table 4-40).  
 
Similarly, the Mental Component Summary (MCS-12) of the SF-12v2  that measured 
the mental HRQoL of the participants in the past four weeks was significantly associated 
with participants’ views of online medication rating websites (PROMEX) (p<0.05) 
(Figure 4-15 and Table 4-40). Contrary to the PCS-12, the significant association 
between MCS-12 and PROMEX was not detected in the path model the investigated the 
association between only MCS-12 and PROMEX, but rather in the overarching path 
model that included the entire participant-reported outcome variables. Participants with 
poor mental HRQoL were more likely to have favorable views of online medication 
rating websites compared to participants with good HRQoL (β= −0.13, p=0.032). Further, 
participants with poor mental HRQoL were more likely to have multiple comorbidities 
than those with good mental HRQoL (β= −0.18, p=0.001). In addition, participants with 
poor mental HRQoL were more likely to have limited health literacy (β= 0.26, p<0.001). 
Interestingly, participants who were younger (β=0.21, p=0.001) and participant who had 
less education (β= 0.16, p=0.007) were more likely to have poor mental HRQoL.  
 
Therefore, the older adults in this study who had poor physical and mental HRQoL 
believed that the online medication rating websites are useful and helpful in facilitating 
the communication with their physicians. Further, the fact that the older adults with poor 
HRQoL were more likely to have multiple comorbidities, take multiple prescription 
medications, have limited health literacy, and lower education is consistent with the 
literature (Low & Molzahn, 2007). What is more interesting is that these very factors not 
only influenced the participants’ HRQoL they also influenced participants’ views of 
online medication rating websites. Elderly participants with multiple comorbidities (i.e., 
chronic diseases) were more likely to view the online medication rating websites more 
favorably than their healthier counterparts were. The hypertensive participants’ views of 
online medication rating websites were directly influenced by their comorbidity score as 
shown in Table 4-39 controlling for sociodemographics, medication adherence, number 
of prescription medications, overall rating of antihypertensive medications,  satisfaction 
with physician communication, and beliefs about medications (β=0.492, p=0.045). 
Further, the comorbidity score indirectly influenced the participants’ views of online 
medication rating websites (i.e., hypertensive and non-hypertensive) (β=0.059, p=0.007) 
(Table 4-40). In addition, participants with limited health literacy were more likely to 
have positive views of online medication rating websites than those with good health 
literacy (β=−0.037, p=0.034) (Table 4-40). Moreover, participants who liked to share the 
health decision with physicians were more likely to view the online medication rating 
websites more favorably than those who liked to keep the health decision to themselves 
or leave it to their physicians (β=0.179, p=0.003) (Table 4-40). 
 
These findings suggest that older adults with multiple chronic health conditions and 
limited health literacy perceive the online medication rating websites more useful in 
terms of facilitating the communication with their physicians than their healthier and 
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more educated counterparts. This partly may be explained by the fact that the online 
patients’ reviews of medications were written in nonprofessional terms and show the 
rating of medications in a simple way (i.e., star ratings) for an average person to 
understand. However, well-educated older adults with good health literacy level may 
prefer to refer to other traditional sources of information (i.e., books, medical articles, 
magazines) should they need to know about a certain medication (Campbell & Nolfi, 
2005). Further, older adults with poor physical HRQoL were more likely to be on 
multiple medications. Therefore, they are more likely to experience medication side 
effects (Borchelt, 1994). This is consistent with the medical literature, in which 
medication side effects had negative impact on both the physical and mental aspects of 
patients’ quality of life (Bebbington et al., 2009). Hence, the favorable opinion of online 
patients’ reviews of medications among older adults with poor physical HRQoL may 
stem from the fact that they want to know about other treatment options that have better 
safety and efficacy profiles than their current medications. In addition, participants with 
poor physical HRQoL were more likely to be unsatisfied with physician communication. 
 
Effective physician-patient communication, in which physicians recognize patients’ 
needs and concerns, listen attentively, and explain thoroughly in a simplified way the 
treatment plan to their patient, is quintessential in any patient-centered care model 
(Berwick, 2009). Research has shown that the quality of physician-patient 
communication can indirectly predict multiple health outcomes such as medication 
adherence and quality of life (Stewart, 1995; Street Jr et al., 2009). Therefore, the older 
adult participants in this study with poor physical HRQoL, who were more likely to be 
unsatisfied with their physicians’ communication, may have felt that the online patients’ 
reviews of medication could facilitate their communication with physicians. This is 
further substantiated when we know that the average amount of time that physicians 
spend with their patients is fifteen minutes ((Belzer, 1999; Morgan, 2003). Further, 
research has shown that older adults receive less information from physicians than their 
younger counterparts receive during their clinic visits (Beisecker, 1988). Thus, older 
adults may want to use the little time they have with their physicians more efficiently, 
and the online patients’ reviews of medications may help them achieve this goal. Further, 
older adults with multiple comorbidities, who were more likely to have poor quality of 
life (i.e., both physical and mental health), were more likely as well to have favorable 
views of the online patients’ reviews of medications. This is consistent with the literature 
in which the presence of multiple health issues among older adults motivated them to 
seek health-related information online (Meloche, 2013).     
 
Most patients like to have a partnership or a therapeutic alliance with physicians to 
manage their health conditions (Bernabeo & Holmboe, 2013; Mazur, Hickam, Mazur, & 
Mazur, 2005). However, many older adults complain about being marginalized in their 
health decision-making process (Gladden, 2000). The majority of participants in this 
study expressed their desire to have an equal partnership with their physicians 
(Table 4-1). Further, older adults in this study who liked to have an equal partnership 
with their physicians were more likely to have favorable views of online patients’ 
reviews of medications. Therefore, these older adults were more likely to believe that the 
online patient reviews of medications will facilitate the communication with their 
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physicians. Hence, the online patients’ reviews of medications could play a patient-
empowering role like other online health-related information (Meloche, 2013; Suter, 
Suter, & Johnston, 2011).   
 
The participants’ satisfaction with physician communication (PCAS-Communication) 
was not associated with their views of the online medication rating websites (PROMEX) 
(Figure 4-9 and Table 4-23). However, multiple sociodemographic factors influenced 
the participants’ satisfaction with their physicians’ communication. Female, married, and 
Caucasian non-Hispanic participants with good health literacy were likely to have higher 
PCAS-Communication scores (p<0.05) (Table 4-23 and Table 4-40). Therefore, these 
participants were more likely to be satisfied with their physician communication. Our 
findings are consistent with the literature. Female patients are usually more satisfied with 
the provided health care than their male counterparts (Arora & McHorney, 2000; Carlin 
et al., 2012). Further, married patients are more likely to be satisfied with medical care 
that the unmarried patients (Hall & Dornan, 1990; Xiao & Barber, 2008). In addition, 
patients with better education and health literacy are more likely to be satisfied with the 
received health care than the patients with less education and limited health literacy (Xiao 
& Barber, 2008). Moreover, whites are more likely than minorities (i.e., blacks, 
Hispanics, and Asians) to be satisfied with the provided health care (Haviland, Morales, 
Reise, & Hays, 2003). Finally, the PCAS-Communication and PCAS-interpersonal 
treatment were highly correlated. The participants in this study, who were satisfied with 
their physician communication, were also likely to be satisfied with their physician 
interpersonal treatment (i.e., amount of time spent, friendliness and warmth received, 
patience, care and concern, and respect). 
 
Participants’ general beliefs about medications (BMQ-Overuse and BMQ-Harm) 
were not associated with their views of the online medication rating websites (PROMEX) 
(Figures 4-12, 4-13 and Tables 4-33, 4-34). However, the BMQ-Overuse and BMQ-
Harm were influenced by several factors. The BMQ-Overuse and BMQ-Harm scores 
were significantly lower among participants who take multiple prescription medications 
(p<0.05) (Tables 4-13 and 4-14). As the number of prescription medications taken by the 
participants increased, their BMQ-Overuse and BMQ-Harm scores decreased. Further, 
participants taking multiple prescription medications were less likely to believe that 
prescription medications are inherently harmful and overprescribed by physicians 
(p<0.05) (Table 4-40). This is consistent with the literature, which shows that patients 
who take multiple prescription medications are more likely to have positive beliefs about 
medications than patients who do not take any prescription medications (Ramstrom, 
2006). Further, participants with good health literacy level were more likely to have a 
lower BMQ-Overuse and BMQ-Harm scores than their counterparts with limited health 
literacy (p<0.05) (Table 4-40). This is also consistent with the literature; patients with 
high literacy level are more likely to have positive beliefs about medications in 
comparison to the ones with limited health literacy level (Horne et al., 2004; Isacson & 
Bingefors, 2002). Additionally, research has shown that effective physician-patient 
communication had a positive impact on patients’ beliefs about medication (Bultman & 
Svarstad, 2000). In our study we have found that the higher the satisfaction with 
physician communication (i.e., high PCAS-Communication score), the more likely the 
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participants will have positive beliefs about medications (low BMQ-Overuse and BMQ-
Harm scores) (p<0.05) (Table 4-40). The impact of participants’ gender on their beliefs 
about medications is controversial. Some studies have indicated that men are more likely 
to have negative views about prescription medications in comparison to women (Horne et 
al., 2004). However, other studies have shown the opposite (Isacson & Bingefors, 2002). 
In this study, we have found that women are more likely to believe that prescription 
medications are being overused and overprescribed (i.e., high BMQ-Overuse scores) 
(p<0.05) (Tables 4-33 and 4-41). Race is another interesting factor. Research has shown 
that Caucasians are more likely to have positive views of prescription medications than 
minorities (i.e., blacks, Hispanics, and Asians), who tend to have negative views of 
medications (Horne et al., 2004; Iihara et al., 2004). Similarly, Caucasians participants in 
this study were less likely to believe that prescription medications are inherently harmful 
or poisonous (i.e., high BMQ-Harm score) in comparison to minority participants (i.e., 
African Americans, Hispanics, and Asians) (p<0.05) (Tables 4-34 and 4-41).  
 
Adherence to antihypertensive medication regimens among the study participants 
who reported having hypertension was measured using Morisky Medication Adherence 
scale (MMAS-8). The number of participants with hypertension who reported low or 
medium adherence levels (i.e., MMAS-8 score ≤6) was 111 participants, which 
represented 50.9% of the hypertensive subsample (Table 4-16). We examined the 
association between the hypertensive participants’ views of online medication rating 
websites (i.e., PROMEX) and their adherence to their antihypertensive medications; 
however, no significant association was found (p≥0.05) (Figure 4-14 and Table 4-38). 
Nonetheless, adherence to antihypertensive medication regimens was associated with 
several variables. Participants who were satisfied with their physicians’ communication 
(i.e., high PCAS-Communication scores) were more likely to achieve high adherence 
levels to their antihypertensive medication regimens (i.e., high MMAS-8 scores) than 
their unsatisfied counterparts (i.e., low PCAS-Communication scores). This is consistent 
with the findings in the literature that effective physician-patient communication is highly 
correlated with better patient adherence (Zolnierek & DiMatteo, 2009). Further, 
participant adherence to antihypertensive medication regimens improved with increasing 
age (Table 4-17). Older participants were more likely to be adherent to their prescribed 
antihypertensive medication regimens (Table 4-38). The role of age as a determinant of 
medication adherence is controversial. Some studies have found that medication non-
adherence is common among the older adults due to their tendency to forget (Krousel-
Wood et al., 2009). However, our results seem to support the findings of other studies, 
which suggest that older adults are more likely to be adherent to their prescribed 
medication regimens than their younger counterparts (Billups et al., 2000; Cohen et al., 
2012).  
 
Race is another sociodemographic factor that has shown to affect patient adherence to 
prescription medications (Rolnick, Pawloski, Hedblom, Asche, & Bruzek, 2013). 
Research has shown that racial differences in medication adherence remains an issue 
even after controlling for insurance status (Zhang & Baik, 2014). In our study, race was 
not associated with adherence to antihypertensive medications in both the path and 
regression analyses; however, the proportion of participants with high level of adherence 
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to antihypertensive medications (i.e., MMAS-8 score=8) was significantly higher among 
Caucasians compared to African Americans, Hispanics, and the other racial groups 
(Table 4-17). Additionally, participants with good health literacy level and positive 
views of medications (i.e., low BMQ-Harm scores) were more likely to have a high 
overall rating of their antihypertensive medication regimens. This, in turn was positively 
associated with medication adherence (Figure 4-14). Participants with high overall rating 
of their antihypertensive medication regimens were more likely to be adherent to these 
medication regimens. This supports the findings of other published studies, which found 
a positive association between hypertensive patients’ overall satisfaction with their 
antihypertensive medications and their medication adherence levels (Bharmal et al., 
2009; Sa’ed et al., 2013). Finally, although researchers have shown significant 
association between patient beliefs about medications and medication adherence, this 
association was not significant among our participants in our study (Horne & Weinman, 
1999). 
 
 
5.4  Participants’ Rating of Their Antihypertensive Medications and Participant-
Reported Outcomes (PROs) 
 
We asked the hypertensive participants to write down the names of their 
antihypertensive medications and rate each one of them on a five-point Likert scale (i.e., 
1-low to 5-high) based on their effectiveness, side effects, cost of medication, ease of use, 
food interactions, and then provide an overall rating to that medication. Since older adults 
with hypertension may take multiple medications to control their hypertension, we 
provided space for four different antihypertensive medications. The higher the rating of 
the medication, the more likely the participants are satisfied with their antihypertensive 
medications. Ten or more hypertensive participants rated the following antihypertensive 
medications: Atenolol, Amlodipine, Hydrochlorothiazide (HCTZ), Lisinopril, Losartan, 
Valsartan, and Metoprolol. Then, we compared the participants’ ratings of these 
medications in terms of their effectiveness, side effects, cost of medication, and ease of 
use, food interactions, and overall ratings (Figure 4-2 and Table 4-20). Although there 
was not a significant difference in the ratings of these medications given the small sample 
size, participants rated them differently. For example, the overall ratings of Amlodipine 
and lisinopril were high and comparable to the other antihypertensive medications; 
however, their side effect ratings were the lowest compared to the other antihypertensive 
medications (Figure 4-7). This could be attributable to the higher likelihood of drug-
induced throat irritation and cough as well as angioedema particularly among the African 
Americans in the case of Lisinopril (Gibbs, Lip, & Beevers, 1999; Naidu, Usha, Rao, & 
Shobha, 2000). Further, the incidence of dizziness and ankle edema with Amlodipine is 
higher among the elderly hypertensive patients compared to their younger counterparts 
(Kloner, Sowers, DiBona, Gaffney, & Marilee, 1996; Naidu et al., 2000). Another 
example is with Hydrochlorothiazide (HTCZ), which had the highest cost of medication 
rating compared to the other antihypertensive medications that were rated by ten or more 
participants (Figure 4-5). This could be explained by the fact that Hydrochlorothiazide as 
well as other diuretics had the lowest out-of-pocket expense per Medicare beneficiary 
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with hypertension per year, according to the U.S. Agency for Healthcare Research and 
Quality (Townsend et al., 2011).  
 
However, since we are interested in the participant-specific ratings of 
antihypertensive medication regimens and not the medication-specific ratings, we have 
taken the average rating of each aspect of medication use (i.e., effectiveness, side effects, 
cost of medication, ease of use, food interaction, and the overall ratings) for every 
participant who reported taking medications for hypertension. The average participant-
specific ratings of the antihypertensive medication regimens across the visited senior 
centers are listed in Table 4-18. All of the participant-specific aspects of medication use 
were positively correlated with each other (p<0.05) (Table 4-19). However, the 
correlations between the rated aspect of medication use and the participant-reported 
outcomes were not all significant (Table 4-22). The participant-specific effectiveness 
rating of the antihypertensive medication regimens was positively correlated with the 
PCAS-Communication, PCAS-interpersonal treatment, and with the PCS-12 of the SF-
12v2 (p<0.05). Further, participant-specific ease of use rating of the antihypertensive 
medication regimens was positively correlated with the PCAS-Communication (p<0.05). 
Moreover, participant-specific overall rating of the antihypertensive medication regimens 
was positively correlated with the PCAS-Communication and PCAS-interpersonal 
treatment and was negatively correlated with the BMQ-Harm. The participant-specific 
overall rating of the antihypertensive medication regimens total correlation with the other 
rated medication use aspects (i.e., effectiveness, side effects, cost of medication, ease of 
use, and food interactions) was the highest among them (i.e., r=0.66) (Table 4-19). 
Further, since the independent variables in the multivariate regression models should be 
strongly related to the dependent variable, and not to each other; we have used the 
participant-specific overall rating of the antihypertensive medication regimens to 
examine the association between the participant-reported outcomes and the participant’ 
rating of their antihypertensive medication regimens (Tabachnick & Fidell, 2001).  
 
The relationship between treatment satisfaction and medication adherence among 
hypertensive participants has been examined before, and was found to be positive and 
significant (Bharmal et al., 2009; Sa’ed et al., 2013). Similarly, the participants’ overall 
rating of their antihypertensive medication regimens, which is a proxy of patient 
satisfaction with their hypertension treatment, was positively associated with their 
medication adherence (p<0.05) (Sa’ed et al., 2013). The higher the overall rating of the 
antihypertensive medication regimens, the more likely the participants with hypertension 
will be adherent to these medication regimens controlling for their age, gender, 
education, race, health literacy, marital status, comorbidities, and number of prescription 
medications (Table 4-40). Although  the relationship between patient satisfaction with 
antihypertensive medication regimens and medication adherence has been studied before 
(Bharmal et al., 2009; Sa’ed et al., 2013), our study findings are unique because we have 
examined this relationship among older adults. Medication adherence is a complex 
psycho-behavioral issue that is influenced by a multitude of factors including age (Gellad 
et al., 2011). Further, medication non-adherence among patients with chronic diseases 
such as hypertension has been linked to serious consequences (Osterberg & Blaschke, 
2005). Therefore, understanding the relationship between treatment satisfaction and 
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medication adherence among older adults could help physicians in identifying strategies 
to address this potential barrier to medication adherence.  
 
Patient satisfaction with physician communication had a positive impact on multiple 
health outcomes including medication adherence (R. Epstein & Street, 2007; Zolnierek & 
DiMatteo, 2009). However, few studies have examined the relationship between 
treatment satisfaction and patient satisfaction with physician communication (Beinart et 
al., 2003; Bultman & Svarstad, 2000). Therefore, we have examined the relationship 
between participant-specific overall ratings of antihypertensive medication regimens and 
the participants’ satisfaction with their physicians’ communication. Participants with 
hypertension, who highly rated their antihypertensive medication regimens, were more 
likely to be satisfied with their physicians’ communication (i.e., high PCAS-
Communication scores) than participants with low overall rating of their antihypertensive 
medication regimens controlling for their age, gender, education, race, health literacy, 
marital status, comorbidities, and number of prescription medications (p<0.05) 
(Table 4-25). This indicates that physicians who effectively communicate with their 
patients (i.e., attentively listen, explain thoroughly, provide help and support) are more 
likely to prescribe medications that work for their patients from the patient perspective, 
and this eventually affects patients’ satisfaction with their physicians’ communication. 
Further, both the participant satisfaction with physician communication (i.e., PCAS-
Communication) and the participant-specific overall rating of the antihypertensive 
medication regimens have significantly affected medication adherence among the older 
adults with hypertension in our study (Figure 4-14). Hence, effective physician-patient 
communication is a crucial element in any successful treatment plan.  
 
The relationship between treatment satisfaction and quality of life has been examined 
in multiple studies. Patient satisfaction with treatment has been linked to quality of life 
improvement (H. Chen et al., 2013; Porter et al., 2012; Stull et al., 2014). However, the 
relationship between patient satisfaction with antihypertensive medications and the 
quality of life among elderly patients has not been examined before. The relationship 
between the two component summaries of the SF-12v2 and the participant-specific 
overall rating of antihypertensive medication regimens was examined in multiple 
regression analyses controlling for age, gender, education, race, health literacy, marital 
status, comorbidities, and number of prescription medications. The Mental Component 
Summary (MCS-12) of the SF-12v2 was not associated with the participant-specific 
overall rating of antihypertensive medication regimens (Table 4-31). However, the 
Physical Component Summary (PCS-12) of the SF-12v2 was positively associated with 
the participant-specific overall rating of antihypertensive medication regimens (p<0.05). 
The higher the participant-specific overall rating of antihypertensive medication 
regimens, the more likely participants will have higher PCS-12 scores (Table 4-32). 
Thus, participants who provided a high overall rating of their antihypertensive medication 
regimens were more likely to have higher physical HRQoL. This indicates that 
participants’ satisfaction with their antihypertensive medication regimens does influence 
their physical HRQoL. Our results are consistent with the findings in the literature, the 
Physical Component Summary (PCS) of the SF-36 was positively correlated with the 
Medication Satisfaction Questionnaire (MSQ) that is used to assess patient satisfaction 
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with their medications (Vernon et al., 2010). Participant satisfaction with physician 
communication was positively correlated with both the physical HRQoL and the overall 
rating of antihypertensive medications (Tables 4-21 and 4-22). Therefore, understanding 
the relationship between patients’ satisfaction with their prescription medications and 
their quality of life may encourage physicians to engage in patient-centered 
communication. 
 
Patient beliefs about medications as well as satisfaction with prescription medications 
have been shown to significantly affect medication adherence (Bharmal et al., 2009; 
Hugon et al., 2014; Sa’ed et al., 2013). However, the relationship between the patients’ 
beliefs about medication and the satisfaction with their prescribed medications has not 
been examined yet. Therefore, we have examined the association between the general 
domain of the Beliefs about Medicines Questionnaire (BMQ) and the participant-specific 
overall rating of antihypertensive medication regimens. The general domain of the BMQ 
consists of two scales: the BMQ-Overuse and the BMQ-Harm. The BMQ-Overuse 
assesses whether the patient believes that prescription medications are overprescribed by 
physicians and overused by patients. The higher the score of the BMQ-Overuse, the more 
likely patients believe that medications are overprescribed and overused, and vice versa. 
On the other hand, the BMQ-Harm assesses whether the patients believe that prescription 
medications are inherently harmful. The higher the BMQ-Harm score, the more likely 
patients believe that prescription medications are harmful, and vice versa (Horne et al., 
1999).  
 
The BMQ-Overuse was not associated with the participants’ overall rating of their 
antihypertensive medication regimens; however, the BMQ-Harm was negatively 
associated with the overall rating of antihypertensive medication regimens (Table 4-22). 
Further, the BMQ-Harm has negatively influenced the overall rating of antihypertensive 
medications, which then positively influenced medication adherence (Figure 4-14). 
Hence, older adults who believe that medications are inherently harmful (i.e., high BMQ-
Harm scores) are less likely to be satisfied with their antihypertensive medication 
regimens (i.e., low overall rating of their antihypertensive medication regimens). 
Moreover, the association between the participants’ overall rating of antihypertensive 
medication regimens and their beliefs about medications was examined in multiple 
regression analyses controlling for the participants’ age, gender, education, race, health 
literacy, marital status, comorbidities, and number of prescription medications. However, 
since we wanted to see whether the participants’ beliefs about medication were affected 
by their satisfaction with the antihypertensive medications; the beliefs about medication 
variables (i.e., BMQ-Harm and BMQ-Overuse) were treated here as dependent variables. 
The participant-specific overall rating of the antihypertensive medication regimen did not 
significantly influence the BMQ-Overuse (p≥0.05) (Table 4-36). However, the 
participant-specific overall rating of the antihypertensive medication regimens did 
negatively influence the BMQ-Harm (p<0.05) (Table 4-37). Thus, the participants’ 
satisfaction with their antihypertensive medication regimens had a positive impact on 
their beliefs about medications. Our results should highlight the importance of choosing 
the right prescription medication for the elderly patients since their medication 
satisfaction influenced both their beliefs about medications as well as their medication 
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adherence. Therefore, effective physician-patient communication should yield positive 
beliefs about medications, better medication satisfaction, and ultimately higher 
medication adherence.  
 
 
5.5  Limitations 
 
We have assessed participants views of online medication rating websites using a new 
developed instrument (i.e., PROMEX). Although, this instrument had an adequate 
internal consistency and high loadings on the construct this tool is intended to assess (i.e., 
value of online medication rating websites to older adults), it has not been validated 
across different patient populations. Furthermore, the participants’ satisfaction with 
antihypertensive medications was assessed using a newly developed tool that has not 
been validated, yet it achieved a high internal consistency reliability (α=0.82). Therefore, 
our findings cannot be generalized to other patient populations due to the aforementioned 
reasons as well as convenience sampling that were used in this study. Further, the 
likelihood of recall bias with respect to the number of prescription medications, name of 
antihypertensive medications, and past medical history is high. Additionally, the 
administered survey consists of a battery of validated questionnaires that requires a 
completion time of at least twenty-five minutes. Hence, it places a significant cognitive 
burden on the respondents particularly with this mode of administration in which the 
respondents has to read, comprehend, recall, and then answer the requested information 
(Bowling, 2005).  Further, the willingness of the respondents to disclose some 
information, which is believed to be sensitive from their own perspective is a common 
limitation in survey research (Bowling, 2005).  For instance, many of the respondents 
refused to answer the question about their estimated annual income even after explaining 
the purpose of this research as well as the anonymity and confidentiality of their 
responses. Thus, we have not controlled for older adults’ annual income in our analyses.  
 
The general domain of the Beliefs about Medicines Questionnaire (BMQ) was used to 
assess participants’ beliefs about medications. Although, research has confirmed a 
significant  association between the general domain of the BMQ and medication 
adherence in general, the specific domain of the BMQ was not included (Horne & 
Weinman, 1999; Sjölander, Eriksson, & Glader, 2013). Among hypertensive participants 
in this study, the general domain of the BMQ has failed to show a consistent association 
with the medication adherence contrary to the specific domain of the BMQ, which 
consistently showed a significant association with medication adherence among this 
patient population (Gatti et al., 2009; Rajpura & Nayak, 2014). In addition, health literacy 
was assessed using a single screening question (Chew et al., 2004). Although, this single 
health literacy-screening question has been validated using both the Test of Functional 
Health Literacy in Adults (TOFHLA) and the Rapid Estimate of Adult Literacy in 
Medicine (REALM) as reference standards, it is not as accurate as these two standard 
tests of health literacy (Wallace et al., 2006).  
 
The utilization of path analyses to examine the relationship between the participants’ 
views of online medication rating websites (i.e., PROMEX) and the participant-reported 
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outcomes (i.e., participant satisfaction with communication, quality of life, beliefs about 
medications, and medication adherence) has several advantages over multiple regressions 
analyses. First, path analysis involves a series of multiple regressions rather than one 
regression. Second, in multiple regression analysis, the relationship between only one 
dependent variable and several independent variables is analyzed; however, no relations 
between the independent variables are analyzed. Nevertheless, in path analysis the 
relationships between the independent variables are analyzed. Therefore, the path 
analysis enables researchers to disentangle complex relationships between multiple 
variables (Streiner, 2005). Further, several hypotheses can be tested by examining both 
the causal (i.e., direct and indirect effects) on as well as the non-causal effects on the 
dependent variables (Lleras, 2005; Nazim & Ahmad). However, the path analysis is not 
limitation-free. The path analysis follows the same theoretical assumptions of the 
multiple regression analyses. Further, the causality in the hypothesized path model is 
recursive (i.e., flows in one direction).  Additionally, the path model has to assume that 
each measured variable is free of measurement errors. These assumptions are difficult to 
meet in social research (Lleras, 2005). Moreover, the path model in this study could not 
explain more than 6% at best of the variance in participants’ views of online medication 
rating websites (i.e., PROMEX). Furthermore, the sample size was another limitation of 
this study. Although, the minimum sample size required for a medium effect size at a 
power=0.80 and α=0.05 was satisfied, the sample size was not large enough to detect 
small sized effects. The sample size of our study is 286, however, the sample size 
required for a power of 0.8 and a small effect size is 757 (J. Cohen, 1992). Finally, this is 
a cross-sectional study where causality cannot be ascertained between HRQoL and 
participants’ views of online medication rating websites as an example; however, we 
clearly can say that there is a significant association between the two that needs to be 
further investigated in better-designed studies such as cohort studies. 
 
 
5.6  Conclusions 
 
In summary, older adults from seven senior centers were surveyed about the 
usefulness of the online medication rating websites in facilitating the communication 
with their physicians using a newly developed questionnaire. Participants with poor 
HRQoL viewed the online medication rating websites more favorably compared to their 
counterparts with good HRQoL. Further, participants with multiple chronic conditions 
had favorable views of the online medication rating websites. Therefore, participants who 
are more likely to take prescription medications favorably viewed the online medication 
rating websites. Moreover, older adults with limited health literacy were more likely to 
view the online medication rating websites more favorably than older adults with good 
health literacy level. Moreover, we have found that participants’ satisfaction with their 
antihypertensive medication regimens was associated with positive participant-reported 
outcomes (i.e., higher physical HRQoL scores, positive beliefs about medications, higher 
satisfaction with physician communication, and better medication adherence).  
 
Older adults’ satisfaction with physician communication was associated with higher 
HRQoL, better medication adherence, positive beliefs about medications, and higher 
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overall rating of antihypertensive medication regimens. Thus, participants with poor 
HRQoL, who were more likely to view the online medication rating websites more 
favorably compared to their counterparts with good of quality of life, were more likely as 
well to have a low level of satisfaction with their physicians’ communication. Further, 
since older adults with poor HRQoL were more likely to have both lower education and 
health literacy, the availability of accessible online health information portrayed in a 
visual and easy to understand language such as the online patient reviews of medications 
may enhance the physician-patient communication, and result in favorable outcomes.  
 
In addition, many older adults feel that their role is marginal in the decision-making 
process. Therefore, many of them expressed their desire to become active partners in the 
health decision-making process together with their physicians (Gladden, 2000). In this 
study, participants who liked to share their health decision with their physicians, were 
more likely to view the online medication rating websites more favorably than their 
counterparts, who liked to either keep their health decision in their own hands or leave it 
to their physicians. Thus, online patient reviews of medications could play a beneficial 
role by empowering older adults to participate actively in decisions related to their health 
care.  
 
Nonetheless, some studies have questioned the integrity of the online health 
information as they frequently contain inaccurate and sometimes misleading information 
(Erdem & Harrison-Walker, 2006). Furthermore, the online health information may strain 
the physician-patient relationship especially when patients think that they know more 
than their physicians or when they ask for a prescription medication and their physicians 
refuse to prescribe it due to valid and clinically sound reasons. Physicians’ concerns 
about the harmful effects of the online health information on the relationship with their 
patients, stems from the fact that they need to spend more time answering and  addressing 
patients’ questions and requests especially if the information that the patients encountered 
online was incorrect or inaccurate (Anderson, Rainey, & Eysenbach, 2003; Erdem & 
Harrison-Walker, 2006). However, most elderly patients like to receive more information 
from their physicians. In addition, elderly patients tend to turn to their physicians as the 
primary source of health information (Campbell & Nolfi, 2005). Further, research has 
shown that each additional minute spent by physicians with their patients during their 
visits is associated with an improvement in patient trust (Fiscella et al., 2004). Therefore, 
physicians’ concern over the possibility of the online health information to have a 
negative impact on the relationship with their patients might be overstated.  
 
Elderly patients are more likely to experience adverse drug events due to their 
diminished physiological reserve (Wasson, 2008). Further, elderly patients are 
underrepresented in most clinical trials that were conducted for the approvals of many 
currently available and widely used drugs (Konrat et al., 2012). Therefore, the creation of 
secure online patient portals by well-known health organizations (i.e., Centers for 
Medicare and Medicaid Services, academic health institutions, Food and Drug 
Administration), where actual patients can share their prescription medication 
experiences with others anonymously, may help in monitoring adverse drug reactions 
among patients in general and the elderly ones in particular. Moreover, the clinical 
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guidelines that are used in the treatment of elderly patients with multiple comorbidities 
have proven ineffective in managing the health conditions of this important segment of 
the patient population (Boyd et al., 2005). Besides the potential role of the online patient 
reviews of medications in the adverse events reporting and post-marketing surveillance, 
they may also help physicians and researchers alike in reviewing the current treatment 
guidelines for elderly patients. Therefore, the roles that online medication-rating websites 
may play in the future might not be limited to enhancing the physician-patient 
communication. 
 
Finally, although the findings of this study suggest that online patient reviews of 
medications may positively influence the patient-physician communication particularly 
among older adults with poor HRQoL, multiple health conditions, lower educations, and 
limited health literacy, the results of this study should be interpreted cautiously due to the 
aforementioned limitations. Future research should examine the impact of the online 
patient reviews of medications as an intervention on physician-patient communication, 
and consequently on other participant-reported outcomes. 
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